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Tick-borne diseases (TBD) are common across the United States and can result in 
critical and chronic disease states in a variety of veterinary patients, specifically 
domesticated dogs. Borreliosis, anaplasmosis, rickettsiosis, ehrlichiosis, and babesiosis 
have been cited as the most common TBDs. Despite recent reports revealing past exposure 
of TBD, there are no molecular epidemiological reports for dogs in Texas. Therefore, data 
to support the level of actively infected dogs in the population is inadequate. Limited 
molecular data for TBDs is due, in part, to the lack of consolidated molecular tools 
available to researchers. Real-time PCR (qPCR) assays are a commonly utilized tool for 
molecular detection of TBDs, and achieve species specificity by assigning each pathogen a 
unique fluorogenic label. However, current limitations of qPCR instruments include 
restricting the number of fluorogenic labels that can be differentiated by the instrument per 
a given reaction. As such, this dissertation explored the development of a qPCR 
methodology, termed layerplexing, that would allow for the simultaneous detection and 
characterization of 11 pathogens responsible for causing common TBDs in domestic dogs. 
Additionally, an endogenous internal positive control was designed and integrated into the 
assay for quality assurance of attained molecular results. Analysis revealed that the 
layerplex assay format was comparable in terms of target sensitivity and specificity to 
other qPCR assays utilized in the field. The layerplex assay was then applied to conducting 
a molecular prevalence investigation of TBDs affecting dogs across Texas ecoregions. By 
conducting molecular prevalence studies for TBDs, updated rates of active exposure and 




indicated molecular prevalence of borrelial, rickettsial, and babesial pathogens varied 
across the Texas study area and indicated specific regions where susceptible hosts may be 
at higher risk for infection with TBD. Furthermore, the layerplex assay lead to the first 
reported molecular detection of Anaplasma platys in Texas and coinfection with Ehrlichia 
canis and A. platys in Texas dogs. Overall, findings from this dissertation provided 
substantial evidence that the layerplex technique can be utilized for grouping multiple 
targets under a single fluorogenic label without impeding diagnostic efficacy. The 
layerplex technique also demonstrated utility in facilitating large scale molecular analyses 
of animals in Texas. Surveillance data obtained from this study may aid public health 
agencies in updating maps depicting high-risk areas of disease and provide baseline data 
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INTRODUCTION AND LITERATURE REVIEW* 
 
Tick-borne diseases affecting dogs 
Tick-borne diseases (TBD) are responsible for significant illnesses in susceptible 
hosts across the United States. Encompassing five major disease groups in the U.S., 
including borreliosis, anaplasmosis, rickettsiosis, ehrlichiosis, and babesiosis, these 
diseases have been reported to the Centers for Disease Control and Prevention (CDC) to 
affect a conservative 48,000 humans every year (Centers for Disease, 2017). At this time, 
however, there are limited epidemiological reports for domestic dogs. Therefore, data to 
support the severity of these diseases within the canine population is inadequate. The most 
prevalent causative agents for the respective canine diseases consist of 11 pathogens of 
bacterial and parasitic origin, as depicted in Table 1-1 and further described below. 
 
Borrelial pathogens 
Borrelial pathogens afflicting dogs are comprised of two groups; those responsible 
for causing Lyme disease (LD) and those residing within the tick-borne relapsing fever 
(TBRF) group. Both groups of spiral-shaped bacteria are responsible for causing 
borreliosis with varying levels of severity. While morphological similarities exist between 
                                                 
* Reprinted with permission from “Novel real-time PCR assays for genomic group identification of tick-
borne relapsing fever species Borrelia hermsii” by Joseph J. Modarelli, Julie Piccione, Pamela J. Ferro, and 
Maria Esteve-Gasent, 2018. Diagnostic Microbiology and Infectious Disease, in press, Copyright 2018 
Elsevier Publications. DOI: 10.1016/j.diagmicrobio.2018.08.001. 
 
* Reprinted with permission from “Molecular identification of Ehrlichia ewingii in a polyarthritic Texas dog” 
by Joseph J. Modarelli, Mindy M. Borst, Julie Piccione, Pamela J. Ferro, and Maria Esteve-Gasent, 2018. 




LD and TBRF, the pathogenesis of disease between the two varies due to phases of 
spirochetemia and bouts of cyclic fever in the latter (Lopez et al., 2016). 
 
Table 1-1. Tick-borne diseases of dogs targeted by this study. 
Disease 
group 
Disease agent Tick vectors Geographical 
distribution† 
Borrelial Borrelia burgdorferi Ixodes scapularis, I. pacificus Northeast, Midwest  
 B. turicatae Ornithodoros turicata South, southeast  
 B. hermsii O. hermsii Western 
 B. parkeri O. parkeri Midwestern 
Rickettsial Ehrlichia canis Rhipicephalus sanguineus Complete 
  Dermacentor variabilis South 
 E. chaffeensis Amblyomma americanum Southeast, southcentral  
 E. ewingii A. americanum Southeast, southcentral  
 Anaplasma phagocytophilum I. scapularis, I. pacificus Northeast, Midwest  
 Rickettsia rickettsii D. variabilis, D. andersoni Southeast, southcentral 
  R. sanguineus, A. cajennense Southeast, southcentral 
Babesial Babesia gibsoni R. sanguineus Complete 
 B. canis vogeli R. sanguineus Complete 
† Geographical distribution within the United States. 
 
Borreliosis 
Lyme disease is caused by Borrelia burgdorferi and is transmitted to the canine 
host by the bite of an infected tick. In the U.S., LD is credited with being the most 
prevalent human tick-borne illness with more than 30,000 annual cases reported to the 
CDC (Centers for Disease, 2017). However, recent studies propose that the true number of 
infections is 10-fold greater than what has been reported in the U.S. alone (Kuehn, 2013). 
While national surveillance data does not currently exist for dog cases, the prevalence of 
LD within the human population alone can be appreciated. 
The most common competent tick vectors for LD in the U.S. include Ixodes 
scapularis and Ixodes pacificus, also known as the deer/blacklegged tick or the western-




(e.g. raccoons and deer) are common hosts for I. scapularis. Other animals, including 
humans and dogs, can act as incidental hosts for the ticks, and may subsequently contract 
the disease if adequately exposed (Littman et al., 2018). Lyme disease is comprised of a 
large system of species, also known as the Borrelia burgdorferi sensu lato (sl) complex. At 
this time, there are approximately 20 species known to cause LD, many of which circulate 
within the U.S.; although it is not fully understood if all species within this group are 
known to establish an infection in dogs (Becker et al., 2016). 
In dogs, clinical signs for LD may be associated with stiffness, lameness, swollen 
joints, inappetence, pyrexia, and fatigue, and are generally considered nonspecific due to 
resembling other tick-borne infections (e.g. flu-like presentation); though the complete lack 
of signs in dogs indicating serological exposure is also common (Littman et al., 2018). If 
an infection occurs, a dog may not show signs until several months after initial infection. If 
left unmanaged, LD may progress to the chronic stage which may result in permanently 
affected skin, joints and nervous system (Littman et al., 2018). Though a characteristic 
rash, known as an erythema migrans, is commonly associated with LD, the ability to 
reliably detect the rash on a non-human animal (e.g. domestic dog) is limited and can result 
in misdiagnosis if the presence of a rash is used as the sole means for differential diagnosis 
(Skotarczak, 2014). 
Reliable diagnostic detection of LD in an affected host is complicated and 
controversial. Though there have been numerous diagnostic assays developed for a variety 
of platforms (e.g. an indirect immunofluorescence assay [IFA], western blots, IDEXX 
SNAP® 4Dx® Plus, polymerase chain reaction [PCR], culture, etc.), few are endorsed for 




diagnosing LD in humans; consisting of first round testing with either an enzyme 
immunoassay (EIA) or an IFA, followed by a Western blot test if a positive was revealed 
in the first round. Similar recommendations exist for dogs (Littman et al., 2018), however, 
veterinary practitioners are not required to follow these guidelines before administering 
treatment. Another diagnostic procedure for detecting LD include bacterial culturing, but is 
not regularly utilized due to being time consuming and expensive (Babady et al., 2008). 
Molecular testing with real-time polymerase chain reaction (qPCR) assays are 
common within the literature, consisting of both singleplex and multiplex assays (Primus 
et al., 2018). Popular gene targets, for example, include 23S rRNA (Courtney et al., 2004), 
flagellar filament cap (filD) (Hojgaard et al., 2014), outer surface protein A (ospA) (Ivacic 
et al., 2007), hbb (encodes a member of histone-like proteins) (Portnoi et al., 2006), and 
flagellin (flaB) (Scott et al., 2016). All genes have proven to be highly specific and 
sensitive as targets for qPCR detection, though the conservation of flaB across the Borrelia 
genus has resulted in increased difficulties when ascertaining a specific species (Wodecka, 
2011). Due to increased importance of LD in human health, few assays have been 
specifically designed for use in a dog model. However, most aforementioned qPCR assays 
can be adapted for use with dogs if properly validated. 
It is important to note that the main limitation of molecular diagnostics for LD is 
the limited spirochetemic stage of pathogenesis. During the acute phase of infection low 
numbers of LD related spirochetes circulate in the blood, and quickly penetrate endothelial 
cells as the infection persists (Coburn et al., 2013). Molecular tools, such as qPCR, may 
only be valuable in detecting infection during the acute stages, therefore reducing the 




molecular detection of LD in blood is considered rare and generally inadvisable, recent 
studies have documented a low percentage of detection of the spirochete in blood samples 
(Primus et al., 2018). As the practicality of molecular methodologies in diagnosing LD 
reliably in noninvasive sample types (e.g. blood vs. tissue biopsies) is restricted, 
serological assays remain the “gold standard” to achieve diagnosis. However, screening 
ticks collected from a potentially infected patient, in contrast to a blood sample, may prove 
efficacious when utilizing molecular assays. 
The other group of species responsible for borreliosis in the U.S. are identified as 
TBRF species, and have been noted as an emerging infectious disease to both animals and 
humans (Lopez et al., 2016). TBRF is a zoonotic blood-borne disease endemic throughout 
many regions of the world (Lopez et al., 2016, Talagrand-Reboul et al., 2018). Species 
responsible for causing TBRF in North America include B. hermsii, B. turicatae, and B. 
parkeri, though the later has not been found to play a major role in reported infections 
(Dworkin et al., 2008). Each of these three species of Borrelia are transmitted through a 
soft tick vector including Ornithodoros hermsi, O. turicata, and O. parkeri, respectively. 
Human infections with TBRF are caused by B. hermsii and B. turicatae, with the majority 
of cases reported in the western United States and associated with B. hermsii. Although 
there is limited documentation of TBRF in dogs, most reports indicate infection with B. 
turicatae (Esteve-Gasent et al., 2017, Piccione et al., 2016, Whitney et al., 2007), with a 
more recent case study identifying B. hermsii (Kelly et al., 2014). 
TBRF infections are hypothesized to be underreported for several reasons, one of 
which is current diagnostics are confounded by genetically similar organisms such as 




Kelly et al., 2014, Piccione et al., 2016). Furthermore, signs and symptoms associated with 
TBRF during febrile states can be similar to LD and most other tick-borne diseases during 
initial stages of infection (i.e. flu-like illness) or when a readily identifiable rash is 
overlooked (Dworkin et al., 2008, Little et al., 2010a, Stanek et al., 2012). However, TBRF 
is only detectable during limited stages, denoted as “relapses”, which may further 
complicate an accurate diagnosis by limiting the window in which a presentation can be 
evaluated (Talagrand-Reboul et al., 2018). Currently, the most reliable method of TBRF 
diagnosis is the observation of spirochetemia through blood smear examination (Esteve-
Gasent et al., 2017). While this diagnostic method is highly specific to TBRF Borrelia 
species, there is currently limited documentation to support microscopic detection during 
non-spirochetemic phases of infection (Piccione et al., 2016). 
Borrelia species responsible for TBRF in susceptible hosts generally display a 
cyclic form of clinical manifestation, hence the name relapsing fever (Dworkin et al., 
2008). In humans, the febrile stage of TBRF persists for roughly three to four days and is 
associated with spirochetemia (Lopez et al., 2016). The bacteria are then systematically 
targeted for elimination by the host immune system, and the host becomes asymptomatic 
for an afebrile stage that lasts roughly seven to ten days (Lopez et al., 2016). Similar to 
LD, TBRF spirochetes utilize antigenic variation during this stage to alter outer surface 
proteins, allowing a population minority to escape from immune system detection and a 
subsequent relapse to occur within the host (Dworkin et al., 2008). 
Interestingly, the TBRF species B. hermsii has been noted to diverge into two 
genetically distinct genomic groups (GG), denoted as GGI and GGII (Schwan et al., 2007). 




human/animal host uniquely, but a recent study has suggested potentially distinctive modes 
of virulence associated with the two genomic groups in a pine squirrel model (Johnson et 
al., 2016). Further characterization of these genomic groups within affected hosts will 
provide insight into the plausibility of genomic group-dependent virulence and 
pathogenicity. The two genomic groups of B. hermsii have also indicated a potentially 
unique geographic distribution in a study limited to infected humans, chipmunks, and 
Ornithodoros hermsi ticks, sampled in the Western United States (Schwan et al., 2007). 
While preliminary, the isolates belonging to GGII were found to mostly cluster in 
northwestern regions while GGI isolates depicted a grouping pattern in both northwestern 
and southwestern regions. It is hypothesized that infected migratory birds may be 
responsible, at least in part, for the geographic distribution of B. hermsii genomic groups 
(Schwan et al., 2007). Further, B. hermsii is predicted to continue migrating, and may 
reach as far south as Texas (Sage et al., 2017). 
Because of the genetic similarities between B. hermsii GGI and GGII, molecular 
detection in research laboratories has been primarily limited to multiple gene specific 
conventional PCR assays with GG identification via sequencing (Policastro et al., 2013). 
While this approach has proven to be mostly effective, it is time consuming, expensive, 
and heavily dependent on sample availability. Reliance on the multilocus sequence typing 
(MLST) method to identify GGs may inhibit future studies aiming to rapidly screen a 
collection of samples, or perform further downstream applications. As TBRF causing 
species are closely related to agents of LD borreliosis, PCR assays that target conserved 




fashion to the cross-reactivity seen on serologic platforms (Esteve-Gasent et al., 2017, 
Piccione et al., 2016). 
While alternative genes limited to TBRF species, such as the Borrelia 
immunogenic protein A (bipA) (Lopez et al., 2010) and the glycerophosphodiester 
phosphodiesterase gene (glpQ) (Schwan et al., 1996), might be more apt targets for qPCR 
development, TBRF species discrimination may prove unsuccessful due to genetic 
conservation between closely related species. Recently limited analysis of a hypothetical 
protein within the bh0260 open reading frame conducted in a previous study has shown 
potential (Policastro et al., 2013). 
Furthermore, studies have not reached a consensus on whether TBRF spirochetes 
can be regularly detected by qPCR methodology through all stages of disease (Lopez et al., 
2014). Due to a cyclic form of clinical manifestation that result in limited spirochetemic 
phases that correlate with febrile states, further studies are needed to determine if 
molecular tools are sufficient in accurately and reliably detecting TBRF species infections. 
 
Rickettsial pathogens 
Rickettsial pathogens of zoonotic importance are represented by three closely 
related genera within the order Rickettsiales: Anaplasma, Ehrlichia, and Rickettsia 
(Renvoise et al., 2011). These genera are responsible for causing rickettsiosis, and 
ehrlichiosis/anaplasmosis, and reside within the families of Rickettsiaceae and 
Anaplasmataceae, respectively. The bacterial species within the rickettsial group are 






Anaplasmosis in dogs is primarily caused by the species Anaplasma 
phagocytophilum and A. platys, while the latter has limited documentation in dogs of 
Texas (Little, 2010). Both pathogens are gram-negative cocci bacteria known for forming 
cellular inclusions, or morulae, in an infected host. Infection with A. phagocytophilum 
causes canine or human granulocytic anaplasmosis (CGA or HGA) by parasitizing 
circulating monocytes (Carrade et al., 2009). In contrast, A. platys targets circulating 
platelets of dogs, and is commonly referred to as infectious canine cyclic 
thrombocytopenia (ICCT) (De Tommasi et al., 2014). Traditionally, A. phagocytophilum 
was considered the only zoonotic cause of anaplasmosis; however, a recent study has 
highlighted the potential for A. platys to emerge as a potential threat to human health 
(Maggi et al., 2013). 
The blacklegged tick and the western-blacklegged tick, as with LD, are also 
responsible for transmitting A. phagocytophilum to susceptible hosts (Woldehiwet, 2010). 
Potential reservoir species in North America include a variety of mammals, including 
rodents, deer, and some birds (Little, 2010). Dog and human exposure to A. 
phagocytophilum is generally highest in the northeast and the west coast of the U.S., and 
correlates with regions featuring the highest activity of the tick vectors. In respect to A. 
platys, the role of a specific tick vector is currently not fully understood. Recent reports 
have reported amplifying A. platys from R. sanguineus sensu lato ticks, however, the 
vector competency of this tick still needs to be further verified (Inokuma et al., 2000, 




nor Sanogo et al. have detected A. platys in U.S. ticks, and therefore, remains vector 
elusive within the U.S. 
Anaplasmosis in dogs due to A. phagocytophilum regularly presents with pyrexia, 
lethargy, and anorexia. Interestingly, it is reported that roughly 60% of dogs that indicate 
exposure to A. phagocytophilum serologically remain asymptomatic (Little, 2010). If left 
untreated, severe disease may arise from increased susceptibility to secondary 
opportunistic infections for the patient (Chan et al., 2013). It is important to note that both 
B. burgdorferi and A. phagocytophilum are transmitted by the same tick species, and 
therefore, coinfections in endemic areas of the country are possible. 
Infection with A. platys is generally considered less severe, and presents with 
recurrent thrombocytopenia that typically resolves without treatment (Little, 2010). 
However, coinfections with A. platys in dogs may complicate disease progression and alter 
prognosis. Studies have documented infection with Ehrlichia canis, alongside A. platys, to 
be a typical coinfection found in dogs (Ybanez et al., 2012). Further, these pathogens may 
circulate together in nature due to a shared tick vector, the brown dog tick. Interestingly, 
despite containing the appropriate tick vectors, competent reservoir hosts, and a naïve 
population of susceptible dogs, neither A. phagocytophilum nor A. platys have been 
detected in Texas dogs outside of seroprevalence indicators. 
Diagnosis of anaplasmosis in infected dogs generally begins with a clinical 
evaluation for a febrile state, or a noted history of tick exposure. A complete blood count 
(CBC) work up on the dog with anaplasmosis may reveal thrombocytopenia and other 
abnormalities, but can resemble other tick-borne infections at this stage of infection (Little, 




testing (e.g. IDEXX SNAP® 4Dx® Plus Test), or serological (e.g. IFA) and molecular 
assays (e.g. PCR) are more specific, and therefore recommended. It should be noted that 
diagnosis may be achieved more efficiently if both molecular and serological tools are 
utilized concurrently (Little, 2010). However, limitations in sensitivity and specificity 
featured across diagnostic modalities may result in inaccurate diagnosis or incomplete 
prevalence studies. Of note, limitations consist of cross-reactions and cross-amplifications 
across serological and molecular assays, respectively (Little, 2010). In these instances, if 
another closely related species is reported in place of anaplasmosis, treatment times may be 
altered and current disease prevalence maps may accumulate inconsistencies. Further, the 
IDEXX SNAP® 4Dx® Plus Test reports findings at the Anaplasma genus level, and 
therefore cannot be utilized for determining a species-specific differential diagnosis 
(IDEXX, 2016). 
In respect to molecular diagnostics, PCR assays are generally designed to amplify 
conserved genes within the respective species’ genomes. The major surface protein 2 
(msp2) of A. phagocytophilum has been shown to be relatively species specific, though 
orthologs have been discovered in closely related Anaplasma spp. (Lin et al., 2004, Sarkar 
et al., 2008). Few molecular diagnostic assays have been developed in respect to A. platys 
and are generally limited to detecting the 23S rRNA gene (Dahmani et al., 2015). A popular 
gene for molecular targeting both Anaplasma spp. is the 16S rRNA gene (Huber et al., 
2017). However, careful consideration must be applied when designing an assay for 
detecting this target due to the close genetic similarity of the 16S rRNA gene shared across 






Within the rickettsiosis disease group, Rocky Mountain spotted fever (RMSF) has 
been reported to be of most concern to canine health (Chomel, 2011). RMSF is caused by 
the gram-negative intracellular pleomorphic bacterial pathogen Rickettsia rickettsii, and is 
transmitted by several tick vectors. Vectors include the American dog tick (Dermacentor 
variabilis), the Rocky Mountain wood tick (D. andersoni), the brown dog tick 
(Rhipicephalus sanguineus), and the cayenne tick (Amblyomma cajennense), all of which 
are found in the U.S. and the transboundary regions with Mexico (Labruna et al., 2011). Of 
note, within transboundary U.S. and Mexican states, prevalence rates of RMSF closely 
correlate with the presence of brown dog ticks on dogs, and therefore potentially represent 
the primary vector in the regions (Alvarez-Hernandez, 2010, Tinoco-Gracia et al., 2018). 
Dogs are highly susceptible to RMSF, and present with similar signs as with 
ehrlichiosis, though in a more advanced form. In addition to typical CBC abnormalities, 
dogs will also present with petechial hemorrhaging due to the bacterium invading 
endothelial cells, as well as advanced neurological signs (Allison and Little, 2013). A rash 
has been known to develop in conjunction with infection, but is not reliable in all cases as 
the rash is short lived and even absent for many canine, and human, patients (Chapman et 
al., 2006). 
It is important to note that R. rickettsii is one species within a larger complex of 
Rickettsia species known as spotted fever group rickettsioses (SFGR). Within the U.S., 
three additional diseases caused by SFGR species have been identified, including 
Rickettsia parkeri rickettsiosis, Pacific Coast tick fever caused by R. philipii (formerly 




Fryxell et al., 2015). Tick vectors for each SFGR species varies slightly, ranging from the 
Gulf Coast tick (Amblyomma maculatum) for R. parkeri (Trout Fryxell et al., 2015), and 
the Pacific Coast tick (Dermacentor occidentalis) for R. philipii (Eremeeva et al., 2018). 
Interestingly, R. akari is not tick-borne but instead spreads through infected mouse-mites 
(Liponyssoides sanguineus) (Zavala-Castro et al., 2009). Of note, all species represented 
within the SFGR in the U.S. have demonstrated zoonotic potential by causing disease in 
humans and dogs (Dall'Agnol et al., 2018, Tomassone et al., 2018). 
In addition, there are also numerous non-pathogenic forms of Rickettsia, R. 
montanensis for example (Uchiyama et al., 2012). These species can persist in canine 
species without causing adverse effects unlike the closely related RMSF causing R. 
rickettsii. Furthermore, these species are genetically similar across numerous genes 
commonly targeted by qPCR assays, and thus potentially result in false positive results 
during general epidemiological screenings of ticks or dogs (Raoult and Parola, 2008). In 
respect to qPCR assay development for differentiating R. rickettsii, popular targets consist 
of the genes encoding the citrate synthase (gltA), rickettsial outer-membrane protein A and 
B (rOmpA, rOmpB), and the 17 kD antigen protein (Kato et al., 2013, Trout Fryxell et al., 
2015). However, these genes are not limited to R. rickettsii and depict high conservation in 
respect to other pathogenic and non-pathogenic rickettsial species. Recently, a gene 
encoding a hypothetical protein (A1G_04230) called rrhyp has revealed high specificity to 
R. rickettsii alone, and may be an apt target for qPCR development (Kato et al., 2013). As 
is the case with B. burgdorferi, R. rickettsii circulates within the blood stream in low 




persists (Kidd et al., 2008). Therefore, molecular techniques may be restricted in detecting 
R. rickettsii during all phases of infection. 
 
Ehrlichiosis 
Ehrlichiosis in dogs is caused by three species within the genus Ehrlichia: E. canis, 
E. chaffeensis, and E. ewingii; and can present with a variety of clinical signs, such as 
lethargy, anorexia, evidence of bleeding, and polyarthritis (Neer et al., 2002). A recent 
species addition to the Ehrlichia genus, known as E. minasensis, has also been suggested 
to cause canine ehrlichiosis, though, its pathogenesis is currently not fully understood 
(Thomson et al., 2018). While treatment is similar, clinical pathology findings can vary 
dramatically between dogs with ehrlichiosis; though, thrombocytopenia and mild anemia 
are common findings, but not definitive (Gieg et al., 2009, Neer et al., 2002). Additional 
recognized species within the Ehrlichia genus, including E. muris and E. ruminantium, are 
currently only of major concern to humans and agriculture animals, respectively (Snowden 
and Simonsen, 2018). However, a recent report has proposed that E. muris may be 
emerging as a threat to canine health (Hegarty et al., 2012). 
The brown dog tick, Rhipicephalus sanguineus, has also been documented as a 
competent vector for transmitting Ehrlichia canis to canine hosts, and in some instances to 
humans (Maeda et al., 1987, Perez et al., 2006). Though the brown dog tick is understood 
to be the most common vector of E. canis, the American wood tick (Dermacentor 
variabilis) has also been reported to competently transmit the pathogen (Chomel, 2011). 
The urban cycle of E. canis is dependent on maintenance within the brown dog tick and its 




ticks’ ability to thrive in domestic home and kennel habitats, along with its ability to 
reservoir E. canis through transovarial and transstadial passages, a tick infested 
environment is sufficient in maintaining a competent infection source of E. canis within 
the environment (Dantas-Torres, 2008). 
Infection with E. canis causes canine monocytic ehrlichiosis (CME) or human 
monocytic ehrlichiosis (HME) by parasitizing circulating monocytes (Harrus et al., 1999). 
CME is an important veterinary pathogen due to its worldwide distribution and severe 
clinical outcomes (Harrus and Waner, 2011). Generally, CME progresses through three 
phases of disease, acute, subclinical, and chronic. Within the acute phase, a majority of 
signs associated with infection closely resemble those seen in anaplasmosis, including 
pyrexia, anemia, dysthymia, lethargy, and inappetence (Harrus and Waner, 2011). 
Additional signs including nasal or ocular discharge may also be noted, as well as a range 
of neurological manifestations (Komnenou et al., 2007). The disease may also enter the 
subclinical phase where, as the name suggests, signs of infection may not be apparent 
(Waner et al., 1997). If an established infection with CME remains undiagnosed, or its 
treatment mismanaged, the disease may reach the chronic phase, where prognosis is poor 
(Mylonakis et al., 2004). As with B. burgdorferi and A. phagocytophilum, coinfections are 
common since the same tick vector can transmit both RMSF and CME/HME pathogens 
(Kordick et al., 1999). Further, E. canis has been documented to circulate alongside other 
tick-borne pathogens such as Hepatozoon canis, and Babesia canis vogeli, again due to a 
shared vector (Gal et al., 2007). In the case of coinfections, disease prognosis becomes 




Ehrlichia chaffeensis, a close relative to E. canis both in family relation and clinical 
presentation, is credited with being one of the main causes of HME in humans (Rikihisa, 
2015). However, recent studies have revealed the ability of E. chaffeensis to colonize dogs 
in addition to humans and depict the seroprevalence of E. chaffeensis in North American 
dogs (Beall et al., 2012, Nair et al., 2016). Therefore, E. chaffeensis should not be omitted 
when determining a differential diagnosis for a dog presenting with signs resembling 
ehrlichiosis. E. chaffeensis is primarily transmitted to a dog/human host by the bite of an 
infected lone star tick (Amblyomma americanum) in the U.S. (Heitman, 2016). E. 
chaffeensis, in contrast to E. canis, is maintained in nature by a sylvatic cycle involving 
lone star ticks and the primary reservoir host, white-tailed deer (Yabsley, 2010). In 
addition, while Rhipicephalus sanguineus is the primary vector for E. canis, studies have 
suggested that this tick can also be a vector for E. chaffeensis (Koh et al., 2016). 
E. ewingii is responsible for causing canine or human granulocytic ehrlichiosis 
(CGE or CHE, respectively) by forming characteristic morulae within circulating 
granulocytes. Like E. chaffeensis, E. ewingii is generally transmitted by the lone star tick 
(Amblyomma americanum), which currently remains the only proven competent vector 
(Gieg et al., 2009, Heitman, 2016). Recently, the tick species A. inornatum has also been 
identified as infected with E. ewingii, though further studies would need to be conducted to 
definitively prove the vector competency of the tick species (Medlin et al., 2015). In Texas, 
both species of opportunistic feeding ticks have been identified harboring E. ewingii (Long 
et al., 2004, Medlin et al., 2015). It has been accepted that E. ewingii is a zoonotic 
pathogen initially recognized as a distinct etiological agent of dogs in 1992 and later of 




ewingii infections in humans in 2008; however, the majority of ehrlichiosis cases are 
reported as E. chaffeensis despite the potential that a proportion of cases currently reported 
may be miscategorized (Harris et al., 2016). Furthermore, a recent study indicated E. 
ewingii infections may have been underreported in humans in the United States by as much 
as 7.0% due to limited molecular testing, nonspecific serological tests, and disease 
treatment prior to etiologic diagnosis (Harris et al., 2016). Clinical presentations of CGE 
are similar to other Ehrlichia species but are noted as generally less severe in comparison. 
However, E. ewingii infections in dogs are more likely to be associated with polyarthritis 
than other species of Ehrlichia (Gieg et al., 2009, Neer et al., 2002). Therefore, E. ewingii 
should be considered in the differential diagnosis of dogs suspected of having 
polyarthropathy. 
In Texas, ehrlichiosis is primarily associated with E. chaffeensis in humans and E. 
canis in dogs with seroprevalence rates of 3.8% and 2.0%, respectively (Beall et al., 2012, 
Harris et al., 2016). Although E. ewingii has not been detected in Texas in recent reviews 
of human ehrlichiosis prevalence, this organism has been reported serologically in Texas 
dogs, which have been implicated as effective sentinels (Beall et al., 2012, Harris et al., 
2016, Heitman, 2016). Further, all three Ehrlichia spp. have an established serological and 
molecular presence in dogs as shown in prevalence studies of states neighboring Texas, 
such as Oklahoma and Arkansas (Beall et al., 2012, Little et al., 2010b). A concern 
remains, however, regarding the detection specificity of serologic assays between other 
species of Ehrlichia, which may lead to pathogen misclassification (Harris et al., 2016). 




tools when conducting Ehrlichia species seroprevalence studies on canines (Qurollo et al., 
2014). 
Difficulties in diagnosing specific Ehrlichia species are due in part to limitations of 
current screening methods. The popular IDEXX SNAP® 4Dx® Plus test utilized by 
veterinarians advertises detection of antibodies for E. canis in addition to other unrelated 
vector-borne infections (Dirofilaria immitis, Borrelia burgdorferi, and Anaplasma spp.). 
However, as stated in a peer reviewed IDEXX publication, this test will also detect 
antibodies recognizing E. ewingii and E. chaffeensis antigens, thus true Ehrlichia species 
identification through this system may not be achievable (IDEXX, 2016). Additionally, in 
serologic techniques utilized by diagnostic laboratories, antibodies against E. ewingii may 
cross-react with targets intended for E. canis, E. chaffeensis, and A. phagocytophilum, thus 
leading to further misclassifications of ehrlichiosis (Harris et al., 2016, Modarelli et al., In 
press, Rodgers et al., 1989). 
While the morulae formed by E. canis and E. chaffeensis are generally found 
within monocytes, those formed by E. ewingii are most commonly observed within 
neutrophils. In addition, the morulae of E. ewingii appear identical morphologically to A. 
phagocytophilum, thus confounding microscopic discrimination between the two agents. It 
was not until the advent of molecular diagnostics that it became conceivable to definitively 
identify between the Ehrlichia species, and to provide an accurate prevalence study of the 
organism within host populations (Buller et al., 1999). Currently, molecular analysis 
through PCR techniques are considered the most sensitive and specific method in 




These three species of Ehrlichia are of specific interest to the public health field 
due to potential zoonotic implications, but remain diagnostically problematic due to the 
conservation observed within the genomes featured across the genus. This lack of 
differentiation between species has resulted in current published qPCR assays unable to 
discriminate specific species at the molecular level, due to targeting the conserved 16S 
rRNA gene (Peleg et al., 2010), or more recently, the citrate synthase (gltA) and heat-shock 
operon (groEL) genes (Ybanez et al., 2012). The scientific importance of differentiating 
these particular species is two-fold, diagnostic applications as well as species level 
surveillance. By monitoring the progression of E. canis, E. chaffeensis, and E. ewingii 
infections within canine hosts, researchers can begin to predict the spillover of the diseases 
into other species’ niches. Although colonization of E. canis in humans and E. chaffeensis 
in canines is generally considered rare, an increased occurrence of these events should alert 
practitioners as the diseases may be adapting new phenotypic traits that could negatively 
affect a broader range of hosts. 
 
Babesial pathogens 
Canine babesiosis is caused by piroplasmic pathogens characterized by 
intraerythrocytic inclusions and a parasitic life cycle that induces hemolytic anemia within 
infected dogs. Within the U.S., four species of Babesia: B. gibsoni, B. canis vogeli, B. 
conradae, and Babesia spp. coco (also known as NC Babesia), are responsible for the 
majority of babesiosis infections in domesticated dogs (Shock et al., 2014). 
Morphologically, these organisms are often referred to as large (B. canis vogeli, NC 




While all aforementioned species can cause severe infection is dogs, currently only B. 
gibsoni and B. canis vogeli are of most concern in the veterinary field (Sudhakara Reddy et 
al., 2016). 
Clinically, canine babesiosis can be significant, but are especially variable 
(Sudhakara Reddy et al., 2016). Generally, infected dogs present as pyrexic and anemic, 
though, advanced forms of disease can also result in organ failure. In most cases, pear-
shaped piroplasms can be viewed within the erythrocytes, though it is unclear if the 
parasite can be viewed microscopically through all phases of pathogenesis within a host 
(Homer et al., 2000). 
While current studies have not confirmed a tick vector for all four pathogens 
causing canine babesiosis within the U.S., several tick species have been strongly 
suspected to play a role in their transmission to canines, such as Ixodid ticks. The ticks 
Haemaphysalis longicornis and Haemaphysalis bispinosa are potential vectors of 
babesiosis as shown in other countries, but have not been identified in the U.S. 
(Birkenheuer et al., 2005). Studies have reported R. sanguineus to be a competent vector 
for B. gibsoni and B. canis vogeli within the U.S.; however, this mode of transmission has 
not been definitively proven (Chomel, 2011, Jongejan et al., 2018). In addition, NC 
Babesia has been detected within A. americanum in several U.S. states, and D. variabilis is 
also a strongly suspected vector of the pathogen (Shock et al., 2014). Further, a competent 
tick vector for B. conradae has not yet been identified, though a recent study reported 





In addition to transmission by ticks, an alternate route of babesiosis transmission to 
canines by direct contact (e.g. fighting) has been proposed (Jefferies et al., 2007), and 
evidence supporting the hypothesis has been documented (Cannon et al., 2016). Studies 
have identified B. gibsoni as a prominent pathogen found in dogs associated with 
dogfighting operations, but other pathogens responsible for causing babesiosis should not 
be ruled out (Cannon et al., 2016, Yeagley et al., 2009). Of note, pit bull-type dogs rescued 
from various dogfighting operations have revealed the presence of B. gibsoni at 33.8% 
(Yeagley et al., 2009), and 39.0% (Cannon et al., 2016) within the dogs, and later 
suggested that further infection transmissions are possible as these fighting dogs are 
reintegrated into the general canine population. Interestingly, Yeagley et al. also reported 
that dogs with indications of fighting, such as scars on the body, were 5.5 times more 
likely to be infected with B. gibsoni than dogs presenting without scars. It should be made 
clear, however, that Babesia species responsible for causing canine babesiosis are not of 
zoonotic concern by either tick or direct blood transmission routes. 
Diagnostic detection of babesiosis is relatively straight forward, and can consist of 
a variety of assay types (e.g. serological, culturing, molecular, blood smear evaluation, 
etc.) (Kubelova et al., 2013). Like many other tick-borne diseases, cross-reactivity can 
occur between species when utilizing serological techniques, limiting species specific 
identification in some cases (Kubelova et al., 2013). Culturing Babesia species from a 
potentially infected host can be achieved but is generally not utilized in veterinary 
diagnostic laboratories due to the extensive training and length of time required to 
successfully propagate the organism (Schuster, 2002). Microscopic detection of the 




routinely performed during clinical presentations or CBCs. However, morphological 
similarities within respective large (B. canis vogeli, NC Babesia) and small (B. gibsoni, B. 
conradae) Babesia groups may render species specific identification impossible. 
Molecular methodologies for detecting the parasite within an infected dog has proven to be 
very successful, even when the organism is not present on blood smear review (Teal et al., 
2012). Frequently utilized targets for qPCR assays consist of the following genes: heat 
shock protein 70 (hsp70), beta-tubulin, two internal transcribed spacers (ITS1 and ITS2), 
and thrombospondin related adhesive protein (P18); though the 18S rRNA gene is by far 
the most documented target (Rozej-Bielicka et al., 2017). 
 
Prevalence of tick-borne pathogens within Texas dogs 
Few molecular prevalence studies concerning TBDs have been conducted in the 
U.S., including limited surveillance of dogs residing in Minnesota (Beall et al., 2008) and 
Oklahoma (Little et al., 2010b), but none within Texas. Instead, the majority of TBD 
prevalence studies in the U.S. have been limited to molecular detection in humans (Harris 
et al., 2016, Heitman, 2016), or serological analyses in dogs (Beall et al., 2012, Bowman et 
al., 2009, Esteve-Gasent et al., 2017, Little et al., 2014, Little et al., 2010b, Qurollo et al., 
2014). Thus, the majority of surveillance investigations for the aforementioned tick-borne 
pathogens that affect Texas dogs are currently limited to brief seroprevalence studies and 
summary reports generated by IDEXX Laboratories. 
Seroprevalence studies in dogs are generally conducted with species or genus 
specific IFA assays, and therefore, indicate past or recent exposure to pathogen(s) by 




generally target specific, there are documented concerns with specificity when applying the 
tools to characterizing infections by tick-borne pathogens (Harrus and Waner, 2011, 
Kamani et al., 2013, Piccione et al., 2016). Therefore, seroprevalence studies should be 
interpreted as baseline for findings and used alongside additional surveillance tools in 
order to determine true prevalence of a specific pathogen(s) in an area of interest. 
The consensus from these reports indicated an approximate tick-borne pathogen 
seroprevalence ranging from 0.2 - 2.0% across Texas (Table 1-2) (Beall et al., 2012, 
Esteve-Gasent et al., 2017, Qurollo et al., 2014). In addition, over the last 5 years IDEXX 
laboratories has documented 11,406 cases of ehrlichiosis, 5,040 of anaplasmosis, and 
2,705 of Lyme disease in dogs from the state of Texas (http://www.dogsandticks.com, 
accessed July 2018). It is important to note, however, that prevalence data for many 
species within each genera (i.e. Borrelia hermsii, B. parkeri, Rickettsia rickettsii, Babesia 
gibsoni, B. canis vogeli) is not currently available due to lack of appropriate screening for 
the respective pathogens. Furthermore, IDEXX data reports are limited to indicating 
exposure at the genus level (Ehrlichia, Anaplasma), and for Lyme disease (Borrelia 
burgdorferi sensu lato) infections, and therefore, are not fully representative of exposure to 
specific species. While the available seroprevalence information is beneficial in providing 
preliminary analysis of dog exposure to various TBDs, the data also brings attention to the 
gaps in knowledge concerning the prevalence of other species also responsible for causing 
disease. 
Although there is seroprevalence documentation of TBDs in Texas dogs, little is 
known about the prevalence of actively infected dogs. Molecular prevalence studies, in 




animal, and therefore, may reveal active infections. Documenting active tick-borne 
infections by molecular analysis may provide updated rates of active exposure within an 
area and indicate specific regions that may contain sentinels of disease. However, it should 
be noted that molecular analysis of an area should be used in conjunction with 
seroprevalence studies to fully characterize the true prevalence, as discussed in more detail 
below. In that respect, serological tools highlight areas that have experienced infection in 
the past, while molecular tools indicate areas currently, or potentially, infected. Together, 




Table 1-2. Documented prevalence of common tick-borne pathogens of dogs in Texas. 
Disease 
group 





Borrelial Borrelia burgdorferi 1.7%* NA (Esteve-Gasent et al., 2017, 
Qurollo et al., 2014) 
 B. turicatae 2.0% NA (Esteve-Gasent et al., 2017) 
 B. hermsii NA NA NA 
 B. parkeri NA NA NA 
Rickettsial Ehrlichia canis 2.6%* NA (Beall et al., 2012, Qurollo et 
al., 2014) 
 E. chaffeensis 0.6%* NA (Beall et al., 2012, Qurollo et 
al., 2014) 
 E. ewingii 0.2%* NA (Beall et al., 2012, Qurollo et 
al., 2014) 
 Anaplasma phagocytophilum 2.2% NA (Qurollo et al., 2014) 
 Rickettsia rickettsii NA NA NA 
Babesial Babesia gibsoni NA NA NA 
 B. canis vogeli NA NA NA 




For example, specific species of concern to canine health, such as Ehrlichia ewingii 
or Anaplasma phagocytophilum, have been documented serologically in Texas dogs, but 




pathogen in an area may indicate true prevalence, concurrent molecular detection of the 
same pathogen will provide more confidence in the findings due to potential cross-
reactivity of the former. Further, species such as Borrelia hermsii and B. parkeri have not 
been detected either serologically or molecularly in Texas dogs. However, recent studies 
have predicted that the tick vectors for the respective pathogens are migrating south and 
may eventually reach Texas (Sage et al., 2017). Therefore, consistent surveillance of these 
pathogens, both serologically and molecularly, will allow public health agencies to better 
prepare for introductions of non-domestic diseases in naïve Texas dog populations. It 
should also be concluded, however, that insufficient screening for the aforementioned 
pathogens in Texas may also be indicative of current lack of prevalence data for the 
organisms in Texas. 
It is also important to note that a majority of available TBD prevalence data is 
based on the analyses of relatively small sample sets of dogs which were collected from 
Texas with no indication of region of origin, and were instead generalized to the state 
level. Ecologists commonly delineate Texas into 10 natural ecological regions, primarily 
based on unique plant communities as a result of differing climate, soil, and weather 
conditions (Figure 1-1). As depicted by the Gould ecoregions of Texas map, each 
ecoregion of Texas offers unique ecological perspectives in respect to habitat and climate 
(Gould et al., 1960). Ranging from west arid deserts, eastern swamps, southern subtropical, 
and a temperate north; in addition to 91mountain peaks contrasted by vast cave systems 
and canyons, the state of Texas is home to a unique geography. Conducting prevalence 










Furthermore, among all U.S. states Texas shares the most significant amount of 
land bordering Mexico. This transboundary region consists of 1,254 miles of common 
border per the Texas Department of Transportation (https://www.txdot.gov/inside-
txdot.html, accessed July 2018). These regions within Mexico, like Texas, provide unique 
ecological niches for many TBDs and their respective tick vectors to thrive. Of most 
concern, the transboundary region has a long history of exchanging pathogens and vectors 
 
Figure 1-1: Gould Ecoregions of Texas. Texas counties divided into ten natural 
ecological regions. Map reprinted with permission courtesy Texas Parks and Wildlife 




that can be detrimental for foreign environments. For example, the highly-invasive tick 
species Rhipicephalus microplus and R. annulatus currently residing within Mexico 
transmit the causative agents for Texas cattle fever (i.e. Babesia bovis and B. bigemina), 
which is potentially threatening Texas cattle (Abdullah et al., 2018, Lohmeyer et al., 2018). 
Although this example details a transboundary risk to cattle, it should be noted that many 
zoonotic canine tick-borne pathogens are circulating unchecked within Mexico, and may 
spillover to Texas dogs (Esteve-Gassent et al., 2014). Therefore, investigations aiming to 
characterize tick-borne prevalence within Texas should also focus on the prevalence of the 
same organisms within Mexico. 
 
Significance to public health 
A majority of tick vectors responsible for transmitting the aforementioned tick-
borne pathogens generally seek blood meals from wildlife, whom consequently serve as 
primary reservoirs for the pathogens through a sylvatic cycle. However, both dogs and 
humans can act as incidental hosts and may potentially manifest disease if exposed 
(Dantas-Torres, 2008, Lopez et al., 2016). Therefore, dogs may be considered effective 
sentinels for human TBDs and might indicate geographical areas of increased zoonotic risk 
(Abdullah et al., 2018, Esteve-Gasent et al., 2017, Mead et al., 2011). The modern 
symbiotic relationship humans and companion animals share presents an extended 
pathway for TBDs to migrate between both species. Pets may bring ticks directly into the 





In addition, increased interaction between companion animals and wildlife may 
also fuel these diseases’ inadvertent migration to pets, and subsequently their owners, 
through the introduction of infected ticks or direct transfer (e.g. fighting) of specific agents. 
One such wildlife-to-domestic migration route may potentially be facilitated through feral 
canids such as coyotes (Canis latrans), especially among southern U.S. states and 
transboundary regions with Mexico. Studies have long suspected coyotes as natural 
reservoirs of TBDs, and their ability to colonize both rural and semi urban areas allow 
them to consistently live amongst both domestic animals and humans (Bischof and Rogers, 
2005, Brzeski et al., 2015, Dworkin et al., 2008, Paras et al., 2012, Starkey et al., 2013). 
Surveillance investigations of TBDs in the coyote population should be conducted 
in order to characterize their role as prospective reservoirs of disease; though to current 
date none have been conducted in Texas. It is important to note, that Texas supports a 
thriving coyote population, contains competent tick vectors for a majority of zoonotic 
TBDs, and resides along the transboundary region with Mexico where reservoirs, vectors, 
and pathogens can freely migrate unburdened. Therefore, Texas represents an ideal region 
to characterize TBD prevalence in order to reveal which geographic areas, if any, are at the 
most risk for wildlife-to-domestic disease transfer, and consequently impacting human 
health. 
 
Limitations in detecting tick-borne pathogens 
Thrombocytopenia is a common and clinically significant finding in veterinary 
patients, most specifically in dogs. Severely decreased platelets (less than 50,000 K/µL) 




destruction, or occasionally with disseminated intravascular coagulation (DIC) or bone 
marrow failure. Thus, significant thrombocytopenia is considered a common 
clinicopathologic finding in TBDs (Carrade et al., 2009, Neer et al., 2002, Piccione et al., 
2016). Clinical signs, pertinent history, and full CBC data are imperative for interpretation 
of thrombocytopenia, but are not ideal tools for determining the specific tick-borne species 
responsible for infection due to similar presentations between species. 
When a TBD is suspected, it is common to review blood smears for potential 
inclusions or circulating organisms. However, as discussed prior, it may not be feasible to 
detect the pathogens responsible for infection during all stages of pathogenesis. Further, 
many tick-borne pathogens are indistinguishable morphologically (i.e. TBRF species, 
Ehrlichia species, Babesia species, etc.), restricting the use of blood smear review for 
determining a species-specific diagnosis. 
Culturing tick-borne pathogens is another potential diagnostic tool for determining 
causative agents of disease. However, many species have demonstrated difficulties in 
obtaining viable cultures, and some have yet to be successfully cultured (Michelet et al., 
2014). Reduced sensitivity, coupled with being labor intensive and time constraining, have 
severely restricted the application of culturing as a practical means of TBD diagnosis. 
Therefore, in a clinical setting small serological panels, or in-house tick-screen assays, are 
often used to rule-out TBDs and determine the causative agent of said disease. 
Gold standard tests are not clearly defined for all TBDs, yet diagnosis primarily 
relies on several serological assays (ELISA, immunofluorescence, and immunoblot) which 
rely on detecting antibody levels generated by the host’s immune response to a pathogen 




antibody production can take up to 28 days (Neer et al., 2002). In some cases, dogs do not 
generate an antibody response of a large enough magnitude to be detectable by the 
currently available serological assays, even when early clinical signs are present (e.g. 
thrombocytopenia) (Maggi et al., 2014). In dogs, clinical signs are similar among several 
TBDs, thus deducing a diagnosis would require multiple serological panels and result in a 
delay in effective treatment. Additionally, high antibody titers may persist for months to 
years following clinical resolution of some tick-borne pathogens, limiting the value of 
monitoring titers during treatment and confounding the detection of repeat or concurrent 
infections (Fritz, 2009, Maggi et al., 2014). Finally, as more vaccinations for TBDs enter 
the market, current serological assays may experience inconclusive results or end in 
misdiagnoses if not DIVA (Differentiating Infected from Vaccinated Animals) strategy 
compatible (Small et al., 2014). 
Occasional cross-reactivity is also a common issue in some serological panels. For 
example, species responsible for causing TBRF can cross react with Borrelia burgdorferi 
serologic tests, resulting in the inaccurate diagnosis of Lyme disease (Piccione et al., 
2016). Further, the popular pen side SNAP® 4Dx® Plus test by IDEXX detects antibodies 
recognizing Ehrlichia (i.e. E. canis, E. chaffeensis, E. ewingii) and Anaplasma (i.e. A. 
phagocytophilum, A. platys) species without discrimination. Thus, true species 
identification through this system may not be achievable (IDEXX, 2016). 
While serologic assays for diagnosing TBDs in veterinary patients are highly 
utilized and provide valuable information, molecular diagnostic tools (e.g. PCR), in 
contrast, are often used for detecting acute infections and monitoring responses to 




pathogens only circulate in blood in low numbers during the acute phase of infection, as is 
the case for B. burgdorferi and R. rickettsii (Kidd et al., 2008, Primus et al., 2018). PCR 
may be valuable in detecting an infection prior to seroconversion but may lose its 
effectiveness as the infection persists. Moreover, current qPCR assays are limited in the 
number of pathogens that can be detected simultaneously. As discussed prior, many 
pathogen species can be responsible for a single TBD in a susceptible dog. Due to the 
limitations in detecting unique pathogen targets imposed by current qPCR technology, this 
diagnostic modality may be restricted in its overall effectiveness as a TBD screening tool, 
as discussed further in the following section. Therefore, the limitations of molecular and 
serological diagnostic tools should be recognized, and may be most effective in 
determining a differential diagnosis when utilized in parallel (Maggi et al., 2014). 
Effective parallel diagnosis has been documented extensively in a human model, 
and can be extrapolated to an animal model. For example, an infected host that produces a 
positive enzyme-linked immunosorbent assay (ELISA) and is detected by qPCR may be 
indicative of an ongoing infection that the immune system has now recognized and 
mounted a response to, with an estimated infection time of three weeks (Chapman et al., 
2006, Wormser et al., 2006). A positive qPCR but negative ELISA may represent an early 
infection in which the immune system has not been able to establish itself against the 
pathogen, with an estimated time of less than three weeks since infection (Johnson, 2011). 
Lastly, a positive ELISA but negative qPCR in asymptomatic animals could represent an 
infection that has reduced bacteremia below detectable levels, due to the immune system 
response or antibiotics treatment, and thus further treatment might not be needed (Chan et 




for the affected animal, allowing tailored treatments and providing a specific time frame of 
pathogen clearing from the host. 
 
A brief history of molecular diagnostic tools 
The history of PCR to become a fundamental tool for molecular analysis is ripe 
with significant innovation and scientific advances. With humble beginnings that can be 
traced back to a simple tool for facilitating traditional gel-based Sanger sequencing, it was 
not until the idea catalyst from Dr. Kary Mullis that this simple technique accelerated into 
the indispensable laboratory tool it is today. 
 
Sanger sequencing 
DNA sequencing was developed as a way to visualize the nucleotide composition 
of a specific sequence. The development of such a system was not immediate, and the 
methodology was tweaked and built upon by various researchers. In 1965 Dr. Fred Sanger 
published an article describing the detection of radiolabeled partial-digested fragments, the 
precursor to traditional first-generation sequencing; or more commonly, Sanger sequencing 
(Sanger et al., 1965). After undergoing various modifications over the next few years, the 
Sanger sequencing method lead to the complete sequencing of the first DNA genome 
(Sanger et al., 1977a, Sanger et al., 1977b). Briefly, the Sanger sequencing method of that 
time encompassed a single short primer binding onto a region of interest and the 
implementation of the dideoxy technique, also known as the “chain-termination” reaction 
(Heather and Chain, 2016). The reaction is then driven by a DNA polymerase enzyme that 




[ddNTPs]). Four parallel reactions are then performed containing each ddNTP on a 
polyacrylamide gel, which allows the DNA sequence to be visualized and pieced together. 
Further iterations of the technique included implementing uniquely radio-labeled 
deoxynucleotides into the reaction, allowing the DNA sequence to be viewed by a 
computer reading the reaction (Heather and Chain, 2016). In recent years, more sequencing 
options have been developed and are widely used (e.g. next-generation sequencing [NGS]), 
though few rely on the Sanger sequencing method to obtain nucleotide data. 
 
Next generation diagnostic tool 
Initially, NGS platforms (e.g. Ion Torrent, HiSeq/MiSeq, GeneReader, etc.) were 
developed for gathering and analyzing long stretches of DNA and RNA that were 
previously unachievable by Sanger sequencing methods. The various NGS systems utilize 
numerous approaches to achieve results, each with their own strengths and limitations 
(Glenn, 2011). Typically, NGS methods have been utilized for full genome sequencing, 
identification of potential genetic diseases, and studying pharmacogenomics of drug 
response (Pareek et al., 2011). These methods have been widely successful, and over the 
years have become increasingly more cost efficient. Due to the rising popularity of the 
technology, an additional branch of NGS has formed concerning diagnostic applications in 
regards to identifying infectious diseases within host samples (Radford et al., 2012). 
Briefly, a sample is collected and DNA/RNA purified from a potentially infected 
host and screened, using NGS methodology, for all present DNA/RNA sequences. The 
obtained nucleic acid sequences are then analyzed for the presence of sequences matching 




theoretically detect all agents circulating in a host sample despite prior knowledge of 
specific pathogens in which to target, as is the case with PCR-based diagnostics discussed 
in the following sections. 
This method, however, is currently experiencing technology restrictions involving 
the analyses of raw data generated by each reaction. Each NGS run collects an immense 
amount of sequence data of varying depth and coverage which has led to bioinformatic 
barriers in efficiently analyzing the information in a timely manner (Finotello et al., 2012). 
This flood of sequence data has become especially debilitating in the analyses of samples 
containing viruses. NGS indiscriminately gathers all available nucleotide sequences, 
resulting in a complex mix of various genetically similar viral pathogens, colloquially 
referred to as quasispecies (Lauring and Andino, 2010). Further, some microbial genomes 
with large mobile elements and highly variable regions can regularly complicate genome 
assembly (Tritt et al., 2012). NGS systems have also been noted as generally less cost 
effective than other diagnostic platforms, with each reaction costing roughly $1000 and 
requiring an estimated 24 hours to generate raw data; limiting regular usage as a tool in 
veterinary diagnostic laboratories seeking to conduct rapid and cost efficient differential 
diagnoses (Frey and Bishop-Lilly, 2015). Though, the overall consensus is that cost and 
time per reaction will continue to decrease over time. 
Therefore, while this technology has demonstrated potential as a versatile 
molecular diagnostic tool, current limitations in cost, time, and general data analyses have 
restricted its use to mainly research endeavors. However, with continued innovations of the 






Dr. Kary Mullis described the notion for what is now known as conventional 
polymerase chain reaction (cnPCR) in 1983 (Mullis, 1990), but was not reported until 1985 
where cnPCR was sparingly utilized in an experiment involving sickle cell anemia 
mutations (Saiki et al., 1985). Briefly, the cnPCR process encompasses the amplification 
of a specific sequence of genomic DNA from any organism of interest by utilizing short 
oligonucleotide primers that match the DNA sequence and drive the reaction. While 
resembling the general protocol for conducting Sanger sequencing with a single primer, 
cnPCR instead incorporates two unique forward and reverse primers into the same 
reaction, representing 5’ and 3’ directionality, respectively. The cnPCR process is then 
subjected to multiple rounds of cycling temperatures which involve denaturing the 
genomic DNA and permitting the annealing of the primers, mimicking in vivo DNA 
replication. The cnPCR method was more thoroughly described in later publications 
released in 1986 (Mullis et al., 1986) and 1987 (Mullis and Faloona, 1987). 
The first iteration of cnPCR utilized DNA polymerase enzymes purified from the 
Escherichia coli bacterium. However, this process severely limited cnPCR methodology as 
the enzyme was heat labile and required additions every subsequent temperature cycle. 
Here, the first significant innovation of the PCR process occurred when a more 
thermostable DNA polymerase enzyme purified from the Thermus aquaticus bacterium 
was incorporated into the reaction and replaced any use of enzymes derived from E. coli 
(Saiki et al., 1988). The enzyme was later cloned and manufactured in a way where the 
cnPCR process could be confined to a single tube with no need to consistently open the 




was made more efficient and utilized throughout a multitude of experiments and 
publications. In 1993 Dr. Kary Mullis’s discovery of PCR lead to his recognition with a 
Nobel Prize in chemistry. Though Dr. Mullis’s contributions to the development of PCR is 
substantial, later advances to the process by other scientific teams have allowed the system 
to evolve into a more versatile tool. 
cnPCR has been implemented in numerous experimental studies, including 
characterizing mutations, gene cloning, molecular diagnostic of pathogens, etc. The first 
use of the cnPCR process as a tool for conducting molecular diagnostics occurred shortly 
after Dr. Mullis published his findings (Drake et al., 1987, Lewis et al., 1993, Musial et al., 
1988). While mostly effective, limitations regarding assay specificity, time efficiency, and 
inability to quantify data influenced the conception of a “real-time” PCR system. 
 
Intercalating molecule PCR 
The first description of a PCR reaction analyzed in “real-time” was in 1993 as 
described in Higuchi et al. (Higuchi et al., 1993). Here, the first iteration of a real-time 
PCR system utilized ethidium bromide that intercalated double stranded DNA during each 
amplification reaction, and then irradiated the samples to view the subsequent fluorescence 
during each amplification cycle at an excitation wavelength of 520 nm (Navarro et al., 
2015). This methodology allowed the starting DNA concentration of a sample to be 
determined, as opposed to the reliance on agarose gel band intensity with cnPCR. 
Furthermore, potential contamination events were significantly reduced by containing the 
DNA amplification and analysis within a single tube. The most common form of 




SYBR® Green reaction utilizes a forward and reverse primer similar to cnPCR, but can 
display results quantitatively or through the analysis of dissociation curves. Dissociation 
curves represent the fluorescence signal dissociating from amplified double stranded DNA. 
The generated dissociation curve is dependent on the length and nucleotide composition of 
the amplified sequence. Reports have indicated that as each target sequence is different in 
length and composition in comparison to one another, sequence multiplexing (i.e. detecting 
and distinguishing multiple pathogens simultaneously) may be accomplished, though the 
current consensus is that specificity is not always maintained (Navarro et al., 2015). 
Limitations regarding the SYBR® Green PCR reaction include the lack of true multiplex 
capabilities, where more than one pathogen can be targeted concurrently without relying 
on generated dissociation curves. Therefore, while SYBR® Green based PCR reactions 
were heavily utilized within the field of molecular diagnostics, limitations involving 
multiplex capabilities reduced the systems usefulness in screening for multiple pathogens 
and determining a differential diagnosis. 
 
Fluorescent molecule PCR 
TaqMan probes were first described in 1996, and depict the addition of fluorogenic 
labeled probes to the PCR process, which allowed for reliable singleplex (i.e. single target) 
or multiplex (i.e. multiple target) detection in a diagnostic setting (Gibson et al., 1996). 
Probes are similar to traditional oligonucleotide (primer) sequences but feature a 
fluorescent moiety on the 5’ end, and an acceptor moiety on the 3’ end that acts as a 
fluorescent quencher when in close proximity to the 5’ end. Probes are designed to anneal 




real-time PCR (qPCR) reaction is then driven by temperature cycles and DNA polymerase, 
similar to cnPCR, but as the new amplicon is generated the probe is sheared from the 
sequence and allowed to emit a fluorescence signal that the qPCR instrument reads and 
interprets in real-time (Navarro et al., 2015). 
Though additional versions of the primer-probe system exist (e.g. Scorpions, 
LUXTM, Angler®, etc.), currently TaqMan probes are considered the most popular tool for 
conducting molecular diagnostics in the veterinary field. It is important to note that a 
majority of U.S. veterinary diagnostic laboratories operate as state reference laboratories, 
and therefore, are required to adhere to guidelines enforced by accreditation agencies (e.g. 
American Association of Veterinary Laboratory Diagnosticians [AAVLD]) and national 
programs (e.g. National Animal Health Laboratory Network [NAHLN]). Laboratories are 
required to maintain NAHLN proficiency testing certifications to participate in state 
surveillance programs, such as screening for high consequence diseases (e.g. avian 
influenza, foot and mouth disease, etc.). NAHLN approved validation analysis has 
currently only been conducted on TaqMan qPCR-based instruments, such as the ABI® 
7500 Fast real-time PCR and the BioRad CFX96 Touch™ Real-Time PCR Detection 
System. As such, the ABI system, for example, has become a common qPCR instrument in 
many veterinary diagnostic laboratories, including the 59 state veterinary diagnostic 
laboratories within the U.S. Therefore, future molecular assays aiming to be implemented 
into veterinary diagnostic laboratories should be developed and validated on the 






Multiplex real-time PCR 
The qPCR system is generally considered more sensitive than cnPCR, though some 
studies have suggested otherwise (Bastien et al., 2008). Regardless, the qPCR system 
allows for the facilitation of multiplex reactions that can detect a variety of pathogens 
simultaneously. Currently, there are a wide assortment of probe fluorophores that emit at a 
specific wavelength typically ranging from 520 nm to 705 nm (Figure 1-2). However, 
current qPCR platforms limit the number of probes that can be detected by a given 
instrument which subsequently limits the number of pathogens that can be screened by a 
single test. For example, the ABI® 7500 Fast Real-Time PCR System offers the ability to 
detect any four compatible fluorogenic probes per qPCR assay. Recently, the detection 
flexibility for the ABI system has been increased to five dyes with the advent of the 7500 
Fast Dx Real-Time PCR System. Another common qPCR instrument includes the BioRad 
CFX96 Touch™ Real-Time PCR Detection System. However, this system is also currently 







In respect to the ABI® 7500 Fast system, recommendations for achieving 
efficacious multiplex testing for four targets (i.e. quadruplex) of interest include utilizing 
the FAM, CFO560, Q670, and TAMRA probes (Figure 1-3). Here, the wavelength (nm) 
distance between each probe represents the minimum distance required in order to reduce 
potential fluorescent interference when analyzed by the instrument. Therefore, although 
current qPCR instruments can detect numerous probe labels over a broad spectrum of 
wavelengths, the limiting factor for the instrument’s diagnostic capability is the inability to 
differentiate between the probes when wavelengths are similar. As such, current 
approaches to molecular screening for more than four to five targets at a time require 
testing to be conducted by more than one multiplex panel. Consequently, comprehensive 
molecular testing of a single sample increases associated costs by requiring more reagents 
and additional time to reach diagnoses. 
 
Figure 1-2: Spectral overlay analysis of common real-time PCR fluorophores. 
Wavelengths (nm) of fluorophores range from 520 to 705. Data generated utilizing the 
Spectral Overlay Tool for Multiplexed qPCR reprinted with permissions from LGC 







Target/probe restrictions can also have an effect on the quality assurance of a qPCR 
assay. There exists the potential, when utilizing qPCR assays for molecular diagnostics, for 
the generation of false negative or false positive results due to assay inhibition during 
nucleic acid extraction and/or qPCR reaction process. The use of an internal control, either 
endogenous or exogenous, to mitigate this issue has become more commonplace but 
requires the use of a separate probe label. Therefore, although qPCR instruments are 
commonly utilized in the field of veterinary diagnostics and multiplex techniques allow for 
the analysis of more than one target concurrently, there is a need for a novel technique that 
can facilitate the detection of more than four to five targets while remaining compatible 
with currently utilized qPCR instruments. It is interesting to note, that while adding more 
targets within the fluorescent spectrum is currently not possible due to the inability of 
qPCR instruments to differentiate between probes emitting similar wavelengths, there may 
 
Figure 1-3: Spectral overlay analysis of fluorophores for real-time PCR 
quadruplex format. Representative fluorophores include FAM, CFO560, TAMRA, 
and Q670, and emit fluorescence (nm) at 520, 559, 583, and 670, respectively. Data 
generated utilizing the Spectral Overlay Tool for Multiplexed qPCR reprinted with 








Another innovation of the general PCR process is represented by a prospective 
molecular diagnostic tool offered by Luminex® Corporations. The Luminex® platform is 
a highly multiplexable microsphere-based system that currently allows for more than 100 
independent fluorescent channels, analogous to TaqMan probes, to be characterized 
concurrently (Dunbar, 2006). Briefly, the Luminex® process consists of coupling cnPCR 
generated products with specific capture probes labeled with fluorescent microspheres, and 
analyzing the products utilizing their instrument (e.g. xMAPTM). This system is 
exceedingly customizable for detecting any target of interest, and eliminates the 
fluorescent probe detection limitation featured by traditional qPCR instruments. Recently, 
this system has been used to simultaneously detect 10 insect-borne pathogens in a host 
sample (Wang et al., 2018). However, the Luminex™ platform requires a minimum of 
three steps to reach usable data, consisting of conducting the cnPCR process, followed by 
coupling the microspheres with the cnPCR products, then transferring the reaction to a 
Luminex® instrument for final analysis. 
Although this methodology has the potential for complete automation of the 
process, there still exists many possible avenues to introduce contaminates into the 
reactions. Further, the Luminex® methodology, in current iteration, requires multiple 
instruments and extended personal attentiveness to generate data. It is also important to 




surveillance of high-impact pathogens. As such, the system is not currently readily 
equipped nor utilized in a majority of veterinary diagnostic laboratories. In contrast, 
multiplex qPCR systems allow for a prepared reaction to be placed into a single instrument 
where results are then provided roughly one to two hours later. Therefore, though the 
Luminex® system will inevitably improve through new versions, current molecular 
diagnostic needs may be best satisfied through modifying current multiplex qPCR 
methodologies. 
 
Modified multiplex real-time PCR 
Within the literature, there is an indicated need for a consolidated molecular tool 
that can screen for a wide variety of pathogens simultaneously for detecting and 
characterizing TBDs of interest. A molecular tool of such kind would be useful not only as 
a potential diagnostic tool, but would also facilitate the construction of disease maps within 
Texas and other underserved areas. Taken together, the main topic of this dissertation is to 
produce a highly multiplexable molecular tool that can screen for numerous tick-borne 
pathogens of interest to canine health, be readily utilizable with current technology, and be 
applicable to conducting molecular prevalence studies within regions containing gaps in 
knowledge. To accomplish these goals, the ideal result of this work would be the discovery 
of a novel technique that modifies the qPCR reaction process while maintaining 
compatibility with commonly utilized probe labels and qPCR instruments. 
A potential avenue to achieve these goals may be through a typically underutilized, 
yet perhaps familiar, technique that may allow numerous pathogens to be detected in a 




pathogen to a single fluorogenic label, as briefly described previously (Wernike et al., 
2013). While Wernike et al. documents the use of a single fluorogenic probe (i.e. Texas 
Red) to label four pathogens responsible for transboundary animal diseases, the technique 
may also be adapted to employ multiple probes within a single assay, and for targeting a 
different group of diseases caused by tick-borne pathogens. Therefore, increased target 
detection may be achieved by layering the targets within each established probes’ emitted 










Figure 1-4: Wavelength analysis of fluorophores for quadruplex real-time PCR 
detection. Targets 1-4 represent potential pathogens labeled with fluorophores FAM, 


























As depicted in Figure 1-4, when the wavelengths (nm) of each fluorophore is 
displayed along the y-axis, the potential to layer multiple pathogens within the same probe 
layer can be observed. As this study aims to simultaneously detect and characterize more 
than four pathogens of interest to canine health, along with an endogenous internal positive 













Figure 1-5: Wavelength analysis of fluorophores for layerplex real-time PCR 
detection. Targets 1-6 represent potential pathogens and are grouped, based on genetic 
similarity, into three groups labeled with FAM, CFO560, and TAMRA, respectively. 
Target 7 represents an endogenous internal positive control mechanism for assay quality 


























As detailed in Figure 1-5, six targeted hypothetical pathogens (1-6) were organized 
into three groups, or layers, based on species similarity and labeled with the same 
fluorogenic probes: 1-2 with FAM (520 nm); 3-4 with CFO560 (559 nm); and 5-6 with 
TAMRA (583 nm). A fourth probe was also needed in order to label a target representing 
an EIPC for diagnostic quality assurance of DNA extractions using Q670 (670 nm). While 
this technique will require extensive sensitivity and specificity validation analysis in order 
to provide evidence of efficacy for use in molecular diagnostics, the technique adheres to 
the detection requirements of commonly utilized by qPCR instruments. 
Thus, within this study, the layerplex qPCR technique will be further investigated 
to determine its potential for use as a consolidated molecular tool that can detect and 
characterize numerous tick-borne pathogens concurrently in both diagnostic and 




Central hypothesis and specific aims 
 
Based on the literature review presented, my central hypothesis is that by utilizing a 
novel multiplexing technique for qPCR assays, termed layerplexing, detection limitations 
set by traditional qPCR instruments can be bypassed, subsequently allowing the detection 
of a multitude of pathogens in one reaction. 
To evaluate this hypothesis experimentally, the following specific aims will be 
carried out using in silico, analytical, and diagnostic validation methodologies; 
 
Aim I:  Establish a canine specific endogenous internal positive control (EIPC-K9) 
that will mitigate potential false-negative results when screening samples 
originating from domestic dogs. 
 
Aim II:  Develop a layerplex qPCR platform for detecting the most prevalent 
pathogens responsible for common tick-borne diseases of dogs in a single 
consolidated molecular assay. 
 
Aim III:  Evaluate the combined EIPC-K9 and layerplex qPCR assay in a molecular 
surveillance investigation of tick-borne diseases in dogs across Texas. 
 
The main objective of this work was to design and develop a novel consolidated 
molecular assay that can detect the most common tick-borne pathogens of interest to 




focused on detecting pathogens in multiple assay formats, therefore limiting their 
usefulness in large scale molecular prevalence studies. As such, a consolidated layerplex 
assay may provide efficacious, rapid, and cost-effective means of screening for tick-borne 
pathogens. Further, the development of a layerplex assay may aid public health agencies in 
updating maps depicting high-risk areas of disease and developing preventative measures 





DEVELOPMENT AND APPLICATION OF A CANINE ENDOGENOUS INTERNAL 
POSITIVE CONTROL FOR USE IN REAL-TIME PCR ASSAYS* 
 
Introduction 
To ensure proper performance of real-time PCR (qPCR) assays, diagnostic 
laboratories utilize internal positive controls (IPC) to monitor nucleic acid extraction and 
subsequent test results (Goncalves-de-Albuquerque Sda et al., 2014, Huhn et al., 2010). 
Traditional IPC methodologies utilize exogenous controls (XIPC) for monitoring qPCR 
assays but feature limitations that may not fully mitigate false-negative results. There are 
many types of XIPCs, such as plasmids and phages. In general, XIPCs are utilized by 
spiking a known quantity of control material along with the biological sample undergoing 
DNA and/or RNA purification (purNA) (Mikel et al., 2015, Schroeder et al., 2013). 
Both control types have subsequent primers/probe sequences designed for detection 
of the XIPC material prepared within multiplex mixtures alongside additional 
primers/probes pertaining to specific pathogens of interest for a respective assay. The 
plasmid approach involves the addition of purNA in the form of a plasmid (containing the 
XIPC specific nucleotide sequence) directly to the biological sample being processed, or to 
the lysis solution, as previously described (Schroeder et al., 2013). This process focuses on 
plasmid presence throughout the qPCR testing process and viability of the utilized master 
                                                 
* Reprinted with permission from “Development and application of a canine endogenous internal positive 
control for use in real-time PCR assays” by Joseph J. Modarelli, Pamela J. Ferro, and Maria Esteve-Gasent, 





mix reagents. The presence of a plasmid in a reaction does not necessarily represent either 
host purNA presence or the occurrence of host cell lysis. The second type of XIPC features 
the addition of a specific phage to the sample or lysis solution, allowing the verification of 
cell lysis, in that the phage purNA will only be amplified under true lysis conditions 
(Mikel et al., 2015). However, this method does not verify the lysis of either the host cell 
or the lysis of any potentially present pathogens, and therefore may not completely monitor 
the efficacy of the purNA extraction process. Thus, uses of EIPCs are subject to potential 
false negative results as these methods are not necessarily fully representative of true 
sample lysis conditions. Therefore, although utilizing an XIPC is generally sufficient, 
cases exist in which an endogenous IPC (EIPC) is necessary. 
The aim of our study was to identify a genetic marker that could be standardized to 
specifically amplify a conserved gene region located within canine mitochondrial DNA 
(mtDNA) for use as an endogenous internal control. The methodology of an EIPC 
mitigates the need to spike a specific amount of an XIPC into an extracted sample, and 
alleviates the necessity to rely on the lysis of a phage for monitoring the purNA extraction 
process. The proposed canine specific EIPC (EIPC-K9) control could potentially work as 
an internally regulated genetic marker that removes the need for additional external control 
reagents to the purNA extraction process. The control would theoretically amplify within a 
qPCR reaction only if the host (Canis sp.) cell has fully lysed. A standardized endogenous 
internal control could benefit future research studies by limiting the time and reagents 
necessary for developing such a control for experiments, as well as provide a means for 
uniform qPCR testing across studies. Although alternative endogenous internal 




targeting these genes as a reference for gene expression analysis (van Rijn et al., 2014). 
Our study focused on targeting a region of mtDNA for identifying the species regardless of 
the sample type being extracted in a veterinary laboratory environment. 
 
Material and methods 
 
Oligonucleotide design 
All available domestic dog (Canis lupus familiaris) mtDNA nucleotide sequences 
available in GenBank (n = 1,129; query Nov 2016) were sorted and independently aligned 
(CLC Main Workbench v.7.7, Qiagen Aarhus, Aarhus, Denmark) for gene sequence 
alignments and nucleotide conservation identification. Subsequent analysis identified the 
most conserved sequence regions in the canine mtDNA complete genomes that featured 
nucleotide mismatches with respect to heterologous species mtDNA complete genomes 
commonly screened in veterinary laboratories (e.g., horse, cat, goat, sheep, white-tailed 
deer, skunk, cow, pig, chicken, raccoon, and red fox; represented by n = 441, 176, 184, 
102, 13, 2, 290, 196, 103, 14, and 6, respectively) for primers-probe selection (data not 
shown). Sequence analysis also included region homology to closely related Canis species 
to ensure adaptive usage of the internal control for future studies aimed at utilizing wildlife 









Primers and probes were positioned over aforementioned sequence regions and 
further analyzed (Primer Express v.3.0, Applied Biosystems, Carlsbad, CA). Sequences 
were then evaluated on the basis of the following criteria: predicted cross-reactivity with 
closely related organisms, internal primer binding properties for hairpin and primer-dimer 
(cross dimerization) potential, physical attributes of primers for extended base-pair repeats 
and runs, length of the desired amplicon, GC-content, melting temperatures (Tm) of 
primers and probes, and desired distance between 3’-end of primer and 5’-end of the probe. 
Oligonucleotide sequences were then searched using BLAST and the C. lupus familiaris 
genome to confirm specificity. 
 
Real-time PCR amplification 
Sequence analysis revealed a 96-bp region targeting the NADH:ubiquinone 
oxidoreductase core subunit 5 (MT-ND5) gene within canine mtDNA as the ideal and 
specific internal control location. Amplifying the selected region with the qPCR assay 
proved efficacious by performing the reaction using primers EIPC.K9mt.12942F and 
EIPC.K9mt.13018R, and dual-labeled probe (BioSearch, Novato, CA) EIPC.K9mt.12980P 
(Table 2-1). The qPCR assay was evaluated in both singleplex and multiplex formats with 
a final reaction volume of 25.0 µL, by following optimal reaction conditions consisting of 
12.5 µL of 2x qPCR Path-ID buffer (Thermo Fisher Scientific, Waltham, MA), 1.0 µL of 
25x primer-probe mix (singleplex: working 25x concentration of primers 
EIPC.K9mt.12942F, EIPC.K9mt.13018R, and probe EIPC.K9mt.12980P-TAMRA at 




concentration and up to 3 additional unique pathogen primer sets and probe labels), 8.0 µL 
template DNA, and 3.5 µL of RNase-free water (Applied Biosystems® 7500 Fast Real-
Time PCR System, Thermo Fisher Scientific ). Recommended cycling conditions include 
an initial activation of the DNA polymerase at 95°C for 10 min, 40 cycles of a 1 s 
denaturation at 95°C, followed by a 30 sec annealing-extension step at 60°C. 
 
 
Table 2-1. Primers and probe used for the detection of Canis lupus familiaris. 
Oligo ID Sequence (5’–3’) Amplicon 
EIPC.K9mt.12942F GGATTCTACTCCAAAGACCTGATCA 
96 bp EIPC.K9mt.13018R GGTTAGGGATGTGGCAACGA 
EIPC.K9mt.12980P TAM-CACGTCGAATACCAACGCCTGAGCC-BHQ2 




A positive amplification control (PAC) and standard for the quantitation of the 
qPCR assay was developed by cloning a 96-bp segment of the MT-ND5 region that spans 
the coordinates 12942 and 13037 of the complete mtDNA genome (GenBank® accession 
EU408254.1). This segment was amplified with the designed primers (Table 1) from a 
template of genomic DNA extracted and purified from C. lupus familiaris blood (MagMax 
Total Nucleic Acid Extraction Kit, KingFisher Flex Purification System, Thermo Fisher 
Scientific), as described previously (Schroeder et al., 2013). The PCR products were then 
cloned in Escherichia coli following manufacturer’s recommendations (TOPO TA Cloning 









qPCR linear dynamic range, efficiency, and analytical sensitivity 
To evaluate the analytical sensitivity of the assay, a 10-fold dilution series was 
conducted with the constructed plasmid PAC to determine a quantification cycle (Cq) 
cutoff for the qPCR assay, as well as provide the limit of detection (LOD) of gene copies. 
An efficiency of 92% and an R2 value of 0.999 was calculated based on the 10-fold 
dilution series (D'Haene et al., 2010). A LOD of 2 plasmid copies at a Cq cutoff of 38.0 
was determined based on the data collected from the generated standard curve. 
 
Analytical and in silico specificity analysis 
The diagnostic specificity of the EIPC-K9 control was assessed by demonstrating 
in duplicate the failure to amplify DNA extracted from opportunistically collected blood 
samples originating from species routinely tested at the Texas A&M Veterinary Medical 
Diagnostic Laboratory (TVMDL; College Station, TX). The species tested included: gray 
wolf, coyote, horse, cat, goat, sheep, white-tailed deer, skunk, cow, pig, chicken, raccoon, 
and red fox (Figure 2-1). Specificity analysis revealed that a positive EIPC-K9 result 
indicates that the tested specimen originates from 1 of 3 Canis species (C. lupus familiaris, 







Figure 2-1: Oligonucleotide analysis of the EIPC-K9 assay in respect to homologous and heterologous species’ 
mitochondrial DNA target sequences. The second column indicates qualitative results (positive or negative) in respect to 
EIPC-K9 specificity to 2 independent blood samples from homologous and heterologous species (dog, gray wolf, coyote, 
horse, cat, goat, sheep, white-tailed deer, skunk, cow, pig, chicken, raccoon, and red fox). Mismatch analysis of base-pair 




Analysis of diagnostic specificity 
To test the detection and sample specificity utility of the EIPC-K9 assay in canine 
samples, DNA was screened from 240 (123 from blood, 71 from urine, 21 from nasal 
swabs, and 25 from tissues biopsies) domestic canine samples, collected opportunistically 
at TVMDL. EIPC-K9 results of the specimens yielded a detection rate of 100%, and their 
mean Cq values were noted (Figure 2-2). One-way ANOVA statistical analysis revealed 
that each specimen type’s mean Cq value was significantly different from every other 
specimen (p - values of <0.0001 for blood-urine, <0.01 for blood-nasal swab, <0.0001 for 
blood-tissue, <0.001 for urine-nasal swab, <0.0001 for urine-tissue, and <0.0001 for nasal 
swab-tissue). This utility may be extrapolated to act as a quality control method, in which 
quality of DNA extracted from a canine sample can be monitored by its subsequent EIPC-
K9 Cq value. EIPC-K9 was not tested against other sample types derived from dogs, given 
that we focused on the evaluation of the internal control in respect to commonly tested 
laboratory specimens. Further studies to determine the efficacy of EIPC-K9 as a standard 
with other sample types, and to evaluate the control under various inhibitory effects, will 







Multiplex qPCR compatibility analysis 
The utility of EIPC-K9 for use in a multiplex format was also tested and proved 
useful (Figure 2-3). The qPCR results revealed no significant inhibition regardless of 
multiplex reaction format in respect to Cq value production by one-way ANOVA analysis 
for EIPC-K9 and the 3 select pathogen assays (Borrelia sp., Ehrlichia sp., and Babesia 
sp.). Although initial analysis using the listed pathogens revealed no significant difference 
for pathogen Cq values, it is important that future use of the control with other targets 
 
Figure 2-2: Canine biological sample analysis with the EIPC-K9. Mean Cq 
values ± standard deviation for sample types screened with the EIPC-K9: 16.8, 20.5, 
22.5, 25.5, respectively. Samples originated from archived TVMDL cases. “Tissue” 
denotes variety of tissue samples used for testing (e.g., lung, kidney, cerebrum, 
brain). One-way ANOVA statistical analysis of sample types in respect to other 






































Limitations of the assay include Cq value irregularity within sample types that may 
be influenced by the nature in which specimens are collected. For example, DNA samples 
derived from blood featured the least variability in respect to produced Cq values, whereas 
 
Figure 2-3: Real-time PCR plex reaction analysis with the EIPC-K9. Mean Cq 
values ± standard deviation from performing duplicate real-time PCR runs using the 
EIPC-K9 assay and various pathogen-specific assays (Borrelia burgdorferi [Bb], 
Ehrlichia canis [Ec], and Rickettsia rickettsii [Rr]) under various plex reaction 
formats. Multiplex assays consisted of duplex (EIPC-K9, Bb), triplex (EIPC-K9, 
Bb, Ec), and quadruplex (EIPC-K9, Bb, Ec, Rr). EIPC-K9 Cq of ~22.0 represents 
genomic DNA (gDNA) purified from canine blood and spiked with each pathogen 
(gDNA at Cq of ~31.0). Concentration of EIPC-K9 and each pathogen is estimated 

































urine and nasal swabs experienced higher variability. Blood collection may feature the 
least inconsistency from animal to animal, whereas a urine or nasal swab sample may be 
collected from animals experiencing various health conditions (hematuria or epistaxis) and 
subsequently influence the cellularity of the sample, resulting in a higher or lower Cq 
value. In addition, sample collection methodology among veterinarians may differ, 
resulting in further irregularities. Additional limitations include potential inhibition by 
EIPC-K9 on low levels of target pathogens in a tested sample, and the lack of true 
analytical specificity evaluations for the control. However, the specificity of the control for 
only amplifying canine targets should be concluded based on the extensive diagnostic 
specificity analysis, including the use of homologous and heterologous species, conducted 
on the control. Finally, as the EIPC-K9 control is limited to detecting genomic DNA, it 
cannot verify the fidelity of the reverse transcription process in assays intended for RNA 
targets. 
The EIPC proved efficacious when supplemented into qPCR assays that screen 
canine samples for pathogens of interest. The control may be incorporated into similar 
assays that feature a melting temperature of 60°C, and may be utilized in multiplex qPCR 
panels of up to 4 detectors. Although limited, obtained data indicate the potential use of 
this assay to monitor cellularity of a sample type, verify cell lysis and DNA extraction, as 





A REAL-TIME PCR LAYERPLEX METHODOLOGY FOR THE DETECTION AND 




Tick-borne diseases (TBD) affecting domestic dogs are prevalent throughout the 
United States and are considered an emerging infectious threat (Chomel, 2011). Tick-borne 
pathogens, including Borrelia hermsii (Bh), B. turicatae (Bt), B. parkeri (Bp), B. 
burgdorferi (Bb), Ehrlichia canis (Ec), E. chaffeensis (Ech), E. ewingii (Ee), Anaplasma 
phagocytophilum (Ap), and Rickettsia rickettsii (Rr), have been documented to infect both 
dogs and humans, resulting in increased zoonotic threats (Chomel, 2011, Dantas-Torres et 
al., 2012, Lopez et al., 2016). Though there is limited documentation of infection with 
pathogens such as Ec in humans, or Bp in both dogs and humans, the risk potential should 
be recognized (Bouza-Mora et al., 2017, Lopez et al., 2016). Further, protozoan parasites 
such as species of Babesia (Bab), have a worldwide distribution and can result in various 
levels of clinical severity (Sudhakara Reddy et al., 2016). Of most concern within U.S. dog 
hosts are B. gibsoni and B. canis vogeli, though B. conradae has also recently been 
implicated in canine babesiosis (Di Cicco et al., 2012, Solano-Gallego and Baneth, 2011). 
Tick vectors responsible for transmitting TBDs vary across disease groups and 
even at the pathogens’ genus level. Currently, proven primary vectors for the assortment of 
pathogens discussed here include various species within the family of Ixodidae (hard ticks) 




appropriate hosts for the majority of these ticks, though dogs and humans can also act as 
incidental hosts for the majority of these tick species (Dantas-Torres et al., 2012, Lopez et 
al., 2016). Given domestic dogs and humans frequently share environments, dogs could be 
considered sentinels for the risk of human exposure to infected tick vectors and may 
indicate geographical areas of increased zoonotic risk (Abdullah et al., 2018, Esteve-
Gasent et al., 2017). 
Gold standard tests are not clearly defined for all TBDs affecting dogs, yet 
diagnosis primarily relies on several serological assays (ELISA, immunofluorescence, and 
immunoblot) and blood smear examination (Esteve-Gasent et al., 2017, Harrus and Waner, 
2011, Otranto et al., 2010). Although clinical signs can be observed within days of 
infection, detectable antibody production can take up to 28 days (Neer et al., 2002). In 
some cases, dogs do not generate an antibody response of a large enough magnitude to be 
detectable by the currently available serological assays, even when clinical signs are 
present (Maggi et al., 2014). In dogs, clinical signs are similar among several tick-borne 
diseases, thus deducing a diagnosis would require multiple serological panels and result in 
a delay in effective treatment. Additionally, high antibody titers may persist for months to 
years following clinical resolution of some tick-borne pathogens, limiting the value of 
monitoring titers during treatment and confounding the detection of repeat or concurrent 
infections (Fritz, 2009, Maggi et al., 2014). As more vaccinations for TBDs enter the 
market, current serological assays may experience inconclusive results or end in 
misdiagnoses if not DIVA (Differentiating Infected from Vaccinated Animals) strategy 
compatible (Small et al., 2014). While serologic assays for diagnosing TBDs in veterinary 




(e.g. PCR), in contrast, are often used for detecting acute infections and monitoring 
responses to treatment due to detecting the presence of the pathogen’s DNA. However, 
some TBD pathogens only circulate in blood in low numbers during the acute phase of 
infection, as is the case for Bb and Rr (Kidd et al., 2008, Primus et al., 2018). PCR may be 
valuable in detecting an infection prior to seroconversion but may lose its effectiveness as 
the infection persists. Therefore, the limitations of molecular and serological diagnostic 
tools should be recognized and may be considered most effective in determining a 
differential diagnosis when utilized in parallel (Maggi et al., 2014). 
Newer molecular assays permit the addition of fluorogenic probes (e.g. quantitative 
real-time PCR, or qPCR) that allows for a technique known as multiplexing, which has 
proven to be a useful tool in screening an animal sample for more than one TBD pathogen 
at a time (Hojgaard et al., 2014, Peleg et al., 2010). Since many TBDs can present with 
similar clinical signs or as coinfections, panels detecting multiple pathogens would be ideal 
for comprehensive pathogen identification. However, current qPCR platforms limit the 
number of probes that can be detected by a given instrument, which subsequently limits the 
number of pathogens that can be screened in a single test. Most of the widely-utilized 
qPCR platforms are limited to multiplexing 4-5 fluorophores in a single reaction without 
interfering with pathogen detection. Current approaches to molecular screening for more 
than four to five targets at a time require the testing to be conducted in more than one 
multiplex panel. Consequently, comprehensive molecular testing of a single sample 
increases associated costs by requiring more reagents and possibly, depending on the 




For these reasons, the development of an affordable molecular screening test for a 
broad array of pathogens is desirable. Many of the molecular assays currently employed 
for detecting these TBDs in dogs include various conventional PCR (gel based), singleplex 
qPCR (single target), or multiplex qPCR assays (multiple targets dependent on instrument 
capabilities) (Annoscia et al., 2017, Courtney et al., 2004, Hojgaard et al., 2014, 
Kledmanee et al., 2009, Peleg et al., 2010, Rodriguez et al., 2015, Sirigireddy and Ganta, 
2005). However, a typically unutilized, yet perhaps familiar, technique that allows 
numerous pathogens to be detected in a single qPCR reaction is the process of assigning 
more than one target pathogen to a single fluorogenic label, as briefly demonstrated in a 
previous study (Wernike et al., 2013). While colloquially referred to as typical qPCR 
multiplexing, this study proposes a terminology distinction to differentiate this qPCR 
technique, herein referred to as layerplexing. Layerplexing represents utilizing any probe 
to label more than one target assay in a given reaction. In contrast, general qPCR 
multiplexing would represent utilizing the same probe but for only labeling a single target 
assay in a reaction. Layerplexing would allow for a large number of unique target assays to 
be grouped under each probe label, up to the qPCR instruments fluorogenic limit (e.g. 11 
targets under 4 probe labels). Once a sample has been screened using the layerplex 
technique (initial layer), subsequent testing using singleplex or multiplexing versions of 
each target assay would then be necessary to identify the specific pathogen(s) responsible 
for infection depending on which initial probe indicated amplification. While additional 
testing is required after the initial layer to characterize positive species, a negative 
layerplex result would indicate that the sample was negative for all pathogens screened. 




surveillance studies. Further, the layerplex technique achieves high-throughput testing for 
all targets by utilizing a single DNA extraction and one qPCR reaction, effectively 
circumventing current qPCR platform’s unique-probe limitations while maintaining 
compatibility with commonly utilized qPCR instruments. 
This study aimed to design a molecular diagnostic tool, using the qPCR layerplex 
technique, that would screen for the most common TBDs affecting domestic dogs by 
simultaneously targeting a broad spectrum of pathogens responsible for causing the TBDs. 
To this end, the pathogenic species that are of most concern to domesticated dogs within 
five TBD groups (i.e. borreliosis, anaplasmosis, rickettsiosis, ehrlichiosis, and babesiosis) 
were determined based on past prevalence studies and subsequently targeted for qPCR 
assay development (Beall et al., 2012, Bowman et al., 2009, Esteve-Gasent et al., 2017, 
Little et al., 2014, Little et al., 2010b, Piccione et al., 2016). In order to consolidate testing 
into a single layerplex format, 10 targeted pathogens were organized into three groups, or 
layers, based on species similarity and labeled with the same fluorogenic probe: borrelial: 
Bh, Bt, Bp, Bb; rickettsial: Ec, Ech, Ee, Ap, Rr; and pan-Babesia species babesial: Bab. A 
fourth probe was also utilized in order to label an 11th target, represented as an endogenous 
internal positive control for diagnostic quality control of DNA extractions (Modarelli et al., 
2018a). Overall, this study details the design and validation of 10 singleplex assays for 
each of the targeted pathogens, and the subsequent validation of integrating 11 assays into 







Material and methods 
 
Reference controls 
Bacteria and protozoa strains used for the analytical sensitivity and specificity 
analysis were as follows. Culture from wildlife isolates: Borrelia hermsii GGI DAH, B. 
hermsii GGII MTW-4, B. turicatae TCBP2, B. parkeri SLO, B. miyamotoi FR64b, B. 
coriaceae Co53, B. anserina BA-2, B. crocidurae DOS-56, and B. recurrentis 132 were 
provided by Dr. Tom Schwann at the Laboratory of Zoonotic Pathogens Rocky Mountain 
Laboratory NIAID Facility. Laboratory isolates: Borrelia burgdorferi B31 MSK5, B. 
burgdorferi B31 A3, B. garinii (ATCC 5183TM), and B. afzelii (ATCC 51567) were 
cultured by Dr. Maria Esteve-Gasent at the Texas A&M College of Veterinary Medicine. 
Laboratory isolates: Babesia conradae Wideload, B. microti CMNI, and B. duncani COA3 
were cultured and provided by Dr. Patricia Conrad at UC Davis School of Veterinary 
Medicine. Laboratory isolates: Babesia canis vogeli Buster, Babesia gibsoni Ruby, 
Babesia duncani WA3, B. bovis Mexico, B. bovis TAMU, B. caballi Mexico, B. cabalii 
USDA, B. divergens Purnell, B. microti Ruebush, B. odocoilei Wisconsin, B. bigemina, 
Theileria equi USDA, and Cytauxzoon felis Tyson were cultured and provided by Dr. 
Patricia Holman at the Texas A&M College of Veterinary Medicine. Genomic DNA 
isolated from FA substrate slides (VMRD, Pullman, WA; Focus Diagnostics, Cypress, CA; 
Protatek, St. Paul, MN): Ehrlichia canis (SLD-IFA-EC), E. chaffeensis (IF1003), 
Anaplasma phagocytophilum (AG-112), Rickettsia rickettsii (SLD-IFA-RMSF), R. typhi 
(SLD-IFA-RMSF), Babesia canis (AG-119), B. gibsoni (AG-123), and Borrelia 




rehydration with 10.0 μL Phosphate-buffered saline (PBS) onto a single slide well and then 
suspended in 90.0 μL PBS. The 100.0 μL solution was then purified using the MagMAXTM 
Nucleic Acid Isolation Kit AMB1836 (Thermo Fisher Scientific, Waltham, MA) following 
manufacturers recommendations adopted from a previous publication (Schroeder et al., 
2013). 16S rRNA gene gBlocks (IDT, San Jose CA) consisting of: Ehrlichia ewingii 
Stillwater (NR_044747, 1435 base pairs), E. ruminantium Welgevonden (NR_074513, 
1507 base pairs), E. muris AS145 (NR_025962, 1428 base pairs). gBlocks were utilized 
for validation purposes due to the inability to obtain genomic DNA for the aforementioned 
isolates. The artificially synthesized gBlocks were constructed based on respective 
pathogen type-strain 16S rRNA sequences found in the National Center for Biotechnology 
Information (NCBI) database. Genomic DNA reference strains provided by the Texas 
A&M Veterinary Medical Diagnostic Laboratory (TVMDL): Ehrlichia canis, Anaplasma 
phagocytophilum, A. marginale, A. centrale, and A. ovis. 
 
Clinical and diagnostic sample collection 
In addition to tick vectors, the ideal pre-mortem biological sample type for 
screening the aforementioned tick-borne pathogens in dogs is whole blood (Bilgic et al., 
2013, Elbir et al., 2013, Rosenberg et al., 2018, Vojdani et al., 2009). DNA detection of Bb 
within blood is considered rare and generally inadvisable, though studies have documented 
a low percentage of detection of the spirochete in blood samples (Babady et al., 2008, 
Primus et al., 2018). Therefore, the majority of validation analysis for the assay detailed in 
this study focused on utilizing ticks and whole blood samples. However, due to the limited 




to simulate infection. 9 infected skin biopsies and 9 joints were harvested for analysis. This 
study also collected 1,171 archived blood samples originating from dogs that were 
submitted to two full-service Texas A&M Veterinary Service Laboratory (TVMDL) 
facilities (i.e. College Station, TX and Amarillo, TX). All samples were archived after the 
15-day hold period in which TVMDL has analyzed the samples and provided results to 
veterinarians, but prior to their destruction and disposal. Further, a total of 211 
Rhipicephalus sanguineus (brown dog ticks), and 35 Ixodes scapularis (black-legged ticks) 
were utilized for this study. 
 
Oligonucleotide design 
Pathogens were separated into three groups (layers) based on species classification: 
borrelial (Borrelia species: Bb, Bh, Bt, Bp); rickettsial (Rickettsiales pathogens: Rr, Ap, 
Ec, Ech, Ee); and babesial (Babesia species: Bab). Assays were designed to target specific 
gene targets (i.e. 16S rRNA for Ehrlichia spp., msp2 for Anaplasma phagocytophilum, 18S 
rRNA for Babesia spp., flaB and bipA for Borrelia spp., and rrhyp for Rickettsia rickettsii) 
based on previous studies (Babady et al., 2008, Courtney et al., 2004, Kato et al., 2013, 
Lopez et al., 2013, Modarelli et al., 2018b, Peleg et al., 2010, Rozej-Bielicka et al., 2017). 
Up to 100 individual nucleotide sequences available in GenBank® greater than 500 bp for 
each target pathogen were acquired, aligned, and evaluated along with homologous and 
heterologous gene sequences from closely related species for each respective layer as 
detailed in the supplementary information (n = 610, 70, 564, 268, 86, and 12 for 16S rRNA, 
msp2, 18S rRNA, flaB, bipA, and rrhyp, respectively; Appendix A 1-5). Due to the 




sequences were limited to only target pathogens for evaluation. CLC Main Workbench 7.7 
(CLCbio, Aarhus, Denmark) was utilized for gene sequence alignments and nucleotide 
mismatch identification. Additional analysis was performed with Primer Express 3.0 
software (Thermo Fisher Scientific, Waltham, MA) to verify primer/probe conformance to 
an annealing temperature of 60ºC and thermoprofile protocol developed for this project. 
Sequences were then evaluated on the basis of previously established criteria, and 
mismatch locations in respect to heterologous pathogens were identified (Modarelli et al., 
2018a). Oligonucleotide sequences were then BLAST® searched against the NCBI 
database and respective pathogen genomes to confirm specificity (Altschul et al., 1990). 
Sequence information and the final reaction concentrations for oligonucleotides utilized in 
the qPCR assay are provided in Table 3-1. All primers and Dual-Labeled BHQ® Probes 
were purchased from a commercial source (LGC Biosearch Technologies, Petaluma, CA). 
Primer and probe sequences for detection of Bb, Bh, Bt, Bp, Ec, Ech, Ee, Ap, Rr, and Bab 
were developed in house, EIPC-K9 was taken from a previous publication, and optimal 
oligonucleotide concentrations were determined through empirical testing (Modarelli et al., 
2018a). 
 
Plasmid positive amplification control DNA 
A single plasmid control featuring the Bb, Bh, Bt, Bp, Ec, Ech, Ee, Ap, Rr, and Bab 
target regions was utilized as a positive amplification control (PAC), and for determination 
of analytical sensitivity and limit of detection (LOD). The plasmid PAC was synthetically 
generated commercially by inserting the select gene fragments into pUC57 plasmid DNA 




(Thermo Fisher Scientific, Waltham, MA). The plasmid was quantified using a 
NanoDrop™ 8000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA). An 
endogenous internal positive control (EIPC-K9) was prepared as described previously 
(Modarelli et al., 2018a). The final PAC was prepared by combining the target pathogen 
plasmid DNA with EIPC-K9 target plasmid DNA at 1,000 and 150,000 copies/μL, 
respectively. The PAC was used for each qPCR run to ensure functionality of the qPCR 
conditions. 
 
Nucleic acid purification 
Nucleic acid purification performed on all samples used in this study for assay 
validation utilized the MagMAXTM Nucleic Acid Isolation Kit AMB1836 (Thermo Fisher 
Scientific, Waltham, MA) following manufacturers recommendations adopted from a 
previous publication (Schroeder et al., 2013). 
 
Layerplex real-time PCR 
In order to facilitate the simultaneous screening off all pathogens in a single 
multiplex format, multiple pathogens were grouped together under specific “layers” and 
labeled with the same Dual-Labeled BHQ® Probe. Termed here as “layerplexing”, four 
unique probes were utilized to accommodate all 10 assays and the endogenous internal 
positive control (EIPC-K9) in a single qPCR reaction. The layerplex qPCR was performed 
with Bb, Bh, Bt, Bp, Ec, Ech, Ee, Ap, Rr, Bab, and EIPC-K9 specific primers and probes 
(Table 3-1) using qPCR Path-IDTM buffer (Thermo Fisher Scientific, Waltham, MA) 




qPCR buffer, 2 μL of 12.5x primer-probe mix consisting of all oligonucleotides in Table 2-
1, 2.5 μL of nuclease-free water, and 8 μL of nucleic acid template. Layerplex qPCR was 
performed using an Applied Biosystems® 7500 Fast Real-Time PCR System (Thermo 
Fisher Scientific). Cycling conditions (thermal profile) consisted of activation and 
denaturation at 95°C for 10 min (1 cycle), and 40 cycles of amplification at 95°C for 1 sec 
and 60°C for 30 sec, for a total run time of 59 min. Samples with a quantification cycle 
(Cq) ≤ 38 were considered positive. 
 
Singleplex and conventional multiplex real-time PCR 
Singleplex analyses for the detection of individual pathogens were conducted by 
following the same qPCR reaction template with modifications to the primer-probe mixes. 
For specific species detection, the associated primer-probe mix was added in place of the 
layerplex primer-probe mix and was dependent upon intended species detection as detailed 
further in Appendix B. Conventional multiplex qPCR analysis where each probe labels 
only one species assay is feasible for a combination of most pathogens, including Borrelia 
spp. and Rickettsiales pathogens. However, as the Ehrlichia spp. share a probe label, 
singleplex analysis would be required if an Ehrlichia spp. infection is suspected. Future 
studies should be conducted in order to further validate individual use of the multiplex 
capabilities. 
 
Confirmatory conventional PCR analysis 
All positive and suspect results from layerplex qPCR analysis were compared with 




16S rRNA gene of Ehrlichia and Anaplasma species (Wen et al., 1997), the ompA gene of 
Rickettsia species, the intergenic spacer sequence (16S rRNA-23S rRNA) of Borrelia 
species (Bunikis et al., 2004), and the 18S rRNA of Babesia species were utilized as 
described previously (Davitkov et al., 2015). Positive (genomic) controls and negative 
controls (water) were included in all PCR assays. All attained DNA amplicons were then 




Polymerase chain reaction efficiency was calculated using the following formula: E 
= 10(–1/slope) – 1 × 100, and R2 was calculated using the method described previously 
(D'Haene et al., 2010). To determine the LOD in terms of copy number, linear regression 
analysis and serial dilutions of the PAC (working stock: 7.59 × 10−5 ng/μL or 1.27 × 105 
copies/μL) were used as template. The LOD was expressed as copy number of the plasmid 
per assay where each copy of the plasmid represents 1 copy of the pathogen’s genome, or 
genome copy equivalents per microliter (GCE/μL). The copy number of the plasmid was 
calculated using the formula: copy number = [mass (g) × 6.022×1023] / [length (bp) × 650 
Da]. Diagnostic test evaluation for determining sensitivity and specificity, with 95% 
confidence intervals, was determined by following previously established formulas (Glas 




Table 3-1. Tick-borne pathogen assays organized by layers and EIPC-K9 PCR primers and probes sequences, amplicon sizes, and 
oligonucleotide concentrations. 
Oligonucleotide Sequence (5′–3′) and reporter dye* Amplicon (bp) Concentration (nM) Target  Reference 
Borrelial 
     Bb.flaB.161F AAGAGGGTGTTCAACAGGAAGG 
75 
450 
flaB This study      Bb.flaB.213R GAGAATTAACTCCGCCTTGAGAA 450 
     Bb.flaB.186P FAM-TCAACAGCCAGCACCTGCTACAGCA-BHQ1 125 
     Bh.flaB.531F-1 GGGCGCAAATCAGGATGAG 
119, 117 
450 
flaB This study 
     Bh.flaB.529F-2 GTGGGAGCAAATCAGGATGAG 450 
     Bh.flaB.647R TCCTCTTGCTGTCCTATCTCTTGC 450 
     Bh.flaB.615P FAM-AGCCTGAGCRCCTTCACCTGCAAAAAGA-BHQ1 125 
     Bt.bipA.728F-1 AGACCGGTACACAGGATTCTAAAGC 
139, 142 
450 
bipA This study 
     Bt.bipA.731F-2 CCGGCACACAGGATTCTAAAAC 450 
     Bt.bipA.869R GTTCCTGCTCCCTGAATAACATTATC 450 
     Bt.bipA.818P FAM-AGTTTTGGGAAGTGTTGTTGGTGGCGT-BHQ1 125 
     Bp.flaB.406F TTGTCCAATAAGTCAGCTGCTCAG 
117 
450 
flaB This study      Bp.flaB.522R TCTTAATGTCCATGAAGCTTGTGC 450 
     Bp.flaB.443P FAM-CTGAAGAGCTTGGAATGCAACCTGCA-BHQ1 125 
Rickettsial 
     Rr.hyp.724702F AGAGTAAATCAACGGAAGAGCAAAAC 
159 
450 
rrhyp This study      Rr.hyp.724860R CCCCTCCACTACCTGCATCAT 450 
     Rr.hyp.724788P CFO560-TCCTCTCCAATCAGCGATTCAGGCA-BHQ1 125 
     Ap.msp2.420F GACTTTCCTAGCATGGAGTTGGTT 
95 
450 
msp2 This study      Ap.msp2.514R GCGTGCCCTTTTGTAATACCTATAA 450 
     Ap.msp2.452P CFO560-CATTTCACCTTACACATGCGCCGGA-BHQ1 125 
     Ech.16S.64F GAACGGACAATTGCTTATAACCTTTT 
111 
450 
16S rRNA This study 
     Ech-Ee.16S.174R CCATCATTTCTAATGGCTATTCCATACT 450 
     Ee.16S.40F CGAACGAACAATTCCTAAATAGTCTCT 114 450 
     Ec.16S.61F GCCTCTGGCTATAGGAAATTGTTAGT 
113 
450 
     Ec.16S.148R CTCGGGGATTATACAGTATTACCCAC 450 
     Ehrl-spp.16S.83P CFO560-AGATTCCTACGCATTACTCACCCGTCTGC-BHQ1 125 
Babesial 
     Babsp.18S.65F-1 CGCATTTAGCGATGGACCA 
94, 93 
450 
18S rRNA This study 
     Babsp.18S.67F-2 GCTTTTAGCGATGGACCATTCA 450 
     Babsp.18S.289R CCTAATTCCCCGTTACCCGTT 450 
     Babsp.18S.228P Q670-CATCAGCTTGACGGTAGGGTATTGGCC-BHQ2 125 
EIPC-K9 






    EIPC.K9mt.13018R GGTTAGGGATGTGGCAACGA 31.25 
    EIPC.K9mt.12980P TAM-CACGTCGAATACCAACGCCTGAGCC-BHQ1 31.25 





Layerplex and singleplex detection of target DNA 
The layerplex assay was designed for the detection of Bh, Bt, Bp, Bb, Ec, Ech, Ee, 
Ap, Rr, and pan-Bab species in domesticated dog diagnostic specimens. Each pathogen 
specific set of oligonucleotides was optimized individually, and then layered together 
based on species similarity into a single-reaction assay. A canine specific endogenous 
internal positive control (EIPC-K9) was utilized in the consolidated layerplex assay 
(Modarelli et al., 2018a). The sequences of all oligonucleotides, their reaction 
concentrations, and their respective target genes are detailed in Table 3-1. 
 
qPCR linear dynamic range, efficiency, and analytical sensitivity 
The linear dynamic range and efficiency of the layerplex qPCR assay, using the 
listed primers and probes (Table 3-1), was determined using serial dilutions of the plasmid 
positive amplification control (PAC). Analytical sensitivity for each pathogen in the 
layerplex assay was assessed in comparison to the respective single pathogen assays. This 
comparison approach was performed to evaluate the multiple oligonucleotides’ 
combinatory effects on performance. Analytical sensitivities of the layerplex and 
singleplex assays were comparable for the detection of all pathogens as indicated by linear 
regression plots (Figure 3-1 A-D). Results were obtained in duplicate experiments to verify 








The singleplex and layerplex assays exhibited 91-105% efficiency (R2 > 0.99) for 
the detection of serial dilutions of each target (Table 3-2). Copy number calculations for 
limit of detection (LOD) of the qPCR were estimated to be roughly 16 genome copy 
equivalents per microliter (GCE/μL) of each target using linear regression analysis and 
serial dilutions of the plasmid PAC; evaluated independently by singleplex and combined 




Figure 3-1. Analytical sensitivity of singleplex and layerplex real-time PCR assays. 
Assays consist of (A) Borrelia species (B. burgdorferi, B. parkeri, B. turicatae, B. 
hermsii), (B) Rickettsiales (Ehrlichia canis, E. ewingii, E. chaffeensis, Anaplasma 
phagocytophilum, Rickettsia rickettsii), (C) Babesia species, and (D) combined 
pathogen layers (borrelial, rickettsial, and babesial) detection. Plasmid positive 
amplification control (PAC) was serial diluted and analyzed by qPCR for each 
singleplex and combined layerplex assays. Each dilution was tested in duplicate. 































































Table 3-2. Assay efficiencies and R2 values for singleplex and layerplex assays. 
Plex Assays Efficiency (%) R2 
Layerplex Borrelial layer 105% 0.998 
 Rickettsial layer 104% 0.999 
 Babesial layer 105% 0.999 
Singleplex Bh 99% 0.996 
 Bt 101% 0.990 
 Bp 99% 0.998 
 Bb 97% 0.996 
 Ap 95% 0.996 
 Rr 97% 0.995 
 Ec 97% 0.996 
 Ech 94% 0.997 
 Ee 91% 1.000 




Analytical and in silico specificity analysis 
Analytical specificity was assessed by demonstrating failure to amplify 
representative species reference controls (i.e. genomic DNA and gBlocks) in duplicate 
testing from each species other than the intended targets. All homologous and heterologous 
reference controls used for analytical specificity analysis are detailed in Table 3-3. Further, 
through in silico analysis of respective gene sequences available through GenBank®, each 
assay was aligned with homologous and heterologous species to verify oligonucleotide 
mismatch analysis against all available strains and isolates gene sequences (Appendix B). 
There was no off-target amplification observed through analytical or in silico analysis from 
any borrelial or rickettsial assay in both layerplex and singleplex formats, thus revealing 
the high specificity of the assays. The babesial layer was designed with the intention to act 
as a pan-Babesia assay for canine, equine, bovine and cervine specific species. In that 
respect, the assay detected the desired canine pathogens and also detected a number of 
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equine, bovine, and human Babesia pathogens as well (i.e. B. canis, B. gibsoni, B. caballi, 
B. odocoilei, B. divergens, and B. bigemina) (Table 3-3). 
 
Table 3-3. Analytical specificities of each layer in the real-time PCR assay. 
 No. of 
samples 
tested 
   
 Layer Result  
Panel Borrelial Rickettsial Babesial 
Borrelial target speciesa 5 Positive Negative Negative 
Borrelia near neighborsb 7 Negative Negative Negative 
Rickettsial target speciesc 5 Negative Positive Negative 
Rickettsiales near neighborsd 6 Negative Negative Negative 
Babesial target speciese 6 Negative Negative Positive 
Babesia near neighborsf 8 Negative Negative Negative 
Tick DNAg 228 Negative Negative Negative 
Canine DNA, blood 1121 Negative Negative Negative 
a Borrelia hermsii GGI, B. hermsii GGII, B. turicatae, B. parkeri, and B. burgdorferi. 
b B. miyamotoi, B. coriaceae, B. anserina, B. crocidurae, B. recurrentis, B. garinii, and B. afzelii.  
c Ehrlichia canis, E. chaffeensis, E. ewingii, Anaplasma phagocytophilum, and Rickettsia rickettsii.  
d E. ruminantium, E. muris, A. marginale, A. central, A. ovis, and R. typhi. 
e B. canis, B. gibsoni, B. caballi, B. odocoilei, B. divergens, and B. bigemina. 
f Babesia conradae, B. microti, B. duncani, B. bovis, Theileria equi, and Cytauxzoon felis. 





Through triplicate testing, quantification cycle (Cq) values derived from qPCR 
analysis were comparable for the detection of all species by singleplex testing and the 
detection of the same species in layerplex format. Further, there was no statistically 
significant inhibition (p > 0.05) between either assay conditions by paired t-test statistical 
analysis of mean Cq values (Figure 3-2, Appendix D 1-3). Results also indicated that the 
EIPC-K9 did not experience significant inhibition in the layerplex format when compared 








Layerplex qPCR performance evaluation using randomly collected animal diagnostic 
samples 
A collection of 1,171 blood samples from domestic dog (Canis lupus familiaris), 
211 brown dog ticks (Rhipicephalus sanguineus), 35 black-legged ticks (Ixodes 
scapularis), and 18 tissues (9 skin and 9 joint) from 9 mice (Mus musculus) infected with 
Borrelia burgdorferi B31 A3, were screened by layerplex qPCR for determining 
diagnostic sensitivity and specificity. Analysis revealed a total of 26, 37, and 5 positives 
from borrelial, rickettsial, and babesial layers, respectively. Positive samples at the layered 
level were then subjected to relevant singleplex analysis to determine species identity, with 
the exception of the 5 babesial layer positives due to the pan-Babesia spp. screening nature 
 
Figure 3-2. Comparison analysis of singleplex real-time PCR assays Cq values 
against combined layerplex real-time PCR assay Cq values. Pathogens assayed are 
as follows: Borrelia burgdorferi (Bb), B. hermsii (Bh), B. turicatae (Bt), B. parkeri 
(Bp), Anaplasma phagocytophilum (Ap), Ehrlichia canis (Ec), E. chaffeensis (Ech), E. 
ewingii (Ee), Rickettsia rickettsii (Rr), Babesia species (Bab), and endogenous internal 
positive control (EIPC-K9). Singleplex qPCR conditions contained only the primers and 
probes needed for respective testing. Layerplex qPCR conditions contained all primers 
and probes listed in Table 1. All assays (singleplex and layerplex) were tested in 
triplicate against the same respective genomic DNA for each species. A paired t-test 
was conducted to statistically analyze Cq values obtained from both assay conditions. 















of the assay in which conventional PCR alone was used for species identification. 
Pathogen species identified from the diagnostic sample set included Ehrlichia canis (19 
from dogs, 18 from brown-dog ticks), Borrelia turicatae (8 from dogs), B. burgdorferi (9 
joint and 9 skin from mice), and Babesia gibsoni (5 from dogs). All positive samples were 
confirmed through relevant conventional PCR and Sanger sequencing. Diagnostic analysis 
at a Cq value cutoff of 38 revealed sensitivity and specificity values of 100% (86.8-100%) 
and 99.8% (99.4-99.9%), 100% (90.5-100%) and 99.1% (98.4-99.5%), and 100% (47.8-
100%) and 100% (99.7-100%) for borrelial, rickettsial, and babesial layers, respectively 
(Table 3-4). Singleplex analysis of relevant pathogen assays revealed similar results. EIPC-
K9 detected 100% of the dog DNA screened in this study at a mean Cq value of 21.2, and 
all sample values were within the appropriate range (Modarelli et al., 2018a). 
 
 
Table 3-4. Diagnostic test evaluation of layerplex assay from analyzed sample set.  
 Borrelial Rickettsial Babesial 
True Positives 26 37 5 
False Positives 3 13 0 
False Negatives 0 0 0 
True Negatives 1396 1375 1420 
Sensitivity 100% (86.8-100%) 100% (90.5-100%) 100% (47.8-100%) 





Early detection and pathogen identification is critical to limiting the impact of 
borreliosis, anaplasmosis, ehrlichiosis, rickettsiosis, and babesiosis on an infected canine 
patient. The ability to screen for all 5 infections simultaneously and rapidly using a single 
sample and test is highly desirable to aid in obtaining a diagnosis. The main benefit of the 
newly termed layerplex qPCR method, described herein, includes the ability to screen for 
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all 10 pathogen specific assays concurrently without a reduction in sensitivity or specificity 
compared to singleplex analysis. The method described herein also allows for an 
endogenous internal positive control (EIPC) to be utilized, despite already targeting 
numerous pathogens, due to the consolidation of probe labels. Though this study utilized 
an EIPC, an exogenous internal positive control (XIPC) could be substituted and probe 
labeled accordingly. 
While the detection of a positive layer from qPCR testing would require additional 
conventional, singleplex and/or multiplex testing to reveal the specific pathogen species 
identity, an obtained negative result by the same method would not require additional 
testing and instead indicate the lack of pathogen presence in the screened sample. As 
treatment is similar for all pathogens screened within the respective layers, diagnosticians 
and veterinarians may find that additional singleplex testing is not necessary for 
appropriate patient treatment. Although treatment can be determined based on results at the 
layer level, it is strongly recommended that positive results be subsequently identified to 
the species level due to public health concern of reportable pathogens screened (e.g. Rocky 
Mountain spotted fever, Lyme disease, etc.). 
It is noteworthy that most assays designed here were able to differentiate between 
species at the primer level (Appendix B). In other words, the oligonucleotide probes 
simply acted as a labeling dye that facilitated qPCR detection under multiplex/layerplex 
conditions. Therefore, SYBR® Green based reactions may also be utilized for sample 
analysis for all described assays in a singleplex approach. While comparable specificity 
and sensitivity can be achieved utilizing SYBR® Green formulation for the assays, the 
ability to screen a sample for all pathogens simultaneously will be limited. However, as 
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this study has indicated no primer inhibition when all assays are combined together, 
multiplexing may be accomplished with SYBR® Green due to potentially unique melting 
temperatures generated by each assay for each respective pathogen. Future studies aimed at 
utilizing the assays with a SYBR® Green reaction should conduct further validation 
analysis. 
Oligonucleotides designed for qPCR detection of the aforementioned tick-borne 
disease have resulted in a unique look into the specificity of oligonucleotides under various 
mismatch conditions. Though the intention of this study was not to determine the exact 
number of mismatches needed to support efficient qPCR differentiation between species, 
data presented here does provide insightful evidence for future qPCR assays aiming to 
differentiate between genetically similar species. As depicted with B. parkeri (Appendix B 
1C), for example, a minimum of 1-2 mismatches in a general primer location, and 1 in the 
3’ position of a primers annealing location, was sufficient in restricting primer annealing 
on a heterologous species, and therefore preventing the extension of DNA polymerase and 
subsequent formation of an undesired amplicon. Additionally, in the case of Ehrlichia 
species detection, analysis revealed that although the probe sequence used for the detection 
of all Ehrlichia species is identical, differentiation can be achieved at the primer level, due 
in part, to the presence of significant mismatches. Further, differentiation was achieved 
even when the probe and reverse primer sequence were identical, as is the case in Ehrlichia 
chaffeensis and E. ewingii, and Borrelia turicatae and B. parkeri (Appendix B 1E and F, C 
and D, respectively). Here, placing the forward primer over detected mismatches, and 
designing the probe to anneal on the species’ sense strand only, achieved species 
differentiation. In this case, the mismatches of the forward primer prevent the DNA 
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polymerase from successfully annealing and cleaving the probe that would anneal onto 
heterologous species, and only provide detection for the appropriate species. 
In specific situations, a number of assays described in this study utilized multiple 
forward primers. The utilization of more than one forward primer was necessary to anneal 
and subsequently detect all strain variants within the intended species. Borrelia hermsii, 
for example, has been described to contain two unique genomic groups (GG), which differ 
slightly genetically (Porcella et al., 2005). Therefore, the assay designed to detect the 
pathogen required two forward primers to compensate for the additional mismatches 
within the flaB gene of the two GG (Appendix B 1B). A similar technique was also 
required for efficient detection of B. turicatae (Appendix B 1D). In the case of the pan-
Babesia assay, two forward primers were utilized in order to detect all canine specific 
species desired with one assay (Appendix B 1J). The pan-Babesia assay proved efficient in 
amplifying a number of additional species including the desired canine specific pathogens. 
Although there are mismatches present in the additional Babesia species detected by the 
assay, the mismatches are mostly situated on the 5’ end of the forward primer and was not 
found to negatively affect primer binding activity. Consequently, the pan-Babesia assay 
allowed for a more thorough screening of a sample for a more complete Babesia species 
repertoire. Future studies should aim to define the limitations of the assay in respect to 
broad-spectrum Babesia species not covered in this study. 
The goal of this study was to evaluate the layerplex methodology for targeting 11 
targets (i.e. 10 tick-borne pathogens and an EIPC) in terms of performance (i.e. LOD, 
efficiency, and R2), and specificity to a wide range of homologous and heterologous 
species reference controls. In that respect, performance of the layerplex qPCR was 
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comparable to other singleplex and duplex qPCR assays available for the detection of tick-
borne pathogens (Annoscia et al., 2017, Courtney et al., 2004, Hojgaard et al., 2014, 
Kledmanee et al., 2009, Peleg et al., 2010, Primus et al., 2018, Rodriguez et al., 2015, 
Sirigireddy and Ganta, 2005). Efficiency and R2 values for all assays in both singleplex 
and layerplex formats were within ideal ranges and were shown to be unaffected by the 
large collection of oligonucleotides present in the assay. In analytical sensitivity testing, 
the layerplex displayed no loss in sensitivity in any layer when compared to the respective 
singleplex qPCR assays. Further, no oligonucleotide-induced inhibition was observed 
when comparing the detection capabilities of the layerplex format to singleplex testing. As 
the layerplex assay depicted in this study revealed efficient detection of 11 targets labeled 
with 4 probes in a layerplex format, further studies are warranted to evaluate the potential 
of detecting more targets than the limited analysis presented here. 
Though linear regression analysis revealed that a Cq value of 36 was an adequate 
positive sample cutoff (Appendix D), diagnostic sample analysis indicated a number of 
false negatives at that cutoff value. When the Cq cutoff value was increase to 38, 
sensitivity evaluations increased to 100%, and eliminated the occurrence of false negatives. 
Therefore, a Cq of 38 should be considered the cutoff value for diagnostic samples in order 
to detect all potentially weak positive samples. It is important to note that analyzing 
samples in terms of a Cq value of 38 increases sensitivity at the expense of specificity. 
Samples presetting Cq values near the cutoff value should be assessed in conjunction with 
additional diagnostic modalities (i.e. serological findings, clinical presentation, etc.). 
Further, due to the lack of identified positive samples for various TBD species (e.g. 
Babesia canis, Borrelia turicatae, Ehrlichia chaffeensis, etc.) current validation analysis 
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can only estimate the diagnostic specificity and sensitivity of these assays until further 
studies are conducted. However, the provided analytical and in silico analysis for each 
assay, accompanied with the diagnostic performance of the respective layered assays, 
should be used as a guideline until additional positive diagnostic samples are supplemented 
into additional analysis. Furthermore, though no coinfections were observed from the 
available diagnostic sample data set, the ability of the layerplex assay to support parallel 
detection through amplification of multiple probe dyes is supported by the linear 
regression analysis that depicted results for all layers labeled independently with unique 
probe dyes during concurrent testing. 
Access to additional reference controls was limited, resulting in substantial reliance 
on in silico analysis of publicly available nucleotide sequences. It is important to note that 
additional Rickettsia rickettsii reference controls, and controls representing near-neighbors 
(i.e. R. parkeri, R. akari, etc.), were not available for evaluation. Additionally, as the R. 
rickettsii assay is targeting a hypothetical protein conserved in R. rickettsii strains only 
(hypothetical protein A1G_04230), available GenBank® sequences were also limited for 
in silico analysis. However, in silico sequence analysis of the R. rickettsii qPCR assay 
depicted conservation within all available R. rickettsii gene sequences, a lack of gene 
similarity in whole genome DNA analysis of other Rickettsia species, and the absence of 
amplification of the available near-neighbor R. typhi reference control (Appendix B 1I). 
Further studies should be conducted to further verify assay specificity in respect to 
additional Rickettsia species reference controls. In silico analysis limitations also extend to 
the Anaplasma phagocytophilum and Borrelia turicatae assays and their respective 
targeted msp2 and bipA genes. As in the case of R. rickettsii, limited msp2 gene sequences 
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are available due to pathogen specific conservation (Courtney et al., 2004). However, the 
bipA gene has been shown to be conserved in other tick-borne relapsing fever (TBRF) 
species, though a majority of these species do not have bipA sequences available in NCBI 
(Lopez et al., 2010). Nevertheless, despite limited in silico analysis of both A. 
phagocytophilum and B. turicatae, qPCR analysis against numerous close neighbor 
reference controls supports assay specificity. In respect to in silico analysis of the Borrelia 
burgdorferi assay, there are numerous mismatches in which the oligonucleotides are 
situated in comparison to gene sequences from various species within the B. burgdorferi 
sensu lato complex (BBSL) (Appendix B 1A). The BBSL group, at present date, contains 
approximately 20 identified spirochete species with public health concern (Becker et al., 
2016). However, due to limited reference control availability it is not conclusive if the 
assay will not cross-amplify and subsequently detect these species during qPCR screening. 
Therefore, future studies should be conducted to verify the specificity of the assay to B. 
burgdorferi sensu stricto when screening samples with unknown BBSL infection status. 
Despite these limitations, this study achieved the goal of simultaneous screening 
for 11 targets through layerplex methodology. Collectively, these findings provide support 
for additional studies to further validate the layerplex qPCR capabilities in terms of 
applying the methodology to different disease groups that require the detection of a broad 
spectrum of pathogens, as well as assessing the methodologies limits of detection in terms 
of targets labeled in a given reaction. In conclusion, this evaluation demonstrates the 
capacity of the layerplex qPCR assay to detect Borrelia hermsii, B. turicatae, B. parkeri, 
B. burgdorferi, Ehrlichia canis, E. chaffeensis, E. ewingii, Anaplasma phagocytophilum, 
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Rickettsia rickettsii, and Babesia species DNA simultaneously with high sensitivity and 




MOLECULAR PREVALENCE AND ECOREGION DISTRIBUTION OF TICK-BORNE 
PATHOGENS IN DOGS OF TEXAS 
 
Introduction 
Due to the increased resistance of ticks to acaricides (Coles and Dryden, 2014), 
ease of travel, and the continuous geographical expansion of ticks (Schurer et al., 2014), 
dogs (canis lupus familiaris) are at continuous risk for tick-borne diseases (TBD) in the 
United States (Chomel, 2011, Fritz, 2009). The groups consisting of borrelial (Borrelia 
turicatae, B. hermsii, B. parkeri, B. burgdorferi), rickettsial (Ehrlichia canis, E. 
chaffeensis, E. ewingii, Anaplasma phagocytophilum, Rickettsia rickettsii), and babesial 
(Babesia gibsoni, B. canis) pathogens have been documented as the most common causes 
of TBDs in dogs (Chomel, 2011, Esteve-Gasent et al., 2017, Sudhakara Reddy et al., 
2016). Primary tick vectors responsible for transmitting these pathogens vary across 
disease groups and even at the pathogens’ genus level, but are contained within the 
families of Ixodidae (hard ticks) and Argasidae (soft ticks) (Dantas-Torres et al., 2012). 
Wildlife are generally considered appropriate reservoir hosts for the majority of these ticks 
and vectored pathogens, though dogs and humans can also act as incidental hosts and 
manifest disease if exposed (Dantas-Torres et al., 2012, Lopez et al., 2016). Consequently, 
dogs are implicated as effective sentinels for human TBDs and may indicate geographical 
areas of increased zoonotic risk (Abdullah et al., 2018, Esteve-Gasent et al., 2017, Mead et 
al., 2011). 
Few molecular prevalence studies concerning TBDs in dogs have been conducted 
in the U.S., including limited surveillance in dogs residing in Minnesota (Beall et al., 2008) 
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and Oklahoma (Little et al., 2010b), but none in Texas. Instead, the majority of TBD 
prevalence studies in the U.S. have been limited to molecular detection in humans (Harris 
et al., 2016, Heitman, 2016), or serological analyses in dogs (Beall et al., 2012, Bowman et 
al., 2009, Esteve-Gasent et al., 2017, Little et al., 2014, Little et al., 2010a, Little et al., 
2010b, Qurollo et al., 2014). The consensus from these reports indicated an approximate 
TBD seroprevalence of 2% across Texas. In addition, over the last 5 years IDEXX 
laboratories have serologically documented 11,406 cases of ehrlichiosis, 5,040 of 
anaplasmosis, and 2,705 of Lyme disease in dogs from the state of Texas 
(http://www.dogsandticks.com, accessed July 2018). This information alone is impressive, 
but does not include any data on canine babesiosis, which has been recently reported in 
Texas dogs (Cannon et al., 2016). Therefore, although there is seroprevalence 
documentation of TBDs in Texas dogs, little is known about the prevalence of actively 
infected dogs. 
The aim of this study was to expand epidemiological data of TBDs in Texas dogs 
by evaluating the molecular prevalence of their respective causative agents with an 
emphasis on ecoregion distribution in Texas. Molecular screening, in contrast to 
serological screening, may identify active infections and indicate specific ecoregions 
containing sentinels of disease. Ecologists commonly delineate Texas into 10 natural 
ecological regions, primarily based on unique plant communities as a result of differing 
climate, soil, and weather conditions (Figure 1-1) (Gould et al., 1960). This study may 
reveal a unique association of TBDs within subsequent ecosystems. To that end, 1,171 
whole-blood dog samples were collected opportunistically from two Texas A&M 
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Veterinary Medical Diagnostic Laboratory (TVMDL) locations (Amarillo and College 
Station) and screened for the presence of tick-borne pathogens. 
This study was designed in order to estimate the molecular prevalence of TBDs in 
domestic dogs of Texas. Conducting a molecular prevalence study of TBDs may provide 
updated rates of active exposure and indicate specific ecoregions that may contain sentinels 
of disease. To our knowledge, this is the first study if its kind in Texas and can provide 
baseline data for future research and public health surveillance programs. 
 
Materials and methods 
 
Study area and samples 
Between June 2016 and February 2018, a total number of 1,171 EDTA whole-
blood samples were collected from domesticated dogs submitted to the Texas A&M 
Veterinary Medical Diagnostic Laboratory (TVMDL). All blood samples were submitted 
initially to the TVMDL for complete blood count (CBC) analysis, and then transferred to 
the College of Veterinary Medicine & Biomedical Sciences at Texas A&M University 
after the 15-day legal hold period, in accordance with the Material Transfer Agreement 
between both institutions. No confidential information regarding the pet owners and/or 
veterinary clinic where the animals were evaluated was provided. No recruitment of 
animals for the study was performed, and the research team did no direct handling of 
animals. 
Blood samples were collected from dogs of different ages, breed, sex, and health 
states, and originated from ten ecoregions of Texas: Blackland Prairie, Cross Timbers, 
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Edwards Plateau, Gulf Prairies, High Plains, Piney Woods, Post Oak Savanah, Rolling 
Plains, South Texas Plains, and Trans-Pecos (Gould et al., 1960). A total of 121 samples 
from each ecoregion, with the exception of 82 from the Trans-Pecos ecoregion due to 
limited availability, were collected in order to estimate true prevalence of disease. The 
sample set number was calculated assuming a TBD prevalence rate of 2% (seroprevalence) 
in Texas at a confidence interval of 95% (Beall et al., 2012, Bowman et al., 2009, Esteve-
Gasent et al., 2017, Humphry et al., 2004, Little et al., 2014, Little et al., 2010a, Little et 
al., 2010b, Qurollo et al., 2014). Blood samples were collected opportunistically from two 
TVMDL clinical pathology departments located in College Station, TX (n = 960) and 
Amarillo, TX (n = 211). Figure 4-1 shows in grey the counties from which samples were 
collected and tested. 
 
DNA extraction and real-time polymerase chain reactions (qPCR) 
From each animal, an aliquot of EDTA whole-blood (50 μL) was DNA purified 
using the MagMAXTM Nucleic Acid Isolation Kit AMB1836 (Thermo Fisher Scientific, 
Waltham, MA) and the KingFisherTM Flex (Thermo Fisher Scientific) automated 
purification system following manufacturers recommendations adopted from a previous 
publication (Schroeder et al., 2013). To evaluate the success of DNA extraction, a canine 
specific endogenous internal positive control (EIPC-K9) targeting the MT-ND5 gene was 
utilized in all qPCR reactions (Modarelli et al., 2018a). 
qPCR analysis for all 11 targets of interest were screened simultaneously utilizing a 
qPCR layerplex methodology (Chapter 2. Provisional patent US 62/563, 780). In 
particular, the pathogens targeted with this assay include: Borrelia burgdorferi sensu lato, 
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B. turicatae, B hermsii (genomic groups I and II), B parkeri, Anaplasma phagocytophilum, 
Ehrlichia canis, E. chaffeensis, E. ewingii, Rickettsia rickettsii and Babesia spp. The 
layerplex qPCR was performed using an Applied Biosystems® 7500 Fast Real-Time PCR 
System (Thermo Fisher Scientific), following primer/probe concentrations and 
thermocycler conditions established in the patent pending disclosure. Samples with a 
quantification cycle (Cq) ≤ 38 were considered positive and confirmed through 
conventional PCR and Sanger sequencing. 
 
DNA sequencing and sequence analysis 
All positive and suspect results from layerplex qPCR analysis were compared with 
those obtained by conventional PCR. Conventional PCR protocols for the detection of the 
16S rRNA gene of Ehrlichia and Anaplasma species (Wen et al., 1997), the 16S rRNA-23S 
rRNA intergenic spacer sequence (IGS) of Borrelia species (Bunikis et al., 2004), and the 
18S rRNA of Babesia species were utilized as described previously (Davitkov et al., 2015). 
Positive (genomic) controls and negative controls (water) were included in all PCR assays. 
All attained DNA amplicons were then Sanger sequenced in both directions to obtain a 
consensus sequence (Eurofins Scientific, Louisville, KY). Consensus sequences were then 
evaluated with CLC Main Workbench (CLCbio, Aarhus, Denmark) and compared with 
published sequences on the National Center for Biotechnology Information (NCBI) 
database using the Basic Local Alignment Search Tool (BLAST). All DNA extractions and 
PCR reactions were prepared and performed under veterinary diagnostic laboratory 
conditions (i.e. biosafety level 2, biosafety cabinets, good laboratory practices) to avoid 





Summary of study area and dog samples 
The 1,171 canine whole blood samples originated from dogs residing in 55.9% 
(142/254) of the total counties in Texas, between June 2016 and February 2018. Due to the 
large geographic size and population dispersion within counties in Texas, the study area 
was separated into rural and urban counties per designations set by the Texas Department 
of State Health Services, which bases distinctions on population census reports 
(https://www.dshs.texas.gov/chs/hprc/counties.shtm, accessed July 2018). In that respect, 
samples originated from 36.4% (426/1171) rural counties, and 63.6% (745/1171) urban 
counties. Within this distinction, samples collected for this study accounted for 45.9% 
(79/172) and 76.8% (63/82) of all counties within either rural or urban settings, 
respectively. Sample coverage of each representative county within the 10 ecoregions of 
Texas ranged as follows: Piney Woods 68.0% (17/25), Gulf Parries 76.5% (13/17), Post 
Oak Savannah 89.3% (25/28), Blackland Prairies 73.7% (14/19), Cross Timbers 75.0% 
(21/28), South Texas Plains 48.0% (12/25), Edwards Plateau 51.9% (14/27), Rolling Plains 
23.8% (10/42), High Plains 38.7% (12/31), and Trans-Pecos 33.3% (4/12). The average 
age of sampled dogs was 7.8 years (range 8 weeks - 20 years). The sex ratio of our sample 
set was 41.8% male, 52.3% female, and 5.9% unreported. 
Of the samples tested, a total of 2.73% (32/1171) dogs across Texas had one or 
more tick-borne pathogen DNA detected by layerplex qPCR analysis and confirmed by 
subsequent conventional PCR and Sanger sequencing. Infections identified included 1.62% 
(19/1171) Ehrlichia canis, 0.17% (2/1171) Anaplasma platys, 0.68% (8/1171) Borrelia 
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turicatae, and 0.42% (5/1171) Babesia gibsoni. The two dogs infected with A. platys were 
also found to be coinfected with E. canis. Further, molecular prevalence rates of each tick-
borne pathogen varied across each ecoregion as depicted in Table 4-1. Additional tick-
borne pathogens screened in the sample set, including Ehrlichia chaffeensis, E. ewingii, 
Rickettsia rickettsii, Anaplasma phagocytophilum, Borrelia burgdorferi, B. hermsii, B. 
parkeri, and Babesia canis, were not detected. 
 
 
Table 4-1. Molecular prevalence of tick-borne pathogens in domestic dogs across Texas 
ecoregions, ranging East to West. 
Ecoregion 
Ehrlichia  Anaplasma  Borrelia  Babesia  
canis platys turicatae gibsoni 
Piney Woods 0.82% (1/121) ND ND 0.82% (1/121) 
Gulf Parries  2.48% (3/121) ND ND 0.82% (1/121) 
Post Oak Savannah ND ND 1.65% (2/121) ND 
Blackland Prairies ND ND 0.82% (1/121) ND 
Cross Timbers 1.65% (2/121) 0.82% (1/121) 1.65% (2/121) 1.65% (2/121) 
South Texas Plains 2.48% (3/121) ND ND 0.82% (1/121) 
Edwards Plateau 0.82% (1/121) ND 0.82% (1/121) ND 
Rolling Plains 4.96% (6/121) 0.82% (1/121) 0.82% (1/121) ND 
High Plains 1.65% (2/121) ND 0.82% (1/121) ND 
Trans-Pecos 1.22% (1/82) ND ND ND 
Total 1.62% (19/1171) 0.17% (2/1171) 0.68% (8/1171) 0.43% (5/1171) 
ND, not detected 
 
Rickettsial molecular findings 
DNA from rickettsial pathogens were detected in a total of 21 (1.79%) rickettsial 
pathogens (19 Ehrlichia canis and 2 Anaplasma platys) across Texas. A higher molecular 
prevalence of E. canis infected dogs were detected in the Rolling plains ecoregion (4.96%), 
followed by a uniform prevalence of 0.82% - 2.48% across all other ecoregions except for 
the Post Oak Savannah and the Blackland Prairies, where E. canis DNA was not detected 
(Table 4-1, Figure 4-1). The mean age of dogs infected with E. canis was 6.3 years, (12 
weeks - 12.5 years), and no predilection of breed or sex was found. In this study, molecular 
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detection was highest in September (n = 6), followed by February (n = 4), but were also 
detected in January, April, June, July, October, and December. Two dogs, aged 7 and 8, 
were found coinfected with E. canis and A. platys. Both dogs originated from different 
central ecoregions (Table 4-1, Figure 4-1) but were detected during the month of February. 
Moreover, 36.8% (including both coinfected dogs) and 63.2% of the dogs were detected in 
rural and urban counties, respectively. The CBC analysis revealed that 94.1% of the 
infected dogs were thrombocytopenic (platelets below reference interval of 200-500 
K/µL), 52.9% were anemic (hematocrit below reference interval 32-50%), and 47.1% 
presented with both anemia and thrombocytopenia. When clinical history was available, 
the most common clinical signs and findings included lethargy (58%), inappetence (43%), 
and known exposure to ticks (43%). All E. canis and A. platys samples identified from 
Texas dogs were uploaded into GenBank® (Appendix E 1-2) and revealed 99 - 100% 
identity to E. canis and A. platys sequences already published. Of note, a single E. canis 
and A. platys coinfected dog was solely responsible for the 99% identity in both pathogen 
sequences, due to a single nucleotide polymorphism (SNP) present within each gene region 
in respect to published sequences. Additional sequence significance was not observed. 
 
Borrelial molecular findings 
A total of 8 (0.68%) Borrelia turicatae infections were detected at a molecular 
prevalence of 0.82 – 1.65% across 6 ecoregions (Table 4-1, Figure 4-1). Further depicted 
in Figure 4-1 were two clusters of counties in which infections were detected; one northern 
cluster maintaining a prevalence at 0.82%, and another located in central Texas ranging 
from 0.82 – 1.65%. The mean age of dogs infected with B. turicatae was 7.3 years, (2 - 10 
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years), and no predilection of breed or sex was indicated. Infections were detected in serial 
months ranging from February to August, with one to two detections per month. 37.5% 
and 62.5% of the infected dogs were detected in rural and urban counties, respectively. 
CBC analysis available for 6 of the dogs revealed that 100% were thrombocytopenic 
(platelets below reference interval of 200-500 K/µL), 16.7% anemic (hematocrit below 
reference interval 32-50%), and only one presented as both. Clinical history was not 
available for a majority of infected dogs, but spirochetemia was observed in 80% of the 
dogs by blood smear review. Sequence analysis of all 8 B. turicatae samples purified from 
Texas dogs indicated 99% identity with B. turicatae strain BTE5EL (CP015629) isolated 
from a Texas human (Christensen et al., 2017, Kingry et al., 2016). Various SNPs were 
observed in each sample, and a phylogenetic tree was generated (Figure 4-2) alongside two 
additional B. turicatae isolates from Texas (i.e. Ornithodoros turicata, CP000049; and 
human, CP015629). Interestingly, the phylogenetic tree revealed four distinct clusters, 
though no specific grouping pattern at the ecoregion level was noted. As depicted in Figure 
3-2, one cluster contained only the tick isolate, two clusters contained seven of the dog 
samples across multiple county origins, and a final cluster comprised of one single dog 
sample alongside the human isolate. All B. turicatae sequences obtained from dogs were 






Figure 4-1. Geographic representation of study area and molecular prevalence of 
tick-borne pathogens in domestic dogs of Texas. Map adapted with permission from 






Babesial molecular findings 
A total of 5 (0.43%) Babesia gibsoni infections were detected at a molecular 
prevalence of 0.82 – 1.65% in 4 eastern ecoregions (Table 4-1, Figure 4-1). The mean age 
of dogs infected with B. gibsoni was 5.2 years, (1.5 - 10 years), and though no predilection 
of sex was found, 80% of the dogs were reported as pit bull-type dogs. Infections were 
distributed in January, February, March, and November. Moreover, 60% and 40% of the 
infected dogs were detected in rural and urban counties, respectively. The CBC analysis 
available for all of the dogs revealed that 100% were thrombocytopenic (platelets below 
reference interval of 200-500 K/µL), 80% anemic (hematocrit below reference interval 32-
50%), and all but one presented as both. Although clinical history was not available for the 
infected dogs, small intraerythrocytic Babesia spp. parasites were observed in 80% of the 
dogs by blood smear review. All B. gibsoni samples purified from Texas dogs were 
 
Figure 4-2. Phylogenetic tree of 16S-23S rRNA intergenic spacer gene sequence 
alignments for Borrelia turicatae. Samples purified from dogs (this study), tick 
(Ornithodoros turicata), and a human in Texas. 
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uploaded into GenBank® (Appendix E 4) and revealed 100% identity to B. gibsoni 
sequences published in GenBank®. 
 
Discussion 
TBDs of domestic dogs are caused by numerous pathogens belonging to multiple 
genera. Typical diseases found in Texas include borreliosis, ehrlichiosis, anaplasmosis, 
rickettsiosis, and babesiosis. While past TBDs prevalence investigations of dogs in Texas 
have focused on seroprevalence studies, and therefore potentially detecting past exposure 
and not active infections, this study aimed to characterize the molecular prevalence of 
active infection(s) in dogs by directly detecting the pathogen(s) in blood samples. To our 
knowledge, this is the first molecular prevalence study of tick-borne pathogens in domestic 
dogs in Texas, and the first molecular report of A. platys in Texas and coinfection of E. 
canis and A. platys in Texas dogs. 
In the present study, the molecular prevalence of TBDs across Texas dogs ranged 
from 0.68% for borreliosis, 1.60% for ehrlichiosis, 0.17% for anaplasmosis, 0.00% for 
rickettsiosis, and 0.43% for babesiosis. As expected, these percentages are slightly lower 
than reported seroprevalence data for Texas as this data represents a current record of 
active infections by molecular analysis and not past or recent exposure detected by 
serological tools (e.g. antibody detection). When prevalence was analyzed by each 
ecoregion, a higher prevalence was found in specific regions that more closely resembles 
past seroprevalence data. The differences in prevalence among ecoregions may be 
attributed to the diverse topography, climate, and habitat features across Texas; 
characterized by west arid deserts, eastern swamps, southern subtropical, and a temperate 
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north. The state of Texas is also home to 91 mountain peaks with a majority located in far 
west Texas, contrasted by vast cave systems and canyons clustered in central and north 
Texas, respectively. 
In respect to rickettsial infections, the highest prevalence was observed in the 
north-central Rolling Plains ecoregion at 5.78% (6 E. canis and 1 A. platys infections), 
followed by the South Texas Plains at 2.48% (3 E. canis infections). It is interesting to note 
that a majority of infections were detected in the Rolling Plains despite having the least 
sample coverage from representative counties when compared to coverage in other 
ecoregions. While these findings may potentially be inflated due to limited ecoregion 
coverage, the data also suggests that a higher prevalence may be determined if more 
samples from other counties within the ecoregion were available for collection. Future 
studies aimed at characterizing E. canis infections in Texas dogs should include collections 
in this ecoregion. 
It is also worth noting that E. canis infections were detected in 80% of the 
ecoregions of Texas, indicating the pathogens ability to colonize dogs in numerous 
habitats. The ability for E. canis to be detected across Texas can be credited to its primary 
tick vector, Rhipicephalus sanguineus (brown dog tick), which is known as a hardy tick 
species found on dogs within either rural or urban settings, and can remain active in a 
variety of climates (Dantas-Torres et al., 2012). The brown dog tick is well known for its 
ability to dwell within homes and parasitize urban dogs, which is further supported by the 
63.2% of E. canis infected dogs detected by this study residing within urban counties 
throughout most of the year. The brown dog tick has also been implicated as a primary 
vector for A. platys, supporting the potential for further coinfections in Texas dogs (Ramos 
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et al., 2014). It is important to note that while A. platys was detected in this study, the 
molecular layerplex assay utilized for screening samples does not detect any other 
Anaplasma species besides A. phagocytophilum (Chapter 2. Provisional patent US 62/563, 
780). Both A. platys infections were incidentally detected through confirmation testing 
with conventional PCR analysis. Therefore, the potential for additional dogs to be actively 
infected with A. platys in Texas should be realized and further investigated. 
In this study no other rickettsial pathogens (i.e. Ehrlichia ewingii, E. chaffeensis, 
Anaplasma phagocytophilum, and Rickettsia rickettsii) were detected despite past studies 
indicating serological evidence of exposure in the study area. Possible considerations for 
the discrepancies include inadequate sample size or coverage of ecoregions for molecular 
detection, previous exposure without active infection, and false positive serologic results. 
Another potential reason for prevalence discrepancies between studies may be due to 
increased cross reactivity or limited specificity featured by serological methods utilized for 
seroprevalence investigations for closely related species currently or previously circulating 
in infected dogs (Modarelli et al., In press). 
Infections by the borrelial pathogen, Borrelia turicatae, were limited at a total 
molecular prevalence of 0.68% across Texas, and was the only borrelial pathogen detected. 
Within Texas, 60% of ecoregions indicated molecular exposure ranging from 0.68 – 
1.65%, with a majority of detection occurring only in north or central Texas. Interestingly, 
data from this study indicated two clusters of counties where B. turicatae infections were 
found. The first cluster was identified in northwest Texas with two dog infections. This 
cluster resembled counties within the same ecoregions described previously in a case 
report of three spirochetemic dogs in north Texas diagnosed with TBRF due to infection 
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with B. turicatae (Whitney et al., 2007). Further, the county locations of the three case 
report dogs reside in the same two ecoregions that contain the northern cluster of B. 
turicatae infected dogs indicated in this study (i.e. High Plains, and Rolling Plains). The 
second cluster, located in central Texas, contained six infected dogs within five counties 
across four ecoregions (i.e. Post Oak Savannah, Blackland Prairies, Cross Timbers, 
Edwards Plateau). A second case report of five dogs also coincide with our findings by 
indicating infections with B. turicatae centered in the Post Oak Savanah, Cross Timbers, 
and the Edwards Plateau ecoregions (Piccione et al., 2016). Geographical clustering of 
samples may be explained by the ecology of its primary soft tick vector, Ornithodoros 
turicata, which has traditionally been associated with the cave system of central Texas, 
therefore corroborating the central cluster observed in this current study (Dworkin et al., 
2008). 
The northern cluster from this study was identified in the High Plains and Rolling 
Plains ecoregions, of which the topography does not typically include cave systems. 
However, both ecoregions contain vast canyons, cliffs, and tunnels, which leads us to 
suspect that this landscape, despite the lack of caves, may provide a competent habitat for 
O. turicata ticks to thrive and transmit B. turicatae to susceptible hosts. It is important to 
note, that a soft tick species (i.e. Carios kelleyi) ecologically similar to O. turicata has been 
collected from bats emerging from cave systems in Texas (Donaldson et al., 2016). 
Donaldson and colleagues suggest that bats may facilitate the dissemination of O. turicata 
ticks given the regular cave locality and opportunistic feeding nature of the ticks. Texas 
Parks and Wildlife report 12 major sites where bats roost in Texas, including 9 
caves/bridges in central Texas ecoregions (i.e. Edwards Plateau, Blackland Prairies), 1 
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tunnel system in north Texas (i.e. Rolling Plains), and 2 bridges in east Texas (i.e. Gulf 
Prairies). Interestingly, bat roosting sites coincide with the two B. turicatae clustering 
locations identified in this study, specifically in the central Edwards Plateau and the 
northern Rolling Plains ecoregions. A similar association has been observed in respect to 
another TBRF species, B. hermsii, where it is hypothesized that infected migratory birds 
may contribute to the geographic distribution of the pathogen (Schwan et al., 2007). 
Therefore, the potential for bats to be implicated in the dispersion of B. turicatae should be 
further explored. 
It is also predicted that O. turicata ticks are sensitive to specific environmental 
conditions that restrict its spread within additional U.S. states that span between the 
established locations of Texas and Florida (Donaldson et al., 2016). Briefly, this intrastate 
region has been described to feature elevated temperatures during the driest quarter of the 
year and low temperatures during the wettest quarter as compared to average readings 
across the country, which may impede the ticks ability to colonize the area (Lopez et al., 
2016). Therefore, the same environmental variables may be viewed within the vastly 
different Texas ecoregions, resulting in the geographical clustering observed within this 
study and both case reports. 
Nevertheless, it should be noted that the clustering may be due to sampling bias 
around both TVMDL facility locations. Sequence analysis of the 16S-23S rRNA IGS gene 
region amplified from all 8 B. turicatae samples were aligned and evaluated for SNP 
groupings in order to identify potential evolutionary support for the two geographical 
cluster locations (Figure 4-2). While SNPs were observed across all samples of B. 
turicatae, and independent clusters were formed within the constructed phylogenetic tree, 
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no remarkable patterns among clusters were noted. Thus, there is no current evidence that 
the two groups are genetically distinct. 
Of the three tick-borne relapsing fever species screened for in this study (i.e. B. 
turicatae, B. parkeri, B. hermsii) only B. turicatae was expected to be circulating in Texas 
dogs (Lopez et al., 2016). However, due to limited past prevalence studies of TBRF in 
Texas, and recent predictions of additional soft tick species migrating south towards Texas 
(i.e. Ornithodoros hermsi, O. parkeri), we included surveillance testing for the respective 
B. hermsii and B. parkeri pathogens in our analysis (Sage et al., 2017). Findings from this 
study support the conclusions of past investigations and emphasize, that currently, the only 
TBRF species that has been detected in Texas is B. turicatae. The lack of B. burgdorferi 
sensu lato detected infections may be due to utilizing blood as a sole sample type, as well 
as the use of single aliquot of blood (50 µL), and should not be viewed as supporting 
evidence for lack of Texas dog exposure to the pathogen (Primus et al., 2018). 
In respect to babesial infections, only Babesia gibsoni was detected and indicated 
limited molecular prevalence from 0.82 – 1.65% across four eastern ecoregions (i.e. Cross 
Timbers, Gulf Prairies, Piney Woods, South Texas Plains). Molecular prevalence of 
Babesia gibsoni within Texas has been established in the past, though it was limited to a 
single analysis of dogs rescued from dog fighting rings, and no indication of specific 
prevalence within the state was available (Cannon et al., 2016). As expected, a breed 
specific association was observed in the present study with 80% of the B. gibsoni 
infections occurring in pit bull-type dogs. In addition to a breed specific genetic 
predisposition for B. gibsoni to infect pit bull-type dogs, these breeds are unfortunately 
more likely to encounter the infection through direct blood transmission from bites, or 
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unsterile ear/tail cropping/docking commonly associated with dog fighting rings (Cannon 
et al., 2016). Data from this study should serve as a reminder in conjunction with findings 
from Cannon et al. to properly screen susceptible dogs for potential infections and carrier 
states, and promptly administer appropriate treatment. 
The layerplex qPCR assay utilized for this study detects pan-Babesia species, 
though only B. canis vogeli was expected to potentially indicate prevalence alongside B. 
gibsoni due to suggestions of a shared tick vector, the brown dog tick (Jongejan et al., 
2018). However, it is important to note that it is currently unknown which babesiosis 
causing pathogens are most prevalent within Texas dogs. Additional Babesia species such 
as B. conradae are expected to re-emerge within the dog population, though, the 
geographic distribution of the pathogen is also unknown and the screening assay used in 
this study does not detect this specific species of Babesia (Di Cicco et al., 2012). Future 
studies aiming to characterize babesial infections within Texas dogs should include B. 
conradae in their analysis. 
Limitations of the study include potential sampling bias due to dog samples 
originating only from two TVMDL locations in contrast to active sample collections 
within the study areas. Further, samples were randomly selected from an archived pool of 
opportunistically collected TVMDL cases, and were only available from counties with 
established TVMDL clients. Ecoregions sampled in this study are represented by counties 
containing submitting veterinarians, and in the case of more rural areas, may not accurately 
reflect the origin of the dog sample. Sample analysis from the Trans-Pecos ecoregion, 
consisting of 83.3% rural counties, was severely restricted due to limited submitted 
samples, resulting in an incomplete sample set. Finally, it is important to note that whole-
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blood samples are not ideal for detecting Borrelia burgdorferi and Rickettsia rickettsii due 
to limited blood-borne circulation, and therefore findings from this investigation may 
differ from true prevalence of the pathogens in the area. However, studies have 
documented a low percentage of detection of the pathogens by PCR in dog and human 
blood samples (Kidd et al., 2008, Primus et al., 2018). In addition, this study based the 121 
dogs desired per ecoregion sample size on prior seroprevalence investigations due to a lack 
of available molecular prevalence data. Findings presented here may not be representative 
of true prevalence of the study area, but should be used as a baseline for future 
investigations. 
Despite these limitations, this study highlights the significance of molecular 
surveillance screening in order to characterize areas where active infections occur. 
Furthermore, it is important to note the zoonotic implication of B. turicatae, E. canis, and 
A. platys detected in this study (Christensen et al., 2017, Maggi et al., 2013, Ojeda-Chi et 
al., 2018). As Texas supports competent tick vectors for all pathogen species detected in 
this study (e.g. Ornithodoros turicata and Rhipicephalus sanguineus), and dogs may 
represent effective sentinels for human TBDs, the zoonotic transmission potential of the 
diseases should be considered in ecoregions indicating an increased molecular prevalence. 
In conclusion, the present study provided an estimation of molecular prevalence of 
various TBDs in domestic dogs of Texas. Our findings indicate that dogs are experiencing 
clinical infections with several pathogens, many of which have zoonotic implications. 
Future studies aiming to further characterize TBDs in Texas should consult the ecoregion 
findings established in this preliminary report when designing new molecular surveillance 




SUMMARY AND CONCLUSIONS 
 
TBDs are common across the United States and can result in critical and chronic 
diseases in a variety of veterinary and human patients. In the U.S. alone, reports indicate 
that roughly 48,000 humans every year are infected with tick-borne pathogens; though 
recent studies estimate the true prevalence to be 10-fold higher. Domestic dogs that inhabit 
urban homes throughout the U.S. are analogously exposed to the same pathogens and have 
been implicated as sentinels for human disease. Due to the documented increasing 
emergence of TBDs it is important, now more than ever, to characterize active infections in 
dogs so that maps depicting high risk areas of disease can be updated. Consequently, these 
maps may aid public health agencies in developing preventative measures for the affected 
areas and veterinary/human populations. However, little is known about the active 
infection prevalence of tick-borne pathogens within dogs, mainly due to a lack of 
consolidated molecular tools that can screen for a variety of causative agents and facilitate 
surveillance investigations for the pathogens. Through this work, the goal of developing a 
highly comprehensive molecular tool that can be applied to veterinary diagnostics and 
prevalence investigations was evaluated. 
To this end, the work detailed in this dissertation addressed three main aims to 
approach the fulfilment of a novel molecular tool for detecting numerous tick-borne 
pathogens threatening canine health. Initially, in chapter II a qPCR quality control 
mechanism, or EIPC, was developed and validated to facilitate the detection of canine 
specific mtDNA, which increases confidence in obtained qPCR results when paired with 
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an assay targeting multiple pathogens. While a fully validated and multiplex qPCR 
compatible canine specific EIPC has not been reported in the literature at present date, this 
study hypothesized that such a control could be developed and featured in a variety of 
multiplex qPCR assays with no added effect on sensitivity or specificity. As such, this 
study revealed the development of EIPC-K9 that monitors the DNA extraction and qPCR 
reaction process along with mitigating false-negative results. Additionally, preliminary 
data generated from testing EIPC-K9 with various biological samples sourced from dogs 
indicated the potential ability to discriminate between host sample types. 
Upon validating a multiplex qPCR compatible EIPC, a similar design strategy was 
applied to developing qPCR assays for each tick-borne pathogen species of interest to 
canine health. Recent literature indicated that the most common bacterial tick-borne agents 
in the U.S. include Borrelia hermsii, B. turicatae, B. parkeri, B. burgdorferi, Ehrlichia 
canis, E. chaffeensis, E. ewingii, Anaplasma phagocytophilum, and Rickettsia rickettsii, 
and have been documented infecting both dogs and humans resulting in increased zoonotic 
threats. Further, the parasitic species Babesia gibsoni and B. canis vogeli have emerged as 
significant threats to canine health. Therefore, this study aimed to simultaneously detect 
and characterize all 11 causative agents for borreliosis, anaplasmosis, rickettsiosis, 
ehrlichiosis, and babesiosis using qPCR instruments readily accessible within veterinary 
diagnostic laboratories. 
As discussed in Chapter III, although all pathogen specific assays, coupled with the 
EIPC, revealed high specificity and sensitivity to the intended targets, there remained an 
issue in respect to combining all assays into a single consolidated panel. Contemporary 
versions of qPCR instruments commonly utilized in veterinary diagnostic laboratories are 
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unable to differentiate between more than four to five unique fluorescent labels 
simultaneously. While current technology restricts the ability to insert additional 
fluorophores within the limited wavelength spectrum, the possibility to instead modify the 
process by manipulating available fluorescent signatures arose. 
In Chapter III a new hypothesis was formed and evaluated regarding an approach to 
modify current multiplex strategies. The technique, termed in this dissertation as 
layerplexing, was briefly introduced in 2013 through work by Wernike et al. and involved 
incorporating multiple targets within the same wavelength signatures emitted by 
fluorescent probes. While the previous team utilized this technique for “layering” four 
targets under one probe, this study extrapolated that a similar approach could facilitate the 
detection of all 11 pathogen/EIPC targets simultaneously. Chapter III demonstrated the 
diagnostic potential of the layerplex technique in efficacious detection and identification of 
all targets of interest with no statistical interference in regards to sensitivity or specificity. 
Further, the fully validated molecular diagnostic tool has been translated into a provisional 
patent (US 62/563, 780) with the goal of commercialization. At this time, the patent 
pending diagnostic tool has been implemented into the TVMDL test catalogue (i.e. 
TickPath layerplex), which allows veterinarians or research teams the ability to utilize the 
tool in various states or countries. By ensuring that diagnosticians and research teams have 
access to a commercial kit that does not require further standardizations, consistent 
methodologies for the detection of these diseases can be established. Subsequently, this 
gives clients who depend on these diagnostic laboratories additional confidence in the 
results they receive. 
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Upon establishing the new layerplex molecular tool in a diagnostic setting, its 
ability to facilitate a molecular prevalence study was evaluated. Chapter IV describes the 
investigation of active infections concerning 11 common tick-borne pathogens in domestic 
dogs of Texas. The state of Texas was selected due to its diverse geographic ecology, 
transboundary relationship with Mexico, and mutualistic collaboration with two state 
veterinary diagnostic laboratories. As no prior molecular prevalence studies of Texas were 
available, our study extrapolated upon recent seroprevalence studies in order to determine 
an appropriate sample size for screening. To our knowledge, this is the first study of its 
kind in Texas and may provide baseline data for future research and public health 
surveillance programs. As such, a representative sample size of 1,171 dogs distributed 
across 10 natural ecological divisions of Texas was collected, and the molecular 
prevalence of borrelial, rickettsial, and babesial pathogens was determined. 
The molecular prevalence of TBDs across Texas dogs ranged from 0.68% for 
borreliosis, 1.60% for ehrlichiosis, 0.17% for anaplasmosis, 0.00% for rickettsiosis, and 
0.43% for babesiosis. While these findings are slightly lower than reported seroprevalence 
data for Texas, it is important to note that this data represents a current record of active 
infections by molecular analysis. When prevalence was analyzed by each ecoregion, a 
higher prevalence was found in specific regions that more closely resembled past 
seroprevalence data. The differences in prevalence among ecoregions may be attributed to 
the diverse topography, climate, and habitat features across Texas. This investigation also 
highlighted the first molecular detection of Anaplasma platys in Texas and hypothesized 
the contribution that bats may have in the dissemination of Borrelia turicatae.  
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Although the works presented here were successful in demonstrating the layerplex 
qPCR technique for determining the molecular prevalence of TBDs within dogs of an 
entire state, limitations of the study exist. For example, future studies are needed to expand 
upon presented validation analysis with emphasis on pathogens not presently detected in 
Texas dogs (e.g. Borrelia parkeri, Ehrlichia chaffeensis, Rickettsia rickettsii, etc.). In 
addition, the inherent nature of the layerplex technique requires testing to be conducted 
initially at the layer level for screening, then with subsequent singleplex or multiplex 
testing for specific species determination. This two-tier testing can aid in the rapid 
screening of large sample sets but may impede diagnostic applications if a species 
identification is desired. Further, when applying the layerplex tool to characterize the 
molecular prevalence of TBDs in Texas dogs, there was no precedent set to model a 
prevalence investigation from. Therefore, the findings presented here should be viewed as 
preliminary until future studies can be conducted to corroborate our analysis. 
Despite these limitations, this study achieved the goal of simultaneous screening 
for 11 targets through layerplex methodology. Collectively, this dissertation provides 
support for additional studies to further validate the layerplex qPCR capabilities in terms of 
applying the methodology to different disease groups that require the detection of a broad 
spectrum of pathogens, as well as assessing the methodologies limits of detection in terms 
of targets labeled in a given reaction. Upon success with the layerplex technique, the next 
logical step includes evaluating the technique with more pathogen specific targets (e.g. 
Anaplasma platys, Rickettsia parkeri, etc.), or other susceptible animal models (e.g. cattle, 
horses, bats, etc.). Theoretically, additional targets may be layered into the reaction without 
resulting in adverse specificity or sensitivity restrictions. The addition of more targets may 
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facilitate a more complete understanding of all tick-borne pathogens implicated in causing 
disease in an area. Furthermore, a more comprehensive molecular screening tool may 
enable a more efficient method of collecting TBD data and provide a means for 
aggregating the data for long term analysis.  
The CDC gathers and monitors all reportable disease data for humans in the U.S., 
including TBDs. Despite the zoonotic implications of TBDs in U.S. dogs, no disease data 
is collected by the CDC nor any other official government agency for veterinary patients 
except for pathogens deemed reportable (e.g. Rocky Mountain spotted fever). Consistent 
characterization of tick-borne pathogens in companion animals may indicate a rise or 
decline of prevalence over years of analysis that can then be correlated to contributing 
factors such as climate fluctuations and transboundary influences. 
Taken together, this work demonstrated the capacity of the layerplex qPCR assay to 
detect 11 common tick-borne pathogens of interest to canine and human health 
simultaneously with high sensitivity and specificity in domesticated dog and tick 
specimens. The success found in these studies have potential to influence molecular 
diagnostic tool development and molecular prevalence investigations, and may one day 





Abdullah S, Helps C, Tasker S, Newbury H, Wall R. Prevalence and distribution of 
Borrelia and Babesia species in ticks feeding on dogs in the U.K. Med Vet Entomol 
2018;32(1):14-22. 
Allison RW, Little SE. Diagnosis of rickettsial diseases in dogs and cats. Vet Clin Pathol 
2013;42(2):127-44. 
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. 
J Mol Biol 1990;215(3):403-10. 
Alvarez-Hernandez G. [Rocky Mountain spotted fever, a forgotten epidemic]. Salud 
Publica Mex 2010;52(1):1-3. 
Annoscia G, Latrofa MS, Cantacessi C, Olivieri E, Manfredi MT, Dantas-Torres F, et al. A 
new PCR assay for the detection and differentiation of Babesia canis and Babesia vogeli. 
Ticks Tick Borne Dis 2017;8(6):862-5. 
Babady NE, Sloan LM, Vetter EA, Patel R, Binnicker MJ. Percent positive rate of Lyme 
real-time polymerase chain reaction in blood, cerebrospinal fluid, synovial fluid, and 
tissue. Diagn Microbiol Infect Dis 2008;62(4):464-6. 
Bastien P, Procop GW, Reischl U. Quantitative real-time PCR is not more sensitive than 
"conventional" PCR. J Clin Microbiol 2008;46(6):1897-900. 
Beall MJ, Alleman AR, Breitschwerdt EB, Cohn LA, Couto CG, Dryden MW, et al. 
Seroprevalence of Ehrlichia canis, Ehrlichia chaffeensis and Ehrlichia ewingii in dogs in 
North America. Parasit Vectors 2012;5:29. 
Beall MJ, Chandrashekar R, Eberts MD, Cyr KE, Diniz PP, Mainville C, et al. Serological 
and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, and 
Ehrlichia species in dogs from Minnesota. Vector Borne Zoonotic Dis 2008;8(4):455-64. 
Becker NS, Margos G, Blum H, Krebs S, Graf A, Lane RS, et al. Recurrent evolution of 
host and vector association in bacteria of the Borrelia burgdorferi sensu lato species 
complex. BMC Genomics 2016;17(1):734. 
Bilgic HB, Karagenc T, Simuunza M, Shiels B, Tait A, Eren H, et al. Development of a 
multiplex PCR assay for simultaneous detection of Theileria annulata, Babesia bovis and 
Anaplasma marginale in cattle. Exp Parasitol 2013;133(2):222-9. 
Birkenheuer AJ, Correa MT, Levy MG, Breitschwerdt EB. Geographic distribution of 
babesiosis among dogs in the United States and association with dog bites: 150 cases 
(2000-2003). J Am Vet Med Assoc 2005;227(6):942-7. 
 
 112 
Bischof R, Rogers DG. Serologic survey of select infectious diseases in coyotes and 
raccoons in Nebraska. J Wildl Dis 2005;41(4):787-91. 
Bouza-Mora L, Dolz G, Solorzano-Morales A, Romero-Zuniga JJ, Salazar-Sanchez L, 
Labruna MB, et al. Novel genotype of Ehrlichia canis detected in samples of human blood 
bank donors in Costa Rica. Ticks Tick Borne Dis 2017;8(1):36-40. 
Bowman D, Little SE, Lorentzen L, Shields J, Sullivan MP, Carlin EP. Prevalence and 
geographic distribution of Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and 
Anaplasma phagocytophilum in dogs in the United States: results of a national clinic-based 
serologic survey. Vet Parasitol 2009;160(1-2):138-48. 
Brzeski, Harrison, Waddell, Wolf, Rabon. Infectious disease and red wolf conservation: 
assessment of disease occurrence and associated risks. Journal of Mammalogy 
2015;96(4):751–61. 
Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikhisa Y, et al. Ehrlichia 
ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999;341(3):148-
55. 
Bunikis J, Tsao J, Garpmo U, Berglund J, Fish D, Barbour AG. Typing of Borrelia 
relapsing fever group strains. Emerg Infect Dis 2004;10(9):1661-4. 
Cannon SH, Levy JK, Kirk SK, Crawford PC, Leutenegger CM, Shuster JJ, et al. 
Infectious diseases in dogs rescued during dogfighting investigations. Vet J 2016;211:64-9. 
Carrade DD, Foley JE, Borjesson DL, Sykes JE. Canine granulocytic anaplasmosis: a 
review. J Vet Intern Med 2009;23(6):1129-41. 
Centers for Disease C. National Notifiable Diseases Surveillance System, 2016 Annual 
Tables of Infectious Disease Data. Atlanta, GA CDC Division of Health Informatics and 
Surveillance 2017. 
Chan K, Marras SA, Parveen N. Sensitive multiplex PCR assay to differentiate Lyme 
spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti. 
BMC Microbiol 2013;13:295. 
Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, et al. Diagnosis 
and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, 
ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other 
health-care and public health professionals. MMWR Recomm Rep 2006;55(RR-4):1-27. 
Chomel B. Tick-borne infections in dogs-an emerging infectious threat. Vet Parasitol 
2011;179(4):294-301. 
Christensen AM, Pietralczyk E, Lopez JE, Brooks C, Schriefer ME, Wozniak E, et al. 
Diagnosis and Management of Borrelia turicatae Infection in Febrile Soldier, Texas, USA. 
Emerg Infect Dis 2017;23(5):883-4. 
 
 113 
Coburn J, Leong J, Chaconas G. Illuminating the roles of the Borrelia burgdorferi 
adhesins. Trends Microbiol 2013;21(8):372-9. 
Coles TB, Dryden MW. Insecticide/acaricide resistance in fleas and ticks infesting dogs 
and cats. Parasit Vectors 2014;7:8. 
Courtney JW, Kostelnik LM, Zeidner NS, Massung RF. Multiplex real-time PCR for 
detection of anaplasma phagocytophilum and Borrelia burgdorferi. J Clin Microbiol 
2004;42(7):3164-8. 
D'Haene B, Vandesompele J, Hellemans J. Accurate and objective copy number profiling 
using real-time quantitative PCR. Methods 2010;50(4):262-70. 
Dahmani M, Davoust B, Benterki MS, Fenollar F, Raoult D, Mediannikov O. 
Development of a new PCR-based assay to detect Anaplasmataceae and the first report of 
Anaplasma phagocytophilum and Anaplasma platys in cattle from Algeria. Comp Immunol 
Microbiol Infect Dis 2015;39:39-45. 
Dall'Agnol B, Souza UA, Weck B, Trigo TC, Jardim MMA, Costa FB, et al. Rickettsia 
parkeri in free-ranging wild canids from Brazilian Pampa. Transbound Emerg Dis 
2018;65(2):e224-e30. 
Dantas-Torres F. Canine vector-borne diseases in Brazil. Parasit Vectors 2008;1(1):25. 
Dantas-Torres F, Chomel BB, Otranto D. Ticks and tick-borne diseases: a One Health 
perspective. Trends Parasitol 2012;28(10):437-46. 
Davitkov D, Vucicevic M, Stevanovic J, Krstic V, Tomanovic S, Glavinic U, et al. Clinical 
babesiosis and molecular identification of Babesia canis and Babesia gibsoni infections in 
dogs from Serbia. Acta Vet Hung 2015;63(2):199-208. 
De Tommasi AS, Baneth G, Breitschwerdt EB, Stanneck D, Dantas-Torres F, Otranto D, et 
al. Anaplasma platys in bone marrow megakaryocytes of young dogs. J Clin Microbiol 
2014;52(6):2231-4. 
Di Cicco MF, Downey ME, Beeler E, Marr H, Cyrog P, Kidd L, et al. Re-emergence of 
Babesia conradae and effective treatment of infected dogs with atovaquone and 
azithromycin. Vet Parasitol 2012;187(1-2):23-7. 
Donaldson TG, Perez de Leon AA, Li AY, Castro-Arellano I, Wozniak E, Boyle WK, et 
al. Assessment of the Geographic Distribution of Ornithodoros turicata (Argasidae): 
Climate Variation and Host Diversity. PLoS Negl Trop Dis 2016;10(2):e0004383. 
Drake TA, Hindler JA, Berlin OG, Bruckner DA. Rapid identification of Mycobacterium 
avium complex in culture using DNA probes. J Clin Microbiol 1987;25(8):1442-5. 
Dunbar SA. Applications of Luminex xMAP technology for rapid, high-throughput 
multiplexed nucleic acid detection. Clin Chim Acta 2006;363(1-2):71-82. 
 
 114 
Dworkin MS, Schwan TG, Anderson DE, Jr., Borchardt SM. Tick-borne relapsing fever. 
Infect Dis Clin North Am 2008;22(3):449-68, viii. 
Elbir H, Henry M, Diatta G, Mediannikov O, Sokhna C, Tall A, et al. Multiplex real-time 
PCR diagnostic of relapsing fevers in Africa. PLoS Negl Trop Dis 2013;7(1):e2042. 
Eremeeva ME, Weiner LM, Zambrano ML, Dasch GA, Hu R, Vilcins I, et al. Detection 
and characterization of a novel spotted fever group Rickettsia genotype in Haemaphysalis 
leporispalustris from California, USA. Ticks Tick Borne Dis 2018;9(4):814-8. 
Esteve-Gasent MD, Snell CB, Adetunji SA, Piccione J. Serological detection of Tick-
Borne Relapsing Fever in Texan domestic dogs. PLoS One 2017;12(12):e0189786. 
Esteve-Gassent MD, Perez de Leon AA, Romero-Salas D, Feria-Arroyo TP, Patino R, 
Castro-Arellano I, et al. Pathogenic Landscape of Transboundary Zoonotic Diseases in the 
Mexico-US Border Along the Rio Grande. Front Public Health 2014;2:177. 
Finotello F, Lavezzo E, Fontana P, Peruzzo D, Albiero A, Barzon L, et al. Comparative 
analysis of algorithms for whole-genome assembly of pyrosequencing data. Brief 
Bioinform 2012;13(3):269-80. 
Frey KG, Bishop-Lilly KA. Next-Generation Sequencing for Pathogen Detection and 
Identification. Methods in Microbiology 2015;42:525-54. 
Fritz CL. Emerging tick-borne diseases. Vet Clin North Am Small Anim Pract 
2009;39(2):265-78. 
Gal A, Harrus S, Arcoh I, Lavy E, Aizenberg I, Mekuzas-Yisaschar Y, et al. Coinfection 
with multiple tick-borne and intestinal parasites in a 6-week-old dog. Can Vet J 
2007;48(6):619-22. 
Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. 
Genome Res 1996;6(10):995-1001. 
Gieg J, Rikihisa Y, Wellman M. Diagnosis of Ehrlichia ewingii infection by PCR in a 
puppy from Ohio. Vet Clin Pathol 2009;38(3):406-10. 
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a 
single indicator of test performance. J Clin Epidemiol 2003;56(11):1129-35. 
Glenn TC. Field guide to next-generation DNA sequencers. Mol Ecol Resour 
2011;11(5):759-69. 
Goncalves-de-Albuquerque Sda C, Pessoa ESR, de Morais RC, Trajano-Silva LA, Regis-
da-Silva CG, Brandao-Filho SP, et al. Tracking false-negative results in molecular 
diagnosis: proposal of a triplex-PCR based method for leishmaniasis diagnosis. J Venom 
Anim Toxins Incl Trop Dis 2014;20:16. 
 
 115 
Gould FW, Hoffman GO, Rechenthin CA. Vegetational areas of Texas. Texas Agricultural 
Experiment Station, Texas A&M University 1960;Leaflet no. 492. 
Harris RM, Couturier BA, Sample SC, Coulter KS, Casey KK, Schlaberg R. Expanded 
Geographic Distribution and Clinical Characteristics of Ehrlichia ewingii Infections, 
United States. Emerg Infect Dis 2016;22(5):862-5. 
Harrus S, Waner T. Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): an 
overview. Vet J 2011;187(3):292-6. 
Harrus S, Waner T, Bark H, Jongejan F, Cornelissen AW. Recent advances in determining 
the pathogenesis of canine monocytic ehrlichiosis. J Clin Microbiol 1999;37(9):2745-9. 
Heather JM, Chain B. The sequence of sequencers: The history of sequencing DNA. 
Genomics 2016;107(1):1-8. 
Hegarty BC, Maggi RG, Koskinen P, Beall MJ, Eberts M, Chandrashekar R, et al. 
Ehrlichia muris infection in a dog from Minnesota. J Vet Intern Med 2012;26(5):1217-20. 
Heitman K, et al. Increasing Incidence of Ehrlichiosis in the United States: A Summary of 
National Surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii Infections in the 
United States, 2008-2012. Am J Trop Med Hyg 2016;94(1):52-60. 
Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring 
of DNA amplification reactions. Biotechnology (N Y) 1993;11(9):1026-30. 
Hojgaard A, Lukacik G, Piesman J. Detection of Borrelia burgdorferi, Anaplasma 
phagocytophilum and Babesia microti, with two different multiplex PCR assays. Ticks 
Tick Borne Dis 2014;5(3):349-51. 
Homer MJ, Bruinsma ES, Lodes MJ, Moro MH, Telford S, 3rd, Krause PJ, et al. A 
polymorphic multigene family encoding an immunodominant protein from Babesia 
microti. J Clin Microbiol 2000;38(1):362-8. 
Huber D, Reil I, Duvnjak S, Jurkovic D, Lukacevic D, Pilat M, et al. Molecular detection 
of Anaplasma platys, Anaplasma phagocytophilum and Wolbachia sp. but not Ehrlichia 
canis in Croatian dogs. Parasitol Res 2017;116(11):3019-26. 
Huhn GD, Badri S, Vibhakar S, Tverdek F, Crank C, Lubelchek R, et al. Early 
development of non-hodgkin lymphoma following initiation of newer class antiretroviral 
therapy among HIV-infected patients - implications for immune reconstitution. AIDS Res 
Ther 2010;7:44. 
Humphry RW, Cameron A, Gunn GJ. A practical approach to calculate sample size for 
herd prevalence surveys. Prev Vet Med 2004;65(3-4):173-88. 
IDEXX. The SNAP®4Dx® Plus Test provides sensitive and specific detection of tick-





March 8 2018]. 
Inokuma H, Raoult D, Brouqui P. Detection of Ehrlichia platys DNA in brown dog ticks 
(Rhipicephalus sanguineus) in Okinawa Island, Japan. J Clin Microbiol 2000;38(11):4219-
21. 
Ivacic L, Reed KD, Mitchell PD, Ghebranious N. A LightCycler TaqMan assay for 
detection of Borrelia burgdorferi sensu lato in clinical samples. Diagn Microbiol Infect Dis 
2007;57(2):137-43. 
Jefferies R, Ryan UM, Jardine J, Broughton DK, Robertson ID, Irwin PJ. Blood, Bull 
Terriers and Babesiosis: further evidence for direct transmission of Babesia gibsoni in 
dogs. Aust Vet J 2007;85(11):459-63. 
Johnson BJ. Laboratory Diagnostic Testing for 
Borrelia burgdorferi Infection. In: Halperin J, editor. Lyme Disease: An Evidence-based 
Approach. CAB International: CDC; 2011. p. 73-88. 
Johnson TL, Fischer RJ, Raffel SJ, Schwan TG. Host associations and genomic diversity 
of Borrelia hermsii in an endemic focus of tick-borne relapsing fever in western North 
America. Parasit Vectors 2016;9(1):575. 
Jongejan F, Su BL, Yang HJ, Berger L, Bevers J, Liu PC, et al. Molecular evidence for the 
transovarial passage of Babesia gibsoni in Haemaphysalis hystricis (Acari: Ixodidae) ticks 
from Taiwan: a novel vector for canine babesiosis. Parasit Vectors 2018;11(1):134. 
Kamani J, Baneth G, Mumcuoglu KY, Waziri NE, Eyal O, Guthmann Y, et al. Molecular 
detection and characterization of tick-borne pathogens in dogs and ticks from Nigeria. 
PLoS Negl Trop Dis 2013;7(3):e2108. 
Kato CY, Chung IH, Robinson LK, Austin AL, Dasch GA, Massung RF. Assessment of 
real-time PCR assay for detection of Rickettsia spp. and Rickettsia rickettsii in banked 
clinical samples. J Clin Microbiol 2013;51(1):314-7. 
Kelly AL, Raffel SJ, Fischer RJ, Bellinghausen M, Stevenson C, Schwan TG. First 
isolation of the relapsing fever spirochete, Borrelia hermsii, from a domestic dog. Ticks 
Tick Borne Dis 2014;5(2):95-9. 
Kidd L, Maggi R, Diniz PP, Hegarty B, Tucker M, Breitschwerdt E. Evaluation of 
conventional and real-time PCR assays for detection and differentiation of Spotted Fever 
Group Rickettsia in dog blood. Vet Microbiol 2008;129(3-4):294-303. 
Kledmanee K, Suwanpakdee S, Krajangwong S, Chatsiriwech J, Suksai P, Suwannachat P, 
et al. Development of multiplex polymerase chain reaction for detection of Ehrlichia canis, 




Koh FX, Panchadcharam C, Tay ST. Vector-Borne Diseases in Stray Dogs in Peninsular 
Malaysia and Molecular Detection of Anaplasma and Ehrlichia spp. from Rhipicephalus 
sanguineus (Acari: Ixodidae) Ticks. J Med Entomol 2016;53(1):183-7. 
Komnenou AA, Mylonakis ME, Kouti V, Tendoma L, Leontides L, Skountzou E, et al. 
Ocular manifestations of natural canine monocytic ehrlichiosis (Ehrlichia canis): a 
retrospective study of 90 cases. Vet Ophthalmol 2007;10(3):137-42. 
Kordick SK, Breitschwerdt EB, Hegarty BC, Southwick KL, Colitz CM, Hancock SI, et al. 
Coinfection with multiple tick-borne pathogens in a Walker Hound kennel in North 
Carolina. J Clin Microbiol 1999;37(8):2631-8. 
Kubelova M, Sedlak K, Panev A, Siroky P. Conflicting results of serological, PCR and 
microscopic methods clarify the various risk levels of canine babesiosis in Slovakia: a 
complex approach to Babesia canis diagnostics. Vet Parasitol 2013;191(3-4):353-7. 
Kuehn BM. CDC estimates 300,000 US cases of Lyme disease annually. JAMA 
2013;310(11):1110. 
Labruna MB, Ogrzewalska M, Soares JF, Martins TF, Soares HS, Moraes-Filho J, et al. 
Experimental infection of Amblyomma aureolatum ticks with Rickettsia rickettsii. Emerg 
Infect Dis 2011;17(5):829-34. 
Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS 
Pathog 2010;6(7):e1001005. 
Lawyer FC, Stoffel S, Saiki RK, Chang SY, Landre PA, Abramson RD, et al. High-level 
expression, purification, and enzymatic characterization of full-length Thermus aquaticus 
DNA polymerase and a truncated form deficient in 5' to 3' exonuclease activity. PCR 
Methods Appl 1993;2(4):275-87. 
Lewis JS, Fakile O, Foss E, Legarza G, Leskys A, Lowe K, et al. Direct DNA probe assay 
for Neisseria gonorrhoeae in pharyngeal and rectal specimens. J Clin Microbiol 
1993;31(10):2783-5. 
Lin Q, Rikihisa Y, Felek S, Wang X, Massung RF, Woldehiwet Z. Anaplasma 
phagocytophilum has a functional msp2 gene that is distinct from p44. Infect Immun 
2004;72(7):3883-9. 
Little SE. Ehrlichiosis and anaplasmosis in dogs and cats. Vet Clin North Am Small Anim 
Pract 2010;40(6):1121-40. 
Little SE, Beall MJ, Bowman DD, Chandrashekar R, Stamaris J. Canine infection with 
Dirofilaria immitis, Borrelia burgdorferi, Anaplasma spp., and Ehrlichia spp. in the United 
States, 2010-2012. Parasit Vectors 2014;7:257. 
Little SE, Heise SR, Blagburn BL, Callister SM, Mead PS. Lyme borreliosis in dogs and 
humans in the USA. Trends Parasitol 2010a;26(4):213-8. 
 
 118 
Little SE, O'Connor TP, Hempstead J, Saucier J, Reichard MV, Meinkoth K, et al. 
Ehrlichia ewingii infection and exposure rates in dogs from the southcentral United States. 
Vet Parasitol 2010b;172(3-4):355-60. 
Littman MP, Gerber B, Goldstein RE, Labato MA, Lappin MR, Moore GE. ACVIM 
consensus update on Lyme borreliosis in dogs and cats. J Vet Intern Med 2018;32(3):887-
903. 
Lohmeyer KH, May MA, Thomas DB, Perez de Leon AA. Implication of Nilgai Antelope 
(Artiodactyla: Bovidae) in Reinfestations of Rhipicephalus (Boophilus) microplus (Acari: 
Ixodidae) in South Texas: A Review and Update. J Med Entomol 2018;55(3):515-22. 
Long SW, Pound JM, Yu XJ. Ehrlichia prevalence in Amblyomma americanum, Central 
Texas. Emerg Infect Dis 2004;10(7):1342-3. 
Lopez JE, Krishnavahjala A, Garcia MN, Bermudez S. Tick-borne relapsing fever 
spirochetes in the Americas. Veterinary Sciences 2016;3(3):16. 
Lopez JE, Schrumpf ME, Nagarajan V, Raffel SJ, McCoy BN, Schwan TG. A novel 
surface antigen of relapsing fever spirochetes can discriminate between relapsing fever and 
Lyme borreliosis. Clinical and Vaccine Immunology 2010;17(4):564-71. 
Lopez JE, Vinet-Oliphant H, Wilder HK, Brooks CP, Grasperge BJ, Morgan TW, et al. 
Real-time monitoring of disease progression in rhesus macaques infected with Borrelia 
turicatae by tick bite. J Infect Dis 2014;210(10):1639-48. 
Lopez JE, Wilder HK, Boyle W, Drumheller LB, Thornton JA, Willeford B, et al. 
Sequence analysis and serological responses against Borrelia turicatae BipA, a putative 
species-specific antigen. PLoS Negl Trop Dis 2013;7(9):e2454. 
Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. Human infection with 
Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987;316(14):853-6. 
Maggi RG, Birkenheuer AJ, Hegarty BC, Bradley JM, Levy MG, Breitschwerdt EB. 
Comparison of serological and molecular panels for diagnosis of vector-borne diseases in 
dogs. Parasit Vectors 2014;7:127. 
Maggi RG, Mascarelli PE, Havenga LN, Naidoo V, Breitschwerdt EB. Co-infection with 
Anaplasma platys, Bartonella henselae and Candidatus Mycoplasma haematoparvum in a 
veterinarian. Parasit Vectors 2013;6:103. 
Mead P, Goel R, Kugeler K. Canine serology as adjunct to human Lyme disease 
surveillance. Emerg Infect Dis 2011;17(9):1710-2. 
Medlin JS, Cohen JI, Beck DL. Vector potential and population dynamics for Amblyomma 
inornatum. Ticks Tick Borne Dis 2015;6(4):463-72. 
 
 119 
Michelet L, Delannoy S, Devillers E, Umhang G, Aspan A, Juremalm M, et al. High-
throughput screening of tick-borne pathogens in Europe. Front Cell Infect Microbiol 
2014;4:103. 
Mikel P, Vasickova P, Kralik P. Methods for Preparation of MS2 Phage-Like Particles and 
Their Utilization as Process Control Viruses in RT-PCR and qRT-PCR Detection of RNA 
Viruses From Food Matrices and Clinical Specimens. Food Environ Virol 2015. 
Modarelli JJ, Borst MM, Piccione J, Esteve-Gasent MD. Molecular identification of 
Ehrlichia ewingii in a polyarthritic Texas dog. Vet Clin Pathol In press. 
Modarelli JJ, Ferro PJ, Esteve-Gasent MD. Development and application of a canine 
endogenous internal positive control for use in real-time PCR assays. J Vet Diagn Invest 
2018a:1040638718795206. 
Modarelli JJ, Piccione J, Ferro PJ, Esteve-Gasent MD. Novel real-time PCR assays for 
genomic group identification of tick-borne relapsing fever species Borrelia hermsii. Diagn 
Microbiol Infect Dis 2018b. 
Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H. Specific enzymatic 
amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp 
Quant Biol 1986;51 Pt 1:263-73. 
Mullis KB. The unusual origin of the polymerase chain reaction. Sci Am 1990;262(4):56-
61, 4-5. 
Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed 
chain reaction. Methods Enzymol 1987;155:335-50. 
Musial CE, Tice LS, Stockman L, Roberts GD. Identification of mycobacteria from culture 
by using the Gen-Probe Rapid Diagnostic System for Mycobacterium avium complex and 
Mycobacterium tuberculosis complex. J Clin Microbiol 1988;26(10):2120-3. 
Mylonakis ME, Koutinas AF, Breitschwerdt EB, Hegarty BC, Billinis CD, Leontides LS, 
et al. Chronic canine ehrlichiosis (Ehrlichia canis): a retrospective study of 19 natural 
cases. J Am Anim Hosp Assoc 2004;40(3):174-84. 
Nair AD, Cheng C, Ganta CK, Sanderson MW, Alleman AR, Munderloh UG, et al. 
Comparative Experimental Infection Study in Dogs with Ehrlichia canis, E. chaffeensis, 
Anaplasma platys and A. phagocytophilum. PLoS One 2016;11(2):e0148239. 
Navarro E, Serrano-Heras G, Castano MJ, Solera J. Real-time PCR detection chemistry. 
Clin Chim Acta 2015;439:231-50. 
Neer TM, Breitschwerdt EB, Greene RT, Lappin MR. Consensus statement on ehrlichial 
disease of small animals from the infectious disease study group of the ACVIM. American 
College of Veterinary Internal Medicine. J Vet Intern Med 2002;16(3):309-15. 
 
 120 
Ojeda-Chi MM, Rodriguez-Vivas RI, Esteve-Gasent MD, Perez de Leon AA, Modarelli JJ, 
Villegas-Perez SL. Ticks infesting dogs in rural communities of Yucatan, Mexico and 
molecular diagnosis of rickettsial infection. Transbound Emerg Dis 2018. 
Otranto D, Testini G, Dantas-Torres F, Latrofa MS, Diniz PP, de Caprariis D, et al. 
Diagnosis of canine vector-borne diseases in young dogs: a longitudinal study. J Clin 
Microbiol 2010;48(9):3316-24. 
Paras KL, Little SE, Reichard MV, Reiskind MH. Detection of Dirofilaria immitis and 
Ehrlichia species in coyotes (Canis latrans), from rural Oklahoma and Texas. Vector Borne 
Zoonotic Dis 2012;12(7):619-21. 
Pareek CS, Smoczynski R, Tretyn A. Sequencing technologies and genome sequencing. J 
Appl Genet 2011;52(4):413-35. 
Peleg O, Baneth G, Eyal O, Inbar J, Harrus S. Multiplex real-time qPCR for the detection 
of Ehrlichia canis and Babesia canis vogeli. Vet Parasitol 2010;173(3-4):292-9. 
Perez M, Bodor M, Zhang C, Xiong Q, Rikihisa Y. Human infection with Ehrlichia canis 
accompanied by clinical signs in Venezuela. Ann N Y Acad Sci 2006;1078:110-7. 
Piccione J, Levine GJ, Duff CA, Kuhlman GM, Scott KD, Esteve-Gassent MD. Tick-
Borne Relapsing Fever in Dogs. J Vet Intern Med 2016;30(4):1222-8. 
Policastro PF, Raffel SJ, Schwan TG. Borrelia hermsii acquisition order in superinfected 
ticks determines transmission efficiency. Infect Immun 2013;81(8):2899-908. 
Porcella SF, Raffel SJ, Anderson DE, Jr., Gilk SD, Bono JL, Schrumpf ME, et al. Variable 
tick protein in two genomic groups of the relapsing fever spirochete Borrelia hermsii in 
western North America. Infect Immun 2005;73(10):6647-58. 
Portnoi D, Sertour N, Ferquel E, Garnier M, Baranton G, Postic D. A single-run, real-time 
PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on 
the hbb gene sequence. FEMS Microbiol Lett 2006;259(1):35-40. 
Primus S, Akoolo L, Schlachter S, Gedroic K, Rojtman AD, Parveen N. Efficient detection 
of symptomatic and asymptomatic patient samples for Babesia microti and Borrelia 
burgdorferi infection by multiplex qPCR. PLoS One 2018;13(5):e0196748. 
Qurollo BA, Chandrashekar R, Hegarty BC, Beall MJ, Stillman BA, Liu J, et al. A 
serological survey of tick-borne pathogens in dogs in North America and the Caribbean as 
assessed by Anaplasma phagocytophilum, A. platys, Ehrlichia canis, E. chaffeensis, E. 
ewingii, and Borrelia burgdorferi species-specific peptides. Infect Ecol Epidemiol 2014;4. 
Radford AD, Chapman D, Dixon L, Chantrey J, Darby AC, Hall N. Application of next-
generation sequencing technologies in virology. J Gen Virol 2012;93(Pt 9):1853-68. 
 
 121 
Ramos RA, Latrofa MS, Giannelli A, Lacasella V, Campbell BE, Dantas-Torres F, et al. 
Detection of Anaplasma platys in dogs and Rhipicephalus sanguineus group ticks by a 
quantitative real-time PCR. Vet Parasitol 2014;205(1-2):285-8. 
Raoult D, Parola P. Rocky Mountain spotted fever in the USA: a benign disease or a 
common diagnostic error? Lancet Infect Dis 2008;8(10):587-9. 
Renvoise A, Merhej V, Georgiades K, Raoult D. Intracellular Rickettsiales: Insights into 
manipulators of eukaryotic cells. Trends Mol Med 2011;17(10):573-83. 
Rikihisa Y. Molecular Pathogenesis of Ehrlichia chaffeensis Infection. Annu Rev 
Microbiol 2015;69:283-304. 
Rodgers SJ, Morton RJ, Baldwin CA. A serological survey of Ehrlichia canis, Ehrlichia 
equi, Rickettsia rickettsii, and Borrelia burgdorferi in dogs in Oklahoma. J Vet Diagn 
Invest 1989;1(2):154-9. 
Rodriguez I, Burri C, Noda AA, Douet V, Gern L. Multiplex PCR for molecular screening 
of Borrelia burgdorferi sensu lato, Anaplasma spp. and Babesia spp. Ann Agric Environ 
Med 2015;22(4):642-6. 
Rosenberg R, Lindsey NP, Fischer M, Gregory CJ, Hinckley AF, Mead PS, et al. Vital 
Signs: Trends in Reported Vectorborne Disease Cases - United States and Territories, 
2004-2016. MMWR Morb Mortal Wkly Rep 2018;67(17):496-501. 
Rozej-Bielicka W, Masny A, Golab E. High-resolution melting PCR assay, applicable for 
diagnostics and screening studies, allowing detection and differentiation of several Babesia 
spp. infecting humans and animals. Parasitol Res 2017;116(10):2671-81. 
Sage KM, Johnson TL, Teglas MB, Nieto NC, Schwan TG. Ecological niche modeling and 
distribution of Ornithodoros hermsi associated with tick-borne relapsing fever in western 
North America. PLoS Negl Trop Dis 2017;11(10):e0006047. 
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed 
enzymatic amplification of DNA with a thermostable DNA polymerase. Science 
1988;239(4839):487-91. 
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic 
amplification of beta-globin genomic sequences and restriction site analysis for diagnosis 
of sickle cell anemia. Science 1985;230(4732):1350-4. 
Sanger F, Air GM, Barrell BG, Brown NL, Coulson AR, Fiddes CA, et al. Nucleotide 
sequence of bacteriophage phi X174 DNA. Nature 1977a;265(5596):687-95. 
Sanger F, Brownlee GG, Barrell BG. A two-dimensional fractionation procedure for 
radioactive nucleotides. J Mol Biol 1965;13(2):373-98. 
 
 122 
Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. 
Proc Natl Acad Sci U S A 1977b;74(12):5463-7. 
Sanogo YO, Davoust B, Inokuma H, Camicas JL, Parola P, Brouqui P. First evidence of 
Anaplasma platys in Rhipicephalus sanguineus (Acari: Ixodida) collected from dogs in 
Africa. Onderstepoort J Vet Res 2003;70(3):205-12. 
Sarkar M, Troese MJ, Kearns SA, Yang T, Reneer DV, Carlyon JA. Anaplasma 
phagocytophilum MSP2(P44)-18 predominates and is modified into multiple isoforms in 
human myeloid cells. Infect Immun 2008;76(5):2090-8. 
Schroeder ME, Johnson DJ, Ostlund EN, Meier J, Bounpheng MA, Clavijo A. 
Development and performance evaluation of a streamlined method for nucleic acid 
purification, denaturation, and multiplex detection of Bluetongue virus and Epizootic 
hemorrhagic disease virus. J Vet Diagn Invest 2013;25(6):709-19. 
Schurer JM, Ndao M, Quewezance H, Elmore SA, Jenkins EJ. People, pets, and parasites: 
one health surveillance in southeastern Saskatchewan. Am J Trop Med Hyg 
2014;90(6):1184-90. 
Schuster FL. Cultivation of Babesia and Babesia-like blood parasites: agents of an 
emerging zoonotic disease. Clin Microbiol Rev 2002;15(3):365-73. 
Schwan TG, Raffel SJ, Schrumpf ME, Porcella SF. Diversity and distribution of Borrelia 
hermsii. Emerg Infect Dis 2007;13(3):436-42. 
Schwan TG, Schrumpf ME, Hinnebusch BJ, Anderson D, Konkel ME. GlpQ: an antigen 
for serological discrimination between relapsing fever and Lyme borreliosis. Journal of 
clinical microbiology 1996;34(10):2483-92. 
Scott JD, Foley JE, Clark KL, Anderson JF, Durden LA, Manord JM, et al. Established 
Population of Blacklegged Ticks with High Infection Prevalence for the Lyme Disease 
Bacterium, Borrelia burgdorferi Sensu Lato, on Corkscrew Island, Kenora District, 
Ontario. Int J Med Sci 2016;13(11):881-91. 
Shock BC, Moncayo A, Cohen S, Mitchell EA, Williamson PC, Lopez G, et al. Diversity 
of piroplasms detected in blood-fed and questing ticks from several states in the United 
States. Ticks Tick Borne Dis 2014;5(4):373-80. 
Sirigireddy KR, Ganta RR. Multiplex detection of Ehrlichia and Anaplasma species 
pathogens in peripheral blood by real-time reverse transcriptase-polymerase chain reaction. 
J Mol Diagn 2005;7(2):308-16. 
Skotarczak B. Why are there several species of Borrelia burgdorferi sensu lato detected in 
dogs and humans? Infect Genet Evol 2014;23:182-8. 
 
 123 
Small CM, Ajithdoss DK, Rodrigues Hoffmann A, Mwangi W, Esteve-Gassent MD. 
Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against 
lyme disease. PLoS One 2014;9(2):e88245. 
Snowden J, Simonsen KA. Ehrlichiosis.  StatPearls. Treasure Island (FL); 2018. 
Solano-Gallego L, Baneth G. Babesiosis in dogs and cats--expanding parasitological and 
clinical spectra. Vet Parasitol 2011;181(1):48-60. 
Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet 2012;379(9814):461-73. 
Starkey LA, West MD, Barrett AW, Saucier JM, O'Connor TP, Paras KL, et al. Prevalence 
of antibodies to spotted fever group Rickettsia spp. and Ehrlichia spp. in coyotes (Canis 
latrans) in Oklahoma and Texas, USA. J Wildl Dis 2013;49(3):670-3. 
Sudhakara Reddy B, Sivajothi S, Varaprasad Reddy LS, Solmon Raju KG. Clinical and 
laboratory findings of Babesia infection in dogs. J Parasit Dis 2016;40(2):268-72. 
Talagrand-Reboul E, Boyer PH, Bergstrom S, Vial L, Boulanger N. Relapsing Fevers: 
Neglected Tick-Borne Diseases. Front Cell Infect Microbiol 2018;8:98. 
Teal AE, Habura A, Ennis J, Keithly JS, Madison-Antenucci S. A new real-time PCR 
assay for improved detection of the parasite Babesia microti. J Clin Microbiol 
2012;50(3):903-8. 
Technologies B. SPECTRAL OVERLAY TOOL FOR MULTIPLEXED QPCR; 2018. 
Available from: https://www.biosearchtech.com/qpcr-multiplex-spectral-overlay-tool. 
2018]. 
Thomson K, Yaaran T, Belshaw A, Curson L, Tisi L, Maurice S, et al. A new TaqMan 
method for the reliable diagnosis of Ehrlichia spp. in canine whole blood. Parasit Vectors 
2018;11(1):350. 
Tinoco-Gracia L, Lomeli MR, Hori-Oshima S, Stephenson N, Foley J. Molecular 
Confirmation of Rocky Mountain Spotted Fever Epidemic Agent in Mexicali, Mexico. 
Emerg Infect Dis 2018;24(9):1723-5. 
Tomassone L, Portillo A, Novakova M, de Sousa R, Oteo JA. Neglected aspects of tick-
borne rickettsioses. Parasit Vectors 2018;11(1):263. 
Tritt A, Eisen JA, Facciotti MT, Darling AE. An integrated pipeline for de novo assembly 
of microbial genomes. PLoS One 2012;7(9):e42304. 
Trout Fryxell RT, Steelman CD, Szalanski AL, Billingsley PM, Williamson PC. Molecular 
Detection of Rickettsia Species Within Ticks (Acari: Ixodidae) Collected from Arkansas 
United States. J Med Entomol 2015;52(3):500-8. 
 
 124 
Uchiyama T, Kishi M, Ogawa M. Restriction of the growth of a nonpathogenic spotted 
fever group rickettsia. FEMS Immunol Med Microbiol 2012;64(1):42-7. 
van Rijn SJ, Riemers FM, van den Heuvel D, Wolfswinkel J, Hofland L, Meij BP, et al. 
Expression stability of reference genes for quantitative RT-PCR of healthy and diseased 
pituitary tissue samples varies between humans, mice, and dogs. Mol Neurobiol 
2014;49(2):893-9. 
Vojdani A, Hebroni F, Raphael Y, Erde J, Raxlen B. Novel Diagnosis of Lyme Disease: 
Potential for CAM Intervention. Evid Based Complement Alternat Med 2009;6(3):283-95. 
Waner T, Harrus S, Bark H, Bogin E, Avidar Y, Keysary A. Characterization of the 
subclinical phase of canine ehrlichiosis in experimentally infected beagle dogs. Vet 
Parasitol 1997;69(3-4):307-17. 
Wang HY, Wu SQ, Jiang L, Xiao RH, Li T, Mei L, et al. Establishment and optimization 
of a liquid bead array for the simultaneous detection of ten insect-borne pathogens. Parasit 
Vectors 2018;11(1):442. 
Wen B, Rikihisa Y, Mott JM, Greene R, Kim HY, Zhi N, et al. Comparison of nested PCR 
with immunofluorescent-antibody assay for detection of Ehrlichia canis infection in dogs 
treated with doxycycline. J Clin Microbiol 1997;35(7):1852-5. 
Wernike K, Hoffmann B, Beer M. Single-tube multiplexed molecular detection of endemic 
porcine viruses in combination with background screening for transboundary diseases. J 
Clin Microbiol 2013;51(3):938-44. 
Whitney MS, Schwan TG, Sultemeier KB, McDonald PS, Brillhart MN. Spirochetemia 
caused by Borrelia turicatae infection in 3 dogs in Texas. Vet Clin Pathol 2007;36(2):212-
6. 
Wildlife TPa. Gould Ecoregions of Texas; 2011. Available from: 
https://tpwd.texas.gov/publications/pwdpubs/media/pwd_mp_e0100_1070ac_34.pdf. 
2018]. 
Wodecka B. flaB gene as a molecular marker for distinct identification of Borrelia species 
in environmental samples by the PCR-restriction fragment length polymorphism method. 
Appl Environ Microbiol 2011;77(19):7088-92. 
Woldehiwet Z. The natural history of Anaplasma phagocytophilum. Vet Parasitol 
2010;167(2-4):108-22. 
Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The 
clinical assessment, treatment, and prevention of lyme disease, human granulocytic 
anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases 
Society of America. Clin Infect Dis 2006;43(9):1089-134. 
 
 125 
Yabsley MJ. Natural history of Ehrlichia chaffeensis: vertebrate hosts and tick vectors 
from the United States and evidence for endemic transmission in other countries. Vet 
Parasitol 2010;167(2-4):136-48. 
Ybanez AP, Perez ZO, Gabotero SR, Yandug RT, Kotaro M, Inokuma H. First molecular 
detection of Ehrlichia canis and Anaplasma platys in ticks from dogs in Cebu, Philippines. 
Ticks Tick Borne Dis 2012;3(5-6):288-93. 
Yeagley TJ, Reichard MV, Hempstead JE, Allen KE, Parsons LM, White MA, et al. 
Detection of Babesia gibsoni and the canine small Babesia 'Spanish isolate' in blood 
samples obtained from dogs confiscated from dogfighting operations. J Am Vet Med 
Assoc 2009;235(5):535-9. 
Zavala-Castro JE, Zavala-Velazquez JE, del Rosario Garcia M, Leon JJ, Dzul-Rosado KR. 







1. GenBank® accession codes for the 16S rRNA gene sequences of Ehrlichia, Anaplasma, and Rickettsia 
species. Sequences utilized for in silico analysis in Appendix B are emphasized in bold. 
 
Rickettsial Species Isolate/Strain GenBank 
E. canis NA U26740 
E. canis GR78 EF011111 
E. canis GR21 EF011110 
E. canis Kiwi HQ844983 
E. canis TWN1 EU106856 
E. canis Kagoshima AF536827 
E. canis NA KM879929 
E. canis 171 KC479023 
E. canis 105 KC479022 
E. canis MSIA JF429693 
E. canis B JX893523 
E. canis A JX893522 
E. canis NGR JN982339 
E. canis NGR JN982336 
E. canis NGR JN622141 
E. canis TWN4 EU143637 
E. canis Nero EU439944 
E. canis TWN GU810149 
E. canis TWN3 EU143636 
E. canis TWN2 EU123923 
E. canis DT HQ290362 
E. canis NA EF139458 
E. canis TWN17 EU139493 
E. canis Kutahya AY621071 
E. canis TWN18 EU178797 
E. canis NA DQ915970 
E. canis NA AY394465 
E. canis VDE AF373613 
E. canis VHE AF373612 
E. canis Gxht67 AF156786 
E. canis Gdt3 AF156785 
E. canis b2-15 KY594915 
E. canis WHBMXZ-124 KX987326 
E. canis M66 KX180945 
E. canis NA KR920044 
E. canis Oklahoma NR_118741 
E. canis S3b KJ659037 
E. canis TrKysEcan3 KJ513197 
E. canis TrKysEcan2 KJ513196 
E. canis TrKysEcan1 KJ513194 
E. canis CMM-19-2002 AB723711 
E. canis CMM-19-2006 AB723712 
E. canis W-137J AB723710 
E. canis E-60 AB723709 
E. canis W-134 AB723708 
E. canis E-89J AB723707 
E. canis Bareilly JX861392 
E. canis Brazil-CO2 EF195135 
E. canis Brazil-CO1 EF195134 
E. canis Hd48 GQ395381 
E. canis NA M73221 
E. canis NA M73226 
E. canis Hd22 GQ395378 
E. canis Hd38-1 GQ395380 
E. canis ECAN_Bkk_07 EU263991 
E. canis NA AF162860 
E. canis Jake CP000107 
E. canis YZ-1 CP025749 
E. chaffeensis X1 KX505292 
E. chaffeensis Arkansas NR_074500 
E. chaffeensis NA AF147752 
E. chaffeensis NA U23503 
E. chaffeensis Arkansas NR_037059 
E. chaffeensis NA AF000721 
E. chaffeensis Arkansas AF416764 
E. chaffeensis NA U60476 
E. chaffeensis NA U86665 
E. chaffeensis NA U86664 
E. chaffeensis NA M73222 
E. chaffeensis West Paces CP007480 
E. chaffeensis Wakulla CP007479 
E. chaffeensis Saint Vincent CP007478 
E. chaffeensis Osceola CP007477 
E. chaffeensis Liberty CP007476 
E. chaffeensis Jax CP007475 
E. chaffeensis Heartland CP007473 
E. chaffeensis Arkansas CP000236 
E. ewingii Stillwater NR_044747 
E. ewingii Stillwater M73227 
E. ewingii 95E9-TS U96436 
E. ewingii 95E7-Mk U96435 
E. muris AS145 NR_025962 
E. muris AS145 NR_121714 
E. muris T-388 KU315171 
E. muris Est1709 KU535865 
E. muris WI22 HQ660491 
E. muris Ip16 AY587608 
E. muris NA AB013009 
E. muris NA AB196302 
E. muris Kh-1550 GU358692 
E. muris NA AB013008 
E. muris Nov-Ip205 GU358691 
E. muris m12 AB275137 
E. muris NA U15527 
E. muris AS145 CP006917 
E. ruminantium Welgevonden NR_074513 
E. ruminantium AaFT299 KJ942239 
E. ruminantium AaFT77 KJ942221 
E. ruminantium Aa2FT306 KJ942213 
E. ruminantium SBF4 KF786044 
E. ruminantium SBF1 KF786042 
E. ruminantium Welgevonden NR_074155 
E. ruminantium MB9_04 DQ640395 
E. ruminantium MB9_03 DQ640394 
E. ruminantium Hmr4 DQ640390 
E. ruminantium Sheep DQ640389 
E. ruminantium Umbanein DQ647616 
E. ruminantium c-4 DQ482922 
E. ruminantium c-3 DQ482921 
E. ruminantium c-2 DQ482920 
E. ruminantium c-1 DQ482919 
E. ruminantium c-3 DQ482918 
E. ruminantium c-2 DQ482917 
E. ruminantium c-1 DQ482916 
E. ruminantium c-1 DQ482915 
E. ruminantium NA U03777 
E. ruminantium NA X62432 
E. ruminantium Welgevonden CR925678 
E. ruminantium Gardel CR925677 
E. ruminantium Welgevonden CR767821 
E. ruminantium Vista AF318022 
E. ruminantium Henrique AF318021 
E. ruminantium ribosomal AF069758 
E. ruminantium rRNA U03776 
E. ruminantium NA X61659 
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E. ruminantium S22 HQ908081 
E. ruminantium Kiswani DQ647615 
A. phagocytophilum 6952 KY486261 
A. phagocytophilum 6097 KY486259 
A. phagocytophilum 6403 KY486258 
A. phagocytophilum 6403 KY462831 
A. phagocytophilum CPLA-HS MG050134 
A. phagocytophilum DKRH-HS MG050133 
A. phagocytophilum ItalyIRH004711 KY319198 
A. phagocytophilum Italy149-12B KY319197 
A. phagocytophilum ItalyIRH012411 KY319196 
A. phagocytophilum ItalyIRH01221 KY319195 
A. phagocytophilum ItalyIRH004811 KY319194 
A. phagocytophilum ItalyH3th-28 KY319193 
A. phagocytophilum JXARSA-32 KU585968 
A. phagocytophilum JXARSA-2 KU585967 
A. phagocytophilum JXARSA-15 KU585966 
A. phagocytophilum HunChun17 KX279357 
A. phagocytophilum RB3 KY458571 
A. phagocytophilum RS10556 KY458570 
A. phagocytophilum Y_G14 16S KU705164 
A. phagocytophilum Y_C35 16S KU705163 
A. phagocytophilum Y_C34 16S KU705162 
A. phagocytophilum Y_A04 16S KU705161 
A. phagocytophilum I_BwReh33  KU705160 
A. phagocytophilum X_BwReh32 KU705159 
A. phagocytophilum 16S-25 KU705130 
A. phagocytophilum W_BwRo6 1 KU705129 
A. phagocytophilum S_BwRo5 1 KU705128 
A. phagocytophilum W_BwRo4 1 KU705127 
A. phagocytophilum 16S-30 KU705126 




A. phagocytophilum ApGDrom1 KF002508 
A. phagocytophilum AAIK4 KR611719 
A. phagocytophilum AAIK3 KR611718 
A. phagocytophilum AAIK2 KR611717 
A. phagocytophilum AAIK1 KR611716 
A. phagocytophilum 14DRS KR092129 
A. phagocytophilum tick-EU329 KM215231 
A. phagocytophilum tick-EU322 KM215230 
A. phagocytophilum d-3216 KM215224 
A. phagocytophilum Aa2FT11 KJ942185 
A. phagocytophilum Aa2FT06 KJ942183 
A. phagocytophilum gw1 KF805344 
A. phagocytophilum Dog2 CP006618 
A. phagocytophilum JMe  CP006617 
A. phagocytophilum HZ2 CP006616 
A. phagocytophilum sheep19 KF293698 
A. phagocytophilum sheep28 KF293697 
A. phagocytophilum sheep29 KF293676 
A. phagocytophilum sheep54 KF293675 
A. phagocytophilum sheep52 KF293673 
A. phagocytophilum sheep50 KF293671 
A. phagocytophilum sheep49 KF293670 
A. phagocytophilum sheep48 KF293669 
A. phagocytophilum Rus30-10 HQ629911 
A. phagocytophilum Bel6-22-07 HQ629915 
A. phagocytophilum BelBmi37 HQ629914 
A. phagocytophilum Rus29-12 HQ629912 
A. phagocytophilum HB-SZ-HGA-S02 HQ171975 
A. phagocytophilum ZJ01/2008 HM439430 
A. phagocytophilum Sv-Ip854 HM366579 
A. phagocytophilum h997 HM138366 
A. phagocytophilum KWDAP5 GU556625 
A. phagocytophilum HLAP327 GU064899 
A. phagocytophilum KWDAP2 GU556622 
A. phagocytophilum KWDAP1 GU556621 
A. phagocytophilum sheep_5010_EM GU236611 
A. phagocytophilum GC19 GU111744 
A. phagocytophilum roe_deer_137_05 GU236574 










A. phagocytophilum ZJ-TT-HGA-O37 GQ500060 
A. phagocytophilum ZJ-TT-HGA-O35 GQ500058 
A. phagocytophilum ZJ-TT-HGA-O23 GQ500047 
A. phagocytophilum BJ-MY-HGA-S13 GQ499986 
A. phagocytophilum BJ-MY-HGA-S2 GQ499977 
A. phagocytophilum BJ-MY-HGA-S1 GQ499956 
A. phagocytophilum AH-MG-HGA-S36 GQ499928 
A. phagocytophilum China-C-Aa GQ412337 
A. phagocytophilum PoTiA2dt EU098007 
A. phagocytophilum PoTiA1dt EU098006 
A. phagocytophilum PoAnA1dt EF693890 
A. phagocytophilum EHR02 EF217398 
A. phagocytophilum EHR1 EF217397 
A. phagocytophilum AH-HGA-9 EF473210 
A. 
phagocytophilum HZ CP000235 
A. phagocytophilum M20 DQ361024 
A. phagocytophilum DBMGH AY886761 
A. phagocytophilum 474 AF481852 
A. phagocytophilum 470 AF481850 
A. phagocytophilum AP-CBHL AF470699 
A. phagocytophilum 16S AF384214 
A. phagocytophilum 16S AF384212 
A. phagocytophilum Jilin-1 DQ342324 
A. phagocytophilum BV-1 AY082656 
A. phagocytophilum TXCTR3 DQ088128 
A. phagocytophilum WA-variant AY741095 
A. phagocytophilum h-1148 KM215222 
A. platys Okinawa AF536828 
A. platys D35 KX792089 
A. platys 4 KT982643 
A. platys QQQ KX447505 
A. platys RRR KX447502 
A. platys Rodo-p1-66 JX976181 
A. platys A.pl.#87 JQ396431 
A. platys Gigio EU439943 
A. platys NA EF139459 
A. platys YY36 MF289478 
A. platys YY33 MF289477 
A. platys b3-7 KY594914 
A. platys dog-72 LC269822 
A. platys dog-99 LC269821 
A. platys dog-166 LC269820 
A. platys WHBMXZ-126 KX987336 
A. platys ZJARSA-8 KU586183 
A. platys WHARSA-7 KU586175 
A. platys WHANSL-27-1 KU586172 
A. platys WHANSA-24-2 KU586168 
A. platys WHAEAP-26 KU586165 
A. platys WHAEAL-17-2 KU586163 
A. platys JXARSA-29 KU586161 
A. platys JXANSA-19 KU586159 
A. platys WHANSE-2 KU586124 
A. platys WHARSP-17 KU586058 
A. platys WHARSL-30 KU586051 
A. platys WHARSA-47-1 KU586031 
A. platys WHARSA-14 KU586028 
A. platys WHANSA-8 KU586006 
A. platys WHANSA-7-4 KU586001 
A. platys WHANSA-6-3 KU585997 
A. platys WHANSA-45-1 KU585989 
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A. platys WHANSA-40 KU585988 
A. platys M48A KX180946 
A. platys P30 KX180944 
A. platys NA KY114935 
A. platys 3ax1 KJ659045 
A. platys 2ax1 KJ659044 
A. platys NA AY530806 
A. platys Okinawa AY077619 
A. platys NA AF303467 
A. platys NA AF399917 
A. platys NA AF287153 
A. platys NA AF286699 
A. platys NA AF156784 
A. platys NA M82801 
A. marginale BAGHS-B47 MG018436 
A. marginale Wayanad 17 MG728098 
A. marginale TVM 3 MG709131 
A. marginale Thrissur 8 MG709056 
A. marginale Thrissur 6 MG709054 
A. marginale Thrissur 5 MG709053 
A. marginale WHANSA-6-2 KU586171 
A. marginale WHAEAP-33 KU586166 
A. marginale JXANSA-2 KU586160 
A. marginale WHANSE-2-1 KU586125 
A. marginale ZJCUTA-30 KU586074 
A. marginale ZJCUTA-2 KU586073 
A. marginale ZJCUTA-10 KU586072 
A. marginale WHCUTA-25 KU586066 
A. marginale WHARSP-30-2 KU586062 
A. marginale WHARSP-19 KU586059 
A. marginale WHARSL-38-1 KU586056 
A. marginale WHARSA-47-2 KU586032 
A. marginale WHANSL-8-1 KU586022 
A. marginale WHANSL-27-2 KU586017 
A. marginale WHANSL-11-1 KU586012 
A. marginale WHANSA-92 KU586011 
A. marginale WHANSA-8-2 KU586005 
A. marginale WHANSA-60-2 KU585998 
A. marginale WHANSA-53-2 KU585995 
A. marginale WHANSA-48 KU585992 
A. marginale WHANSA-45-2 KU585990 
A. marginale JXANSA-8 KU585964 
A. marginale JXANSA-34 KU585963 
A. marginale JXANSA-24 KU585960 
A. marginale Uganda MT27 KU686794 
A. marginale Uganda MT28 KU686793 
A. marginale Uganda MT34 KU686792 
A. marginale Uganda MT30 KU686791 
A. marginale Uganda MT29 KU686790 
A. marginale Uganda MT31 KU686789 
A. marginale Uganda MT38 KU686788 
A. marginale Uganda KT7 KU686787 
A. marginale Uganda MT32 KU686786 
A. marginale Uganda MT37 KU686782 
A. marginale Uganda MT35 KU686781 
A. marginale Uganda MT33 KU686780 
A. marginale Uganda KT9 KU686779 
A. marginale Uganda MT42 KU686778 
A. marginale Uganda KT10 KU686777 
A. marginale Uganda KT6 KU686776 
A. marginale Uganda MT39 KU686775 
A. marginale Uganda MT36 KU686774 
A. marginale AM-SAR2011 KP877314 
A. marginale Zaria KJ095114 
A. marginale NA AB916498 
A. marginale NA LC007100 
A. marginale NA AB916499 
A. marginale Sivas SS101 KJ183086 
A. marginale Sivas SS84 KJ183083 
A. marginale NA CP006847 
A. marginale NA CP006846 
A. marginale C6A JQ839012 
A. marginale C7D JQ839011 
A. marginale 5C JQ839009 
A. marginale 4C JQ839008 
A. marginale ZJ02/2009 HM439433 
A. marginale K1 GU129918 
A. marginale NA FJ155998 
A. marginale NA CP001079 
A. marginale Ishigaki-2007 FJ226454 
A. marginale TG26 DQ000617 
A. marginale IG42 DQ000616 
A. marginale GP4 DQ000615 
A. marginale BS19 DQ000614 
A. marginale BS16 DQ000613 
A. marginale NA AY048816 
A. marginale Hongan buffalo DQ341369 
A. marginale 16S AJ633048 
A. marginale Zimbabwe AF414878 
A. marginale Uruguay AF414877 
A. marginale non-tailed AF414875 
A. marginale F12 AF414874 
A. marginale Veld AF414873 
A. marginale Eland AF414872 
A. marginale South Africa AF414871 
A. marginale NA AF311303 
A. marginale South Idaho AF309868 
A. marginale Virginia AF309866 
A. marginale NA CP000030 
A. marginale 58 M60313 
A. marginale WHARSL-28 KU586048 
A. marginale ZJCUTA-6 KU586076 
A. marginale ZJCUTA-5 KU586075 
A. marginale WHARSA-30 KU586030 
A. marginale WHANSL-41 KU586021 
A. marginale WHCUTA-8 KU586067 
A. marginale WHANSL-24-1 KU586015 
A. marginale WHAEAL-17-1 KU585973 
A. marginale WHANSA-36 KU585984 
A. marginale CPY31 KM009068 
A. marginale AMSP4-MDK2 KX989511 
A. marginale AMSP4-MDK1 KX989510 
A. marginale HiP_5AM KY305599 
A. marginale KNP_582AM KY305598 
A. ovis BAGHS-B47 MG018436 
A. ovis Wayanad 17 MG728098 
A. ovis TVM 3 MG709131 
A. ovis Thrissur 8 MG709056 
A. ovis Thrissur 6 MG709054 
A. ovis Thrissur 5 MG709053 
A. ovis WHANSA-6-2 KU586171 
A. ovis WHAEAP-33 KU586166 
A. ovis JXANSA-2 KU586160 
A. ovis WHANSE-2-1 KU586125 
A. ovis ZJCUTA-30 KU586074 
A. ovis ZJCUTA-2 KU586073 
A. ovis ZJCUTA-10 KU586072 
A. ovis WHCUTA-25 KU586066 
A. ovis WHARSP-30-2 KU586062 
A. ovis WHARSP-19 KU586059 
A. ovis WHARSL-38-1 KU586056 
A. ovis WHARSA-47-2 KU586032 
A. ovis WHANSL-8-1 KU586022 
A. ovis WHANSL-27-2 KU586017 
A. ovis WHANSL-11-1 KU586012 
A. ovis WHANSA-92 KU586011 
A. ovis WHANSA-8-2 KU586005 
A. ovis WHANSA-60-2 KU585998 
A. ovis WHANSA-53-2 KU585995 
A. ovis WHANSA-48 KU585992 
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A. ovis WHANSA-45-2 KU585990 
A. ovis JXANSA-8 KU585964 
A. ovis JXANSA-34 KU585963 
A. ovis JXANSA-24 KU585960 
A. ovis Uganda MT27 KU686794 
A. ovis Uganda MT28 KU686793 
A. ovis Uganda MT34 KU686792 
A. ovis Uganda MT30 KU686791 
A. ovis Uganda MT29 KU686790 
A. ovis Uganda MT31 KU686789 
A. ovis Uganda MT38 KU686788 
A. ovis Uganda KT7 KU686787 
A. ovis Uganda MT32 KU686786 
A. ovis Uganda MT37 KU686782 
A. ovis Uganda MT35 KU686781 
A. ovis Uganda MT33 KU686780 
A. ovis Uganda KT9 KU686779 
A. ovis Uganda MT42 KU686778 
A. ovis Uganda KT10 KU686777 
A. ovis Uganda KT6 KU686776 
A. ovis Uganda MT39 KU686775 
A. ovis Uganda MT36 KU686774 
A. ovis AM-SAR2011 KP877314 
A. ovis Zaria KJ095114 
A. ovis NA AB916498 
A. ovis NA LC007100 
A. ovis NA AB916499 
A. ovis Sivas SS101 KJ183086 
A. ovis Sivas SS84 KJ183083 
A. ovis NA CP006847 
A. ovis NA CP006846 
A. ovis C6A JQ839012 
A. ovis C7D JQ839011 
A. ovis 5C JQ839009 
A. ovis 4C JQ839008 
A. ovis ZJ02/2009 HM439433 
A. ovis K1 GU129918 
A. ovis NA FJ155998 
A. ovis NA CP001079 
A. ovis Ishigaki-2007 FJ226454 
A. ovis TG26 DQ000617 
A. ovis IG42 DQ000616 
A. ovis GP4 DQ000615 
A. ovis BS19 DQ000614 
A. ovis BS16 DQ000613 
A. ovis NA AY048816 
A. ovis Hongan buffalo DQ341369 
A. ovis 16S AJ633048 
A. ovis Zimbabwe AF414878 
A. ovis Uruguay AF414877 
A. ovis non-tailed AF414875 
A. ovis F12 AF414874 
A. ovis Veld AF414873 
A. ovis Eland AF414872 
A. ovis South Africa AF414871 
A. ovis NA AF311303 
A. ovis South Idaho AF309868 
A. ovis Virginia AF309866 
A. ovis NA CP000030 
A. ovis 58 M60313 
A. ovis WHARSL-28 KU586048 
A. ovis ZJCUTA-6 KU586076 
A. ovis ZJCUTA-5 KU586075 
A. ovis WHARSA-30 KU586030 
A. ovis WHANSL-41 KU586021 
A. ovis WHCUTA-8 KU586067 
A. ovis WHANSL-24-1 KU586015 
A. ovis WHAEAL-17-1 KU585973 
A. ovis WHANSA-36 KU585984 
A. ovis CPY31 KM009068 
A. ovis AMSP4-MDK2 KX989511 
A. ovis AMSP4-MDK1 KX989510 
A. ovis HiP_5AM KY305599 
A. ovis KNP_582AM KY305598 
A. centrale NA AF283007 
A. centrale 16 EF520690 
A. centrale 14 EF520689 
A. centrale 8 EF520688 
A. centrale 1 EF520687 
A. centrale CC EF520686 
A. centrale South Africa AF414869 
A. centrale Vaccine AF414868 
A. centrale NA AB211164 
A. centrale LP17 MF289482 
A. centrale LP10 MF289481 
A. centrale JJ5 MF289480 
A. centrale ZJ68 KP062966 
A. centrale ZJ64 KP062965 
A. centrale ZJ62 KP062964 
A. centrale Uganda KT5 KU686784 
A. centrale Uganda KT8 KU686783 
A. centrale C4B JQ839010 
A. centrale HIP/A8/e KC189842 
A. centrale HIP/A8/d KC189841 
A. centrale HIP/A8/c KC189840 
A. centrale NA AB588977 
A. centrale HLAC222 GU064903 
A. centrale NA AF318944 
A. centrale Israel AF309869 
A. bovis Y258 KY425447 
A. bovis Y257 KY425445 
A. bovis Y201 KY425441 
A. bovis Y197 KY425439 
A. bovis Y196 KY425435 
A. bovis Y111 KY425433 
A. bovis Y102 KY425431 
A. bovis Y85 KY425429 
A. bovis Y83 KY425426 
A. bovis Y59 KY425423 
A. bovis Y11 KY425420 
A. bovis Zhongxian FJ169957 
A. bovis SG176_HL EU181143 
A. bovis SG175_HL EU181142 
A. bovis Tottori-97 HM131218 
A. bovis Hiroshima-Z27 HM131217 
A. bovis ribosomal AY144729 
A. bovis FL17 MF289479 
A. bovis Shandong JN2 KY242455 
A. bovis WHHLHP-119 KX987337 
A. bovis WHARSL-38-2 KU586176 
A. bovis WHARSA-40-2 KU586174 
A. bovis WHANSA-6-1 KU586170 
A. bovis WHANSA-24-1 KU586167 
A. bovis WHANSL-8 KU586023 
A. bovis 20/China/2013 KP314253 
A. bovis 19/China/2013 KP314252 
A. bovis 18/China/2013 KP314251 
A. bovis 17/China/2013 KP314250 
A. bovis 15/China/2013 KP314249 
A. bovis 14/China/2013 KP314248 
A. bovis 13/China/2013 KP314247 
A. bovis 12/China/2013 KP314246 
A. bovis 11/China/2013 KP314245 
A. bovis 10/China/2013 KP314244 
A. bovis 9/China/2013 KP314243 
A. bovis 8/China/2013 KP314242 
A. bovis 6/China/2013 KP314240 
A. bovis 4/China/2013 KP314239 
A. bovis 1/China/2013 KP314236 
A. bovis ZJ98 KP062959 
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A. bovis ZJ69 KP062958 
A. bovis ZJ66 KP062957 
A. bovis ZJ54 KP062956 
A. bovis ZJ46 KP062955 
A. bovis ZJ15 KP062954 
A. bovis ZJ12 KP062953 
A. bovis TYM19 LC012818 
A. bovis TYM14 LC012817 
A. bovis KUM7 LC012813 
A. bovis KUM5 LC012812 
A. bovis KOC4 LC012811 
A. bovis 115 KM114613 
A. bovis 85 KM114612 
A. bovis 88 KM114611 
A. bovis sika35 LC060988 
A. bovis CMS-34_20111224 AB983439 
A. bovis CFT-27_20111223 AB983438 
A. bovis 3ay KJ659043 
A. bovis 3ax KJ659042 
A. bovis 2ay KJ659041 
A. bovis 2ax KJ659040 
A. bovis CFT-27-2010 AB723716 
A. bovis CFT-27-2009 AB723715 
A. bovis CFT-24-2010 AB723714 
A. bovis CFT-24-2009 AB723713 
A. bovis Am-vole57 JX092098 
A. bovis China-chipmunk25 JX092096 
A. bovis Kh-Hc215 JX092094 
A. bovis Am-Hc60 JX092092 
A. bovis Ab38B AB588969 
A. bovis Ab59B AB588965 
A. bovis raccoon513 GU937023 
A. bovis raccoon510 GU937022 
A. bovis raccoon501 GU937021 
A. bovis raccoon499 GU937020 
A. bovis raccoon493 GU937019 
A. bovis raccoon490 GU937018 
A. bovis raccoon464 GU937017 
A. bovis raccoon462 GU937016 
A. bovis raccoon458 GU937015 
A. bovis raccoon453 GU937014 
A. bovis raccoon439 GU937013 
A. bovis raccoon426 GU937012 
A. bovis raccoon109 GU937011 
A. bovis Yu12 JN558829 
A. bovis R7 JN558828 
A. bovis G55 JN558825 
A. bovis G49 JN558824 
A. bovis G21 JN558823 
A. bovis G1 JN558822 
A. bovis B7 JN558819 
A. bovis YX4 JN558817 
A. bovis G41 HQ913646 
A. bovis ES1090 HQ913645 
A. bovis ES1019 HQ913644 
A. bovis HLAB352 GU064902 
A. bovis HLAB187 GU064901 
A. bovis AB-KGHL AF470698 
A. bovis NA U03775 
R. typhi Wilmington L36221 
R. typhi NA M20499 
R. typhi Wilmington U12463 
R. rickettsii NA M21293 
R. rickettsii R L36217 
R. rickettsii 1995H02 DQ150694 
R. rickettsii 1995H01 DQ150691 
R. rickettsii 1994C02 DQ150688 
R. rickettsii 1991C03 DQ150685 
R. rickettsii 1989C01 DQ150682 
R. rickettsii NA U11021 
2. GenBank® accession codes for the 18S rRNA gene sequences of Babesia and Theileria species. Sequences 
utilized for in silico analysis in Appendix B are emphasized in bold. 
 
Babesia Species Isolate/Strain GenBank 
B. canis vogeli NA HM590440 
B. canis vogeli NA AY072925 
B. canis vogeli TWN2 HQ148664 
B. canis vogeli TWN1 HQ148663 
B. canis vogeli 2B-158459 KY290979 
B. canis vogeli 192704 KY290978 
B. canis vogeli 105796 KY290977 
B. canis vogeli 59239 KY290976 
B. canis vogeli dog 102 KT323936 
B. canis vogeli cat 100 KT323935 
B. canis vogeli dog 94 KT323934 
B. canis vogeli dog 86 KT323933 
B. canis vogeli cat 73 KT323932 
B. canis vogeli Belem Bv02 KT333456 
B. canis vogeli Dog#149 JX871891 
B. canis vogeli Dog#44 JX304683 
B. canis vogeli Dog#31 JX304682 
B. canis vogeli Dog#26 JX304681 
B. canis vogeli Dog#23 JX304680 
B. canis vogeli Dog#22 JX304679 
B. canis vogeli Dog#19 JX304677 
B. canis vogeli Guangxi KJ939326 
B. canis vogeli SK-011 JX112785 
B. canis vogeli RO/FMVB/B/9 HQ662635 
B. canis vogeli NA JF825145 
B. canis vogeli dog AY150061 
B. canis vogeli NA EU084681 
B. canis vogeli Venezuela DQ297390 
B. canis vogeli Spain 1 DQ439545 
B. canis vogeli USA AY371198 
B. canis vogeli Egypt AY371197 
B. canis vogeli Brazil AY371196 
B. canis vogeli Brazil AY371195 
B. canis vogeli Brazil AY371194 
B. canis canis Dog-1 KT008057 
B. canis canis BccTR2 KF499115 
B. canis canis 2 EU622793 
B. canis canis 1 EU622792 
B. canis canis NA AY072926 
B. canis canis Bd6-2 AY962187 
B. canis canis Bd6-1 AY962186 
B. canis canis NA AY649326 
B. canis canis D5 AY527063 
B. canis canis 43 ldrf DQ869308 
B. canis canis dog DQ869307 
B. canis canis Dog#5 KC593879 
B. canis canis Dog#1 KC593878 
B. canis canis Dog#1 KC593877 
B. canis canis 204A/13b KP216422 
B. canis canis RO/FMVB/B/7 HQ662634 
B. canis canis BCC2 FJ209025 
B. canis canis BBC1 FJ209024 
B. canis canis NA EU152128 
B. canis canis NA AY321119 
B. canis rossi Dog-76 DQ111764 
B. canis rossi Dog-74 DQ111763 
B. canis rossi Dog-69 DQ111762 
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B. canis rossi Dog-55 DQ111761 
B. canis rossi Dog-44 DQ111760 
B. canis rossi RLB1501/cl3 KY463434 
B. canis rossi RLB1535/cl1 KY463433 
B. canis rossi RLB1501/cl2 KY463432 
B. canis rossi RLB1501/cl1 KY463431 
B. canis rossi RLB1535/cl2 KY463430 
B. canis rossi RLB1535/cl3 KY463429 
B. canis rossi N4 AB935166 
B. canis rossi N3 AB935165 
B. canis rossi N2 AB935164 
B. canis rossi N1 AB935163 
B. canis rossi RLB67 JQ613105 
B. canis rossi RLB42 JQ613104 
B. canis rossi Dog#127, #135 AB303075 
B. canis rossi 
Dog#25, #354, 
#398 AB303074 
B. canis rossi Dog#23 AB303073 
B. canis rossi Dog#8 AB303072 
B. canis rossi Dog#2 AB303071 
B. canis rossi NA KC453992 







B. gibsoni Assam 2 KF928958 
B. gibsoni Ludhiana 3 KF511956 
B. gibsoni Ludhiana 2 KF511955 
B. gibsoni Kolkata 2 KF171474 
B. gibsoni Kolkata 3 KF171473 
B. gibsoni Siliguri KF171471 
B. gibsoni Dehradoon KF171470 







B. gibsoni 218/Assam KF112075 
B. gibsoni 178/Assam KF112074 
B. gibsoni TWN5 FJ769388 
B. gibsoni TWN4 FJ769387 




B. gibsoni Bab/Asm-41/11/Ind KF606867 
B. gibsoni Johor 314 KU500921 
B. gibsoni Pahang7 KU500920 
B. gibsoni Johor 282 KU500919 
B. gibsoni Sarawak 40 KU500918 
B. gibsoni Sarawak 18 KU500917 
B. gibsoni Selangor 53 KU500916 
B. gibsoni Sabah24 KU500915 
B. gibsoni WH123 KP666168 
B. gibsoni WH121 KP666167 
B. gibsoni WH120 KP666166 
B. gibsoni WH114 KP666165 
B. gibsoni WH110 KP666164 
B. gibsoni WH91 KP666163 
B. gibsoni WH87 KP666162 
B. gibsoni WH82 KP666161 
B. gibsoni WH71 KP666160 
B. gibsoni WH61 KP666159 
B. gibsoni WH58 KP666158 
B. gibsoni WH56 KP666157 
B. gibsoni WH54 KP666156 
B. gibsoni WH35 KP666155 
B. gibsoni BD37 LC008285 
B. gibsoni BD05 LC008284 
B. gibsoni BD02 LC006968 
B. gibsoni Punjab KC954653 
B. gibsoni Kolkata-1 KC811803 
B. gibsoni Assam KC811802 
B. gibsoni Bareilly-1 KC811801 
B. gibsoni TWN5 JQ710685 
B. gibsoni KOR07-20 EU430494 
B. gibsoni KOR06-104 EU430493 
B. gibsoni KOR06-102 EU430492 
B. gibsoni KOR0685 EU430491 
B. gibsoni KOR0675 EU430490 
B. gibsoni KOR0674 EU430489 
B. gibsoni KOR0656 EU430488 
B. gibsoni KOR0654-4 EU430487 
B. gibsoni KOR0644-2 EU430486 
B. gibsoni KOR0501-10 EU430481 
B. gibsoni NRCPD AB478326 
B. gibsoni Aomori AB118032 
B. gibsoni TWN1 EF587269 
B. gibsoni TWN2 EF587268 
B. gibsoni CMVL-01/2014 KY563118 
B. gibsoni CMVL Apr-13 KY524481 
B. gibsoni G135 LC169085 
B. gibsoni G112 LC169084 
B. gibsoni G111 LC169083 
B. gibsoni MB_P3 LC168621 
B. gibsoni MB_D2 LC168620 
B. gibsoni YGC17 LC012809 
B. gibsoni YGC15 LC012808 
B. gibsoni YGC14 LC012807 
B. gibsoni YGC11 LC012806 
B. gibsoni YGC10 LC012805 
B. gibsoni YGC8 LC012804 
B. gibsoni YGC7 LC012803 
B. gibsoni TKS20 LC012802 
B. gibsoni TKS5 LC012801 
B. gibsoni OSK7 LC012800 
B. gibsoni OSK3 LC012799 
B. gibsoni NGS6 LC012798 
B. gibsoni KUM4 LC012797 
B. gibsoni KUM3 LC012796 
B. gibsoni KUM2 LC012795 
B. gibsoni KGW18 LC012794 
B. gibsoni KGS4 LC012793 
B. gibsoni KGS1 LC012792 
B. gibsoni HNXY-2/2013 KJ715178 
B. gibsoni Nanjing1081 HG328237 
B. gibsoni Nanjing0010 HG328236 
B. gibsoni Nanjing0009 HG328235 
B. gibsoni SK-013 JX112784 
B. gibsoni Pig/J78 JX962780 
B. gibsoni Aydin JN562745 
B. gibsoni 11HS EU084680 
B. gibsoni NA EU084679 
B. gibsoni NA EU084678 
B. gibsoni WM-1 EU084677 
B. gibsoni Okinawa dog-15 AY077718 
B. bigemina Swiss_6 KM046917 
B. bigemina JRHC-1 JX974332 
B. bigemina Umiam KF112076 
B. bigemina Hs5 HQ688689 
B. bigemina Hs4 HQ688688 
B. bigemina Hs3 HQ688687 
B. bigemina Hs2 HQ688686 
B. bigemina Hs1 HQ688685 
B. bigemina Bab/Umi-H2/Ind KF606866 
B. bigemina Bab/Umi-Hi/12/Ind KF606865 
B. bigemina Bab/Umi-C2/12/Ind KF606864 
B. bigemina Bab/Umi-T2/10/Ind KF606863 
B. bigemina RG JQ437264 
B. bigemina Bond JQ437261 
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B. bigemina ZJK17 KP710228 
B. bigemina TS103 KP710227 
B. bigemina CZ52 KP710226 
B. bigemina TJ09 KP710225 
B. bigemina SJZ26 KP710224 
B. bigemina MT26 KU206297 
B. bigemina MT25 KU206296 
B. bigemina KT4 KU206295 
B. bigemina MT24 KU206294 
B. bigemina MT23 KU206293 
B. bigemina MT22 KU206292 
B. bigemina MT21 KU206291 
B. bigemina TB5 KX115425 
B. bigemina Trkene3yumurta KP745624 
B. bigemina Trkoz10 KP745623 
B. bigemina NA JQ723014 
B. bigemina biLushi JX495402 
B. bigemina PISJD34 JX104106 
B. bigemina 563 HQ840960 
B. bigemina 493 HQ840959 
B. bigemina B_bi19 EF458206 
B. bigemina B_bi18 EF458205 
B. bigemina B_bi17 EF458204 
B. bigemina B_bi16 EF458203 
B. bigemina B_bi14 EF458202 
B. bigemina B_bi12 EF458201 
B. bigemina B_bi11 EF458200 
B. bigemina B_bi10 EF458199 
B. bigemina B_bi09 EF458198 
B. bigemina B_bi08 EF458197 
B. bigemina B_bi07 EF458196 
B. bigemina B_bi06 EF458195 
B. bigemina B_bi05 EF458194 
B. bigemina B_bi04 EF458193 
B. bigemina B_bi03 EF458192 
B. bigemina B_bi02 EF458191 
B. bigemina B_bi01 EF458190 
B. bigemina BRC02 FJ426361 
B. bigemina Israel EF612434 
B. bigemina Spain_1 DQ785311 
B. microti US-Bm5 LC314658 
B. microti US-Bm4 LC314657 
B. microti US-Bm3 LC314656 
B. microti US-Bm2 LC314655 
B. microti US-Bm1 LC314654 
B. microti IpSG13-18-1 LC127372 
B. microti IpSG13-16-3 LC127371 
B. microti IpSG13-10-2 LC127370 
B. microti IpSG13-1-2 LC127369 



















B. microti Omsk-vole92_2013 KU955525 
B. microti Omsk-vole57_2013 KU955524 
B. microti Omsk-vole45_2013 KU955523 
B. microti Omsk-vole24_2013 KU955522 
B. microti BmSSR218-3 LC005772 
B. microti BmSSR218-2 LC005771 
B. microti BmSSR218-1 LC005770 
B. microti BmSSR209-3 LC005769 
B. microti BmSSR209-1 LC005768 
B. microti BmSSR206-3 LC005767 
B. microti BmSSR206-2 LC005766 
B. microti BmSSR206-1 LC005765 
B. microti BmSSR190-5 LC005764 
B. microti BmSSR190-4 LC005763 
B. microti BmSSR190-3 LC005762 
B. microti BmSSR170-3 LC005761 
B. microti BmSSR170-2 LC005760 
B. microti BmSSR170-1 LC005759 
B. microti BmSSR168-3 LC005758 
B. microti BmSSR168-1 LC005757 
B. microti BmSSR167-9 LC005756 
B. microti BmSSR167-3 LC005755 
B. microti BmSSR167-1 LC005754 
B. microti BmSSR161-2 LC005753 
B. microti BmSSR159-1 LC005752 
B. microti TC-2012-C1 KF410827 
B. microti TC-2012-B99 KF410826 
B. microti TC-2012-B87 KF410825 
B. microti TC-2012-B1 KF410824 
B. microti Omsk-vole110 KC581934 
B. microti Yunnan-2 KC147723 
B. microti Yunnan-1 KC147722 
B. microti Ubl-104 AY943958 
B. microti Sbl-11 AY943957 
B. microti Gray AY693840 
B. microti AF41002 AY918952 
B. microti AF2143 AY918951 
B. microti SN87-1 AY144702 
B. microti P8803 AY144701 
B. microti Rula AY144700 
B. microti MT006 AY144699 
B. microti S837 AY144698 
B. microti Naushon AY144697 
B. microti Nantucket AY144696 
B. microti Pl2845Ips AY144695 
B. microti Spooner AY144694 
B. microti Russia AY144693 
B. microti C5D182 AY144692 
B. microti VHSC1 AY144691 
B. microti GLS027Cg AY144690 
B. microti 400 AY144687 
B. microti NA AB219802 
B. microti MM-1 EU168705 
B. microti Jena/Germany EF413181 
B. microti NA AB197940 
B. microti NA AY094354 
B. microti Bm3 KX008036 
B. microti Bm2 KX008035 
B. microti Bm1 KX008034 
B. microti HLJ605 KU204798 
B. microti HLJ552 KU204797 
B. microti HLJ479 KU204796 
B. microti HLJ429 KU204795 
B. microti HLJ97 KU204794 
B. microti HLJ44 KU204793 
B. microti 4IV KT844560 
B. microti 3IV KT844559 
B. microti 2IV KT844558 
B. microti 1IV KT844557 
B. microti 5BA KT844556 
B. microti 4BA KT844555 
B. microti 3BA KT844554 
B. microti 2BA KT844553 
B. microti NA KT867773 
B. microti NA KT318132 
B. microti Irk-Ip332 KJ486556 
B. microti CNMM-2 AB736270 
B. microti CNMM-1 AB731747 
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B. microti Yunnan-3 KC147724 
B. microti Rat/6 JX962781 
B. microti Fox/J28 JX962779 
B. microti hlj72 JQ993429 
B. microti 449-L JQ609304 
B. microti JM1 AB576641 
B. microti Nov-Ip307 GU057383 
B. microti NA AY789075 
B. microti Kh-1026 GU057386 
B. microti Kh-Ip67 GU057384 
B. microti RI 
XR_00245
9986 
B. caballi B1_CABRBEQ179 EU642513 
B. caballi A_CABEQ30 EU642512 
B. caballi B1_CABRBEQ164 EU888904 
B. caballi CABEQ51_B1 EU888901 
B. caballi CABEQ50_B1 EU888900 
B. caballi B2_CABRBEQ115 EU642514 
B. caballi NA KJ549665 
B. caballi EqP-117 JX049130 
B. caballi NA MF384422 
B. caballi Jaboticabal KY952238 
B. caballi 142 KY952236 
B. caballi 157 KY952235 
B. caballi 151 KY952234 
B. caballi 143 KY952233 
B. caballi Bacab5 KX375825 
B. caballi Bacab1 KX375824 
B. caballi U244 AB734409 
B. caballi A134 AB734408 
B. caballi A135 AB734407 
B. caballi A139 AB734406 
B. caballi A195 AB734405 
B. caballi A161 AB734404 
B. caballi A188 AB734403 
B. caballi A142 AB734402 
B. caballi U237 AB734401 
B. caballi U243 AB734400 
B. caballi U244 AB734399 
B. caballi U232 AB734398 
B. caballi U231 AB734397 
B. caballi T23 AB734396 
B. caballi U240 AB734395 
B. caballi A214 AB734394 
B. caballi A158 AB734393 
B. caballi A123 AB734392 
B. caballi T103 AB734391 
B. caballi T90 AB734390 
B. caballi T64 AB734389 
B. caballi T48 AB734388 
B. caballi T16 AB734387 
B. caballi T4 AB734386 
B. caballi NA FJ209026 
B. caballi NA AY309955 
B. caballi EB1 AY534883 
B. caballi NA Z15104 
B. divergens NA AY144688 
B. divergens Spanish_2 MG944238 
B. divergens IpSG14-2-2 LC279018 
B. divergens IPSG13-13-1 AB975389 
B. divergens Trbrt35 KP745627 
B. divergens IpSG10 KC493555 
B. divergens C139 FJ944826 
B. divergens 1802A FJ944825 
B. divergens Bob2 FJ944824 
B. divergens CF2000 FJ944823 
B. divergens Rouen 87 FJ944822 
B. divergens B2 EU182595 
B. divergens B1 EU182594 
B. divergens HLJ216 KU377437 
B. divergens HLJ216 KU204799 
B. divergens R105 KM657258 
B. divergens Spanish KF533077 
B. divergens Aug-43 AB861507 
B. divergens Aug-40 AB861506 
B. divergens 18-Aug AB861505 
B. divergens 4-Aug AB861504 
B. divergens Aug-38 AB857846 
B. divergens Jul-33 AB857845 
B. divergens 25-Aug KC465974 
B. divergens 12-Jul KC465977 
B. divergens Aug-41 KC465976 
B. divergens 20-Jul KC465975 
B. divergens Aug-51 KC465973 
B. divergens RD54 JQ929916 
B. divergens CVD7 GQ304525 
B. divergens CVD2 GQ304524 
B. divergens Nov-Ip316 GU057385 
B. divergens NA AY789076 
B. divergens BAB105 AY046576 
B. divergens B_di09 EF458228 
B. divergens B_di10 EF458229 
B. divergens B_di08 EF458227 
B. divergens B_di07 EF458226 
B. divergens B_di06 EF458225 
B. divergens B_di05 EF458224 
B. divergens B_di04 EF458223 
B. divergens B_di03 EF458222 
B. divergens B_di02 EF458221 
B. divergens B_di01 EF458220 
B. divergens B_di11 EF458219 
B. divergens NA AY572456 
B. divergens NA AJ439713 
B. divergens NA U16370 
B. divergens NA Z48751 
B. bovis BRC01 FJ426364 
B. bovis Bareilly KF928959 
B. bovis BBOV2 L19077 
B. bovis BBOV3 L19078 
B. bovis USDA HQ264112 
B. bovis USDA HQ264111 
B. bovis H8 HQ264110 
B. bovis NR8 HQ264106 
B. bovis NR8 HQ264105 
B. bovis USDA GU906886 
B. bovis Merida GU906885 
B. bovis Merida GU906884 
B. bovis Merida GU906883 
B. bovis H81 JQ437262 
B. bovis 8284 JQ437260 
B. bovis ZJK15 KP710223 
B. bovis TS35 KP710222 
B. bovis Trbrt36 KP745628 
B. bovis NA JQ723013 
B. bovis boLushi JX495403 
B. bovis cow AY150059 
B. bovis B_bo18 EF458218 
B. bovis B_bo17 EF458217 
B. bovis B_bo16 EF458216 
B. bovis B_bo10 EF458215 
B. bovis B_bo09 EF458214 
B. bovis B_bo08 EF458213 
B. bovis B_bo07 EF458212 
B. bovis B_bo05 EF458211 
B. bovis B_bo03 EF458210 
B. bovis B_bo01 EF458209 
B. bovis B_bo19 EF458208 
B. conradae NA AF158702 
B. vulpes 1061L KJ871352 
B. vulpes 910L KJ871351 
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B. vulpes 03/00349 KT223483 
B. duncani BAB1615 HQ289870 
B. duncani Bdu KX008042 
B. duncani Bdi KX008037 
B. duncani BAB2 HQ285838 
Theileria 
(Babesia) equip RJ20 KJ573374 
Theileria 
(Babesia) equi RJ19 KJ573373 
Theileria 
(Babesia) equi RJ15 KJ573372 
Theileria 
(Babesia) equi RJ4 KJ573371 
Theileria 
(Babesia) equi RJ2 KJ573370 
Theileria 
(Babesia) equi B_LFEQ164 EU642511 
Theileria 
(Babesia) equi B_LFEQ47 EU642510 
Theileria 
(Babesia) equi B_RBEQ105 EU642509 
Theileria 
(Babesia) equi A1_RBEQ178 EU642508 
Theileria 
(Babesia) equi A2_RBEQ101 EU642507 
Theileria 
(Babesia) equi LFEQ23_A EU888906 
Theileria 
(Babesia) equi LFEQ178_C EU888905 
Theileria 
(Babesia) equi LFEQ189_C EU888903 
Theileria 
(Babesia) equi RBEQ63_A EU888902 
Theileria 
(Babesia) equi TE/18s/GUJ KP995259 
Theileria 
(Babesia) equi Te0022_CA JX177673 
Theileria 
(Babesia) equi Te0001_FL JX177672 
Theileria 
(Babesia) equi Te0002_TX JX177671 
Theileria 
(Babesia) equi Te0004_TX JX177670 
Theileria 
(Babesia) equi Ho233 JQ390047 
Theileria 
(Babesia) equi NA KF559357 
Theileria 
(Babesia) equi 203-7 JQ657703 
Theileria 
(Babesia) equi KNU HM229408 
Theileria 
(Babesia) equi KNU HM229407 
Theileria 
(Babesia) equi ET1 AY534882 
Theileria 
(Babesia) equi H16 KY111762 
Theileria 
(Babesia) equi H12 KY111761 
Theileria 
(Babesia) equi H01 KY111760 
Theileria 
(Babesia) equi RJ18 KX722525 
Theileria 
(Babesia) equi RJ3 KX722524 
Theileria 
(Babesia) equi RJ17 KX722523 
Theileria 
(Babesia) equi RJ16 KX722522 
Theileria 
(Babesia) equi RJ14 KX722521 
Theileria 
(Babesia) equi RJ13 KX722520 
Theileria 
(Babesia) equi RJ12 KX722519 
Theileria 
(Babesia) equi RJ11 KX722518 
Theileria 
(Babesia) equi RJ10 KX722517 
Theileria 
(Babesia) equi RJ9 KX722516 
Theileria 
(Babesia) equi RJ8 KX722515 
Theileria 
(Babesia) equi RJ7 KX722514 
Theileria 
(Babesia) equi RJ6 KX722513 
Theileria 
(Babesia) equi RJ5 KX722512 
Theileria 
(Babesia) equi RJ1 KX722511 
Theileria 
(Babesia) equi A11N KX227641 
Theileria 
(Babesia) equi 156N KX227640 
Theileria 
(Babesia) equi 347C KX227639 
Theileria 
(Babesia) equi B1 KX227638 
Theileria 
(Babesia) equi 3011C KX227637 
Theileria 
(Babesia) equi U4S KX227636 
Theileria 
(Babesia) equi U2S KX227635 
Theileria 
(Babesia) equi T1N KX227634 
Theileria 
(Babesia) equi PA20 KX227633 
Theileria 
(Babesia) equi PA13 KX227632 
Theileria 
(Babesia) equi PA46 KX227631 
Theileria 
(Babesia) equi O5S KX227630 
Theileria 
(Babesia) equi O2S KX227629 
Theileria 
(Babesia) equi G6 KX227628 
Theileria 
(Babesia) equi F14C KX227627 
Theileria 
(Babesia) equi E37C KX227626 
Theileria 
(Babesia) equi 5512N KX227625 
Theileria 
(Babesia) equi 177S KX227624 
Theileria 
(Babesia) equi 101J KX227623 
Theileria 
(Babesia) equi PA21 KX227622 
Theileria 
(Babesia) equi 20J KX227621 
Theileria 
(Babesia) equi 9C KX227620 
Theileria 
(Babesia) equi 459N KX227619 
Theileria 




(Babesia) equi Swiss-5 KM046922 
Theileria 
(Babesia) equi Swiss-4 KM046921 
Theileria 
(Babesia) equi Swiss-3 KM046920 
Theileria 
(Babesia) equi Swiss-2 KM046919 
Theileria 
(Babesia) equi Swiss-1 KM046918 
Theileria 
(Babesia) equi JJ42 KM819520 
Theileria 
(Babesia) equi El Obied46 AB515315 
Theileria 
(Babesia) equi Kosti5 AB515314 
Theileria 
(Babesia) equi Omdurman2 AB515313 
Theileria 
(Babesia) equi Khartoum North15 AB515312 
Theileria 
(Babesia) equi Atbara13 AB515311 
Theileria 
(Babesia) equi Atbara8 AB515310 
Theileria 
(Babesia) equi Atbara5 AB515309 
Theileria 
(Babesia) equi Atbara2 AB515308 
Theileria 
(Babesia) equi Atbara1 AB515307 
Theileria 
(Babesia) equi T42 AB733379 
Theileria 
(Babesia) equi T10 AB733378 
Theileria 
(Babesia) equi U225 AB733377 
Theileria 
(Babesia) equi T95 AB733376 
Theileria 
(Babesia) equi A200 AB733375 
Theileria 
(Babesia) equi T8 AB733374 
Theileria 
(Babesia) equi A129 AB733373 
Theileria 
(Babesia) equi A128 AB733372 
Theileria 
(Babesia) equi dog AY150064 
Theileria 
(Babesia) equi Spain-2 AY150063 
Theileria 
(Babesia) equi Spain-1 AY150062 
Theileria 
(Babesia) equi Spain-3 DQ287951 
Theileria 
(Babesia) equi NA Z15105 
Cytauxzoon felis NA L19080 
Cytauxzoon felis 309 KU306948 
Cytauxzoon felis 307 KU306947 
Cytauxzoon felis 303 KU306946 
Cytauxzoon felis 53aug KU306945 
Cytauxzoon felis 26-Aug KU306944 
Cytauxzoon felis 20-Aug KU306943 
Cytauxzoon felis 18-Aug KU306942 
Cytauxzoon felis 13-Aug KU306941 
Cytauxzoon felis 7-Oct KU306940 
Cytauxzoon felis NA AF399930 
Cytauxzoon felis NA GU903911 
3. GenBank® accession codes for the bipA gene sequences of Borrelia species. Sequences utilized for in 
silico analysis in Appendix B are emphasized in bold. 
 
Borrelia Species Isolate/Strain GenBank 
B. turicatae FCB-1 C845531 
B. turicatae NA GU270942 
B. turicatae 91E135 HM008710 
B. turicatae 95PE570 KC845528 
B. turicatae TCB-2 KC845530 
B. turicatae 95PE1807 KC845527 
B. turicatae BTE5EL CP015630 
B. turicatae TCB-1 KC845529 
B. parkeri HR1 CP007036 
B. hermsii SWA GQ869822 
B. hermsii SIS GQ869821 
B. hermsii RUM GQ869820 
B. hermsii REN GQ869819 
B. hermsii RAL GQ869818 
B. hermsii OKA-3 GQ869817 
B. hermsii OKA-2 GQ869816 
B. hermsii OKA-1 GQ869815 
B. hermsii MTW-4 GQ869814 
B. hermsii MTW-3 GQ869813 
B. hermsii MTW-2 GQ869812 
B. hermsii MIL GQ869811 
B. hermsii MCN GQ869810 
B. hermsii MAT GQ869809 
B. hermsii Man GQ869808 
B. hermsii LAK-5 GQ869807 
B. hermsii LAK-4 GQ869806 
B. hermsii LAK-3 GQ869805 
B. hermsii LAK-2 GQ869804 
B. hermsii LAK-1 GQ869803 
B. hermsii HS1 GQ869802 
B. hermsii HAN GQ869801 
B. hermsii HAL GQ869800 
B. hermsii GMC GQ869799 
B. hermsii GAR GQ869798 
B. hermsii FRS GQ869797 
B. hermsii FRO GQ869796 
B. hermsii FRE GQ869795 
B. hermsii EST GQ869794 
B. hermsii CON GQ869792 
B. hermsii CMC GQ869791 
B. hermsii CAR GQ869790 
B. hermsii BYM GQ869789 
B. hermsii BRO GQ869788 
B. hermsii BAK GQ869787 
B. hermsii ALL GQ869786 
B. hermsii YOR GQ869824 
B. hermsii DAH GQ869793 
B. hermsii DAH FJ446703 






4. GenBank® accession codes for the flaB gene sequences of Borrelia species. Sequences utilized for in 
silico analysis in Appendix B are emphasized in bold. 
 
Borrelia Species Isolate/Strain GenBank 
B. turicatae FCB AY934630 
B. turicatae TCB-2 AY934629 
B. turicatae TCB-1 AY934628 
B. turicatae PE1-926 AY934627 
B. turicatae 99PE-1807 AY934626 
B. turicatae 95PE-570 AY934625 
B. turicatae 91E135 AY934624 
B. turicatae 91E135 AY604979 
B. turicatae 91E135 NC_008710 
B. parkeri CA221 AY934623 
B. parkeri CA220 AY934622 
B. parkeri CA219 AY934621 
B. parkeri CA218 AY934620 
B. parkeri CA216 AY934619 
B. parkeri RML AY604980 
B. parkeri HR1 CP007022 
B. parkeri SLO NZ_CP005851 
B. miyamotoi HoHe KT932823 
B. miyamotoi ARH554 KT452933 
B. miyamotoi ARH624 KT452932 
B. miyamotoi ARH615 KT452930 
B. miyamotoi ARH657 KT452931 
B. miyamotoi CT13-2396 CP017126 
B. miyamotoi ARH656 KT452934 
B. miyamotoi Izh-16 CP024351 
B. miyamotoi Izh-4 CP024390 
B. miyamotoi Yekat-6 CP024316 
B. miyamotoi Izh-5 CP024205 
B. miyamotoi Izh-14 CP024371 
B. miyamotoi Yekat-1 CP024333 
B. miyamotoi FR64b CP004217 
B. miyamotoi CA17-2241 CP021872 
B. miyamotoi 13T392 KU749379 
B. miyamotoi 15H532 KU749378 
B. coriaceae NA DQ320140 




B. anserina Es CP013704 
B. anserina PL DQ849626 
B. anserina BA2 CP005829 
B. crocidurae DOS-27 JX292911 
B. crocidurae DOU-1b JX292912 
B. crocidurae DOU-686 JX292913 
B. crocidurae DOU-690 JX292914 
B. crocidurae DOU JX292915 
B. crocidurae DOS-2 JX292916 
B. crocidurae DOS-3 JX292917 
B. crocidurae DOS-6 JX292919 
B. crocidurae DOS-5 JX292918 
B. crocidurae DOS-7 JX292920 
B. crocidurae DOS-13 JX292921 
B. crocidurae DOS-16 JX292922 
B. crocidurae Achema GU357619 
B. crocidurae DOS-56 JX292925 
B. crocidurae KOS-46 JX292924 
B. crocidurae KOS-39 JX292923 
B. crocidurae Achema CP003426 
B. recurrentis A1 DQ346814 
B. recurrentis 107 AY604982 
B. recurrentis A2 DQ346815 
B. recurrentis A3 DQ346816 
B. recurrentis A4 DQ346817 
B. recurrentis A6 DQ346819 
B. recurrentis A5 DQ346818 
B. recurrentis A18 DQ346831 
B. recurrentis A17 DQ346830 
B. recurrentis A16 DQ346829 
B. recurrentis A15 DQ346828 
B. recurrentis A14 DQ346827 
B. recurrentis A13 DQ346826 
B. recurrentis A12 DQ346825 
B. recurrentis A11 DQ346824 
B. recurrentis A10 DQ346823 
B. recurrentis A9 DQ346822 
B. recurrentis A8 DQ346821 
B. recurrentis A7 DQ346820 
B. recurrentis A1 CP000993 
B. burgdorferi DG1-04 DQ016625 
B. burgdorferi GL56-07 HM345910 
B. burgdorferi D69-04 DQ016620 
B. burgdorferi T90-5-02 HM345911 
B. burgdorferi Bb_V2 MF150052 
B. burgdorferi Bb_V3 MF150053 
B. burgdorferi Bb_V6 MF150055 
B. burgdorferi Bb_V5 MF150054 
B. burgdorferi Bb_V7 MF150056 
B. burgdorferi Tr293 AB091813 
B. burgdorferi NA AB189460 
B. burgdorferi CA8 GQ247741 
B. burgdorferi B331 CP017201 
B. burgdorferi Pabe CP019916 
B. burgdorferi Pali CP019844 
B. burgdorferi B31-5A1 CP009656 
B. burgdorferi CA382 CP005925 
B. burgdorferi N40 CP002228 
B. burgdorferi JD1 CP002312 
B. burgdorferi ZS7 CP001205 
B. burgdorferi B31 AE000783 
B. afzelii A1_Aag_Waw KY626318 
B. afzelii A1_Afl_Waw KY626319 
B. afzelii B1_Aag_Waw KY626320 
B. afzelii B2_Aag_Waw KY626321 
B. afzelii B3_Aag_Waw KY626322 
B. afzelii B4_Aag_Waw KY626323 
B. afzelii B5_Aag_Waw KY626324 
B. afzelii B6_Afl_Waw KY626325 
B. afzelii Ba_V1a MF150047 
B. afzelii Ba_V1b MF150048 
B. afzelii Ba_V2cc MF150049 
B. afzelii Ba_v2ct MF150050 
B. afzelii Ba_V2tc MF150051 
B. afzelii NA AB236667 
B. afzelii Tr38 AB091806 
B. afzelii Tr96 AB091808 
B. afzelii NA AB189459 
B. afzelii DB19N7-04 GQ918147 
B. afzelii 41-M-11 KF894063 
B. afzelii 9W10-04 FJ874924 
B. afzelii Mr11 AB178334 
B. afzelii Mp6 AB178335 
B. afzelii 29-MD-11 KF894069 
B. afzelii 21-O-12 KF894067 
B. afzelii 25-M-11 KF894068 
B. afzelii 14-MD-12 KF894066 
B. afzelii 9-S-11 KF894065 
B. afzelii 80-M-11 KF894064 
B. afzelii CFC8E AB178780 
B. afzelii Mp4 AB178779 
B. afzelii 51-S-12 KF894070 
B. afzelii OS17-07 HM345909 
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B. afzelii ST19-05 HM345908 
B. afzelii ZL109-07 HM345907 
B. afzelii BO23 CP018262 
B. afzelii K78 CP009058 
B. afzelii Tom3107 CP009212 
B. afzelii HLJ01 CP003882 
B. afzelii Pko CP002933 
B. afzelii Pko CP000395 
B. garinii D106-04 DQ016621 
B. garinii D7-04 DQ016622 
B. garinii DB1F7-04 DQ650331 
B. garinii DB18N6-04 DQ650333 
B. garinii T32-5-05 DQ650336 
B. garinii PB35-99 HM345897 
B. garinii DB74-01 HM345898 
B. garinii T40-10-02 HM345902 
B. garinii T53-9-02 HM345901 
B. garinii ZL148-07 HM345900 
B. garinii DB60-01 HM345899 
B. garinii RP54-05 HM345906 
B. garinii ST12-05 HM345905 
B. garinii T44-4-02 HM345904 
B. garinii T41-2-02 HM345903 
B. garinii Bg_vA MF150057 
B. garinii Bg_vAa MF150058 
B. garinii Bg_vC MF150062 
B. garinii Bg_vBb MF150061 
B. garinii Bg_vBa MF150060 
B. garinii Bg_vB MF150059 
B. garinii Bg_vDf MF150069 
B. garinii Bg_vDe MF150068 
B. garinii Bg_vDd MF150067 
B. garinii Bg_vDc MF150066 
B. garinii Bg_vDb MF150065 
B. garinii Bg_vDa MF150064 
B. garinii Bg_vCa MF150063 
B. garinii Bg_vEa MF150070 
B. garinii Bg_vEb MF150071 
B. garinii Bg_vEc MF150072 
B. garinii Bg_vEd MF150073 
B. garinii Bg_vEf MF150074 
B. garinii Tr77 AB091807 
B. garinii Tr309 AB091814 
B. garinii Mr8 AB178325 
B. garinii Mr3 AB178326 
B. garinii Mr10 AB178327 
B. garinii Nr267 AB178328 
B. garinii Mp5 AB178329 
B. garinii Mr12 AB178330 
B. garinii 23-M-11 KF894053 
B. garinii 39-M-11 KF894052 
B. garinii Mp7 AB178332 
B. garinii 61-M-11 KF894058 
B. garinii 56-M-11 KF894057 
B. garinii 67-S-12 KF894056 
B. garinii 66-S-12 KF894055 
B. garinii 60-S-12 KF894054 
B. garinii 77-M-11 KF894061 
B. garinii 58-M-11 KF894060 
B. garinii 55-M-11 KF894059 
B. garinii Nsk-10-06 EU979630 
B. garinii SZ CP007564 
B. hermsii GGI LAK-4 DQ855533 
B. hermsii GGI ELD DQ855531 
B. hermsii GGI HS1 EF583449 
B. hermsii GGI HS1 GU357620 
B. hermsii GGI WAD AY597794 
B. hermsii GGI MAN AY597793 
B. hermsii GGI ALL AY597791 
B. hermsii GGI GAR AY597790 
B. hermsii GGI FR0 AY597789 
B. hermsii GGI SIS AY597788 
B. hermsii GGI RAL AY597787 
B. hermsii GGI BAK AY597786 
B. hermsii GGI BYM AY597785 
B. hermsii GGI CAR AY597784 
B. hermsii GGI SWA AY597783 
B. hermsii GGI FRE AY597782 
B. hermsii GGI C0N AY597781 
B. hermsii GGI HAL AY597780 
B. hermsii GGI BR0 AY597779 
B. hermsii GGI DAH AY597777 
B. hermsii GGI HS1 CP014349 
B. hermsii GGI MIT-24 KX171817 
B. hermsii GGI YBT-21 KX171812 
B. hermsii GGI YBT-12 KX171807 
B. hermsii GGI YBT-7 KX171805 
B. hermsii GGI YBS-1171 KX171804 
B. hermsii GGI WHT-8 KX171798 
B. hermsii GGI DM-31 KX171797 
B. hermsii GGI WHS-90 KX171796 
B. hermsii GGI LAK-6 KX171792 
B. hermsii GGI WAR KC883464 
B. hermsii GGI CC1 JF737019 
B. hermsii GGI EST AY597792 
B. hermsii GGI OWL GQ175063 
B. hermsii GGI YB-Th-60 GQ175059 
B. hermsii GGI HCT-4 KJ995789 
B. hermsii GGI COR KJ995774 
B. hermsii GGI DAH 2E7 CP014808 
B. hermsii GGII LAK-5 DQ855534 
B. hermsii GGII LAK-3 DQ855532 
B. hermsii GGII REN AY597805 
B. hermsii GGII OKA-3 AY597804 
B. hermsii GGII OKA-2 AY597803 
B. hermsii GGII OKA-1 AY597802 
B. hermsii GGII HAN AY597801 
B. hermsii GGII SIL AY597800 
B. hermsii GGII LAK-2 AY597799 
B. hermsii GGII LAK-1 AY597798 
B. hermsii GGII RUM AY597797 
B. hermsii GGII GMC AY597796 
B. hermsii GGII CMC AY597795 
B. hermsii GGII YOR AY597806 
B. hermsii GGII MAT DQ855535 
B. hermsii GGII MIL AY597778 
B. hermsii GGII YBS-60 KX171799 
B. hermsii GGII MIT-27 KX171816 
B. hermsii GGII MIT-26 KX171815 
B. hermsii GGII MIS-491 KX171814 
B. hermsii GGII MIS-1014 KX171813 
B. hermsii GGII YBT-20 KX171811 
B. hermsii GGII YBT-18 KX171810 
B. hermsii GGII YBT-17 KX171809 
B. hermsii GGII YBT-13 KX171808 
B. hermsii GGII YBT-10 KX171806 
B. hermsii GGII YBS-1143 KX171803 
B. hermsii GGII YBS-479 KX171802 
B. hermsii GGII YBS-266 KX171801 
B. hermsii GGII YBS-70 KX171800 
B. hermsii GGII WHS-88 KX171795 
B. hermsii GGII WHS-81 KX171794 
B. hermsii GGII WHS-40 KX171793 
B. hermsii GGII WCB-1 KC883463 
B. hermsii GGII LP0 EF595741 
B. hermsii GGII MTW-2 EU194843 
B. hermsii GGII MTW-1 EU194839 
B. hermsii GGII COT-7 KJ995784 
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5. GenBank® accession codes for the msp2 gene sequences of Anaplasma phagocytophilum. Sequences 
utilized for in silico analysis in Appendix B are emphasized in bold. 
 
Anaplasma Species Isolate/Strain GenBank 
A. phagocytophilum HZ CP000235 
A. phagocytophilum AP-V1 AY780258 
A. phagocytophilum LL AY568558 
A. phagocytophilum MRK AY568557 
A. phagocytophilum NY-31 AY541007 
A. phagocytophilum NY-36 AY541006 
A. phagocytophilum NY-37 AY541005 
A. phagocytophilum OS AY541004 
A. phagocytophilum Trustom AY541003 
A. phagocytophilum AVK-HLPA1 AY541002 
A. phagocytophilum Gaillard AY541001 
A. phagocytophilum MN-2 AY541000 
A. phagocytophilum MN-9 AY540999 
A. phagocytophilum S1025/09 JF893912 
A. phagocytophilum S2630/07 JF893911 
A. phagocytophilum S2614/07 JF893910 
A. phagocytophilum S1829/04 JF893909 
A. phagocytophilum S1741/07 JF893908 
A. phagocytophilum S1729/08 JF893907 
A. phagocytophilum S1523/07 JF893906 
A. phagocytophilum S1379/06 JF893905 
A. phagocytophilum S1220/08 JF893904 
A. phagocytophilum S1201/05 JF893903 
A. phagocytophilum S1085/09 JF893902 
A. phagocytophilum S1074/09 JF893901 
A. phagocytophilum S1071/08 JF893900 
A. phagocytophilum S654/04 JF893899 
A. phagocytophilum Cc20 FJ812387 
A. phagocytophilum Ce9 FJ812384 
A. phagocytophilum NY18 AY164513 
A. phagocytophilum 6497 JN656334 
A. phagocytophilum 9774 JN656332 
A. phagocytophilum 630300 JN656333 
A. phagocytophilum 8776 JN656331 
A. phagocytophilum 232 JN656330 
A. phagocytophilum 15526 JN656329 
A. phagocytophilum 6385 JN656328 
A. phagocytophilum S2872/07 JN656327 
A. phagocytophilum 2838 JN656326 
A. phagocytophilum S1710/05 JN656325 
A. phagocytophilum 8340 JN656324 
A. phagocytophilum 14524 JN656323 
A. phagocytophilum 50 JN656319 
A. phagocytophilum 6380 JN656318 
A. phagocytophilum 633200 JN656317 
A. phagocytophilum KD JN656316 
A. phagocytophilum 4 JN656315 
A. phagocytophilum 67 JN656314 
A. phagocytophilum 1219 JN656313 
A. phagocytophilum 614 JN656312 
A. phagocytophilum 14908 JN656310 
A. phagocytophilum 20684 JN656311 
A. phagocytophilum 3547 JN656309 
A. phagocytophilum 754 JN656308 
A. phagocytophilum 7444 JN656307 
A. phagocytophilum 8074 JN656306 
A. phagocytophilum 29W JN656304 
A. phagocytophilum 20489 JN656305 
A. phagocytophilum S2070/03 JN656303 
A. phagocytophilum 152595 JN656302 
A. phagocytophilum 680200 JN656301 
A. phagocytophilum 44 JN656300 
A. phagocytophilum 19555 JN656299 
A. phagocytophilum 9698 JN656298 
A. phagocytophilum 14888 JN656297 
A. phagocytophilum R1592 JN244019 
A. phagocytophilum ovine 5 AY706393 
A. phagocytophilum Elsa AY706392 
A. phagocytophilum JM CP006617 







1. Singleplex in silico specificity analysis depicted by oligonucleotide alignments for the forward primer, 
reverse primer, and probe sequences of (A) B. burgdorferi, (B) B. hermsii, (C) B. parkeri, (D) B. turicatae, 
(E) E. ewingii, (F) E. chaffeensis, (G) E. canis, (H) A. phagocytophilum, (I) R. rickettsii, and (J) pan-Babesia 
assays in 5’ to 3’ orientation. Assays were evaluated for analytical specificity against representative closely 
related species as indicated in S5-S10. Respective primers and probes used for analysis are highlighted in 
grey. The sequences for other species are only shown when they differ from respective species sequences. A 
dot indicates identity with the respective species sequence. Dashes in (A)-(C), (E)-(G) and (J) refer to an 
in/del, dashes in (D), (H) and (I) refer to absence of gene sequences. The second column indicates specificity 
in qualitative results (positive or negative). An asterisk represents hypothetical analysis based on NCBI 





























1. Limit of detection analysis of the Borrelia species assays. Quantification cycle (Cq) values reported in 







B. hermsii B. burgdorferi B. parkeri B. turicatae 
Cq  Cq  Cq  Cq  
1 75.91 1.27E+11 NA NA NA NA 
1.00E-06 7.59E-05 127200 21.3 21.3 22.4 21.4 
1.00E-07 7.59E-06 12720 24.6 24.6 25.8 24.9 
1.00E-08 7.59E-07 1272 27.8 27.8 29.0 28.1 
1.00E-09 7.59E-08 127 30.9 30.9 32.4 31.5 
1.00E-10 7.59E-09 13 33.9 35.3 36.3 35.0 
5.00E-11 3.80E-09 6 36.1 36.0 36.5 36.7 
2.50E-11 1.90E-09 3 36.8 36.4 37.7 35.6 
 
2. Limit of detection analysis of the Ehrlichia, Anaplasma, and Rickettsia species assays. Quantification 
cycle (Cq) values reported in mean from duplicate testing. Plasmid DNA concentrations not tested are 
represented by NA. 
 
 
3. Limit of detection analysis of the Babesia species assays. Quantification cycle (Cq) values reported in 









1 75.91 1.27E+11 NA 
1.00E-06 7.59E-05 127,200 21.8 
1.00E-07 7.59E-06 12,720 24.6 
1.00E-08 7.59E-07 1,272 28.0 
1.00E-09 7.59E-08 127 32.0 
2.50E-10 1.90E-08 32 34.2 
1.25E-10 9.49E-09 16 35.6 
 
4. Limit of detection analysis of the Borrelial, Rickettsial, and Babesial layers evaluated in layerplex format. 
Quantification cycle (Cq) values reported in mean from duplicate testing. Plasmid DNA concentrations not 







Borrelial  Rickettsial  Babesial  
Cq  Cq  Cq  
1 75.91 1.27E+11 NA NA NA 
1.00E-06 7.59E-05 127,200 23.2 23.0 22.1 
1.00E-07 7.59E-06 12,720 26.0 25.7 24.8 
1.00E-08 7.59E-07 1,272 29.1 29.0 28.1 
1.00E-09 7.59E-08 127 32.8 32.5 31.5 
2.50E-10 1.90E-08 32 34.6 34.4 33.5 







E. canis E. chaffeensis E. ewingii A. phagocytophilum R. rickettsii 
Cq  Cq  Cq  Cq  Cq  
1 75.91 1.27E+11 NA NA NA NA NA 
1.00E-06 7.59E-05 127,200 22.1 23.6 23.2 21.8 22.1 
1.00E-07 7.59E-06 12,720 25.4 27.1 26.6 25.2 25.5 
1.00E-08 7.59E-07 1,272 28.5 30.3 30.1 28.3 28.8 
1.00E-09 7.59E-08 127 31.9 34.0 33.7 31.9 32.2 
2.50E-10 1.90E-08 32 34.8 36.5 35.8 34.7 33.7 





1.  Paired t-test statistical analysis of Borrelia species with singleplex (SP) and Layerplex (LP) qPCR testing. 
Mean values reported as quantification cycles (Cq) from triplicate testing.  
 
 B. hermsii B. turicatae B. parkeri B. burgdorferi 
SP LP SP LP SP LP SP LP 
Mean 26.040 27.306 23.550 25.713 26.018 25.912 25.061 25.297 
Variance 1.133 0.254 0.245 0.191 0.014 0.014 0.003 0.014 
Observations 3 3 3 3 3 3 3 3 
P(T≤) two-tail 0.068 0.723 0.423 0.125 
 
2.  Paired t-test statistical analysis of Ehrlichia, Anaplasma, and Rickettsia species with singleplex (SP) and 
layerplex (LP) qPCR testing. Mean values reported as quantification cycles (Cq) from triplicate testing.  
 
 E. canis E. chaffeensis E. ewingii A. phagocytophilum R. rickettsii 
SP LP SP LP SP LP SP LP SP LP 
Mean 25.434 25.253 25.429 25.475 25.387 25.280 25.906 25.894 25.302 25.394 
Variance 0.017 0.032 0.011 0.005 0.005 0.003 0.280 0.091 0.001 0.017 
Observations 3 3 3 3 3 3 3 3 3 3 
P(T≤) two-tail 0.252 0.207 0.146 0.941 0.272 
 
3.  Paired t-test statistical analysis of Babesia species with singleplex (SP) and layerplex (LP) qPCR testing. 
Mean values reported as quantification cycles (Cq) from triplicate testing.  
 
 Babesia spp. 
SP LP 
Mean 25.196 25.126 
Variance 0.001 0.001 
Observations 3 3 
P(T≤) two-tail 0.135 
 
4.  Paired t-test statistical analysis of the canine specific endogenous internal positive control (EIPC-K9) with 
singleplex (SP) and layerplex (LP) qPCR testing. Mean values reported as quantification cycles (Cq) from 




Mean 25.673 25.175 
Variance 0.026 0.166 
Observations 3 3 






1. GenBank accession codes for the 16S rRNA gene sequences of Anaplasma.  
 
GenBank Sample County 
MH620179 23-33TX Wilbarger 
MH620180 22-07TX Burnet 
 
2. GenBank accession codes for the 16S rRNA gene sequences of Ehrlichia canis.  
 
GenBank Sample County 
MH620182 18-75TX  Potter 
MH620183 19-12TX  Potter 
MH620184 23-72TX  Armstrong 
MH620185 25-20TX  Wilbarger 
MH620186 25-47TX  Armstrong 
MH620187 21-77TX  Tarrant 
MH620188 18-58TX  Nueces 
MH620189 24-55TX  Nueces 
MH620190 24-68TX  Nueces 
MH620191 22-07TX  Burnet 
MH620192 22-58TX  Midland 
MH620193 25-55TX  Nacogdoches 
MH620194 26-10TX  Schleicher 
MH620195 18-43TX  El Paso 
MH620196 22-16TX  Maverick 
MH620197 25-74TX  Cameron 
MH620198 21-36TX Karnes 
MH620199 23-33TX  Wilbarger 
MH620200 25-24TX Lubbock 
 
3. GenBank accession codes for the 16S rRNA-23S rRNA IGS sequences of Borrelia turicatae.  
 
GenBank Sample County 
MH620360 23-25TX Randall 
MH620361 05-07TX Coryell 
MH620362 14-46TX Gillespie 
MH620363 09-77TX Coryell 
MH620364 22-43TX Armstrong 
MH620365 24-24TX DeWitt 
MH620366 24-25TX Caldwell 
MH620367 25-25TX Gonzales 
 
4. GenBank accession codes for the 18S rRNA gene sequences of Babesia gibsoni.  
 
GenBank Sample County 
MH620201 04-49TX Burnet 
MH620202 04-50TX Burnet 
MH620203 20-58TX Harris 
MH620204 27-23TX Panola 
MH620205 27-32TX Hidalgo 
 
